<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for IUP 1489395374806 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.broadinstitute.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN'>STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN</a></td><td><a href='STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN.html'>Details ...</a></td><td>31</td><td>0.66</td><td>2.06</td><td>0.000</td><td>0.018</td><td>0.020</td><td>1240</td><td>tags=42%, list=11%, signal=47%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP'>SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP</a></td><td><a href='SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP.html'>Details ...</a></td><td>40</td><td>0.55</td><td>1.98</td><td>0.000</td><td>0.093</td><td>0.160</td><td>542</td><td>tags=30%, list=5%, signal=31%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KRASNOSELSKAYA_ILF3_TARGETS_UP'>KRASNOSELSKAYA_ILF3_TARGETS_UP</a></td><td><a href='KRASNOSELSKAYA_ILF3_TARGETS_UP.html'>Details ...</a></td><td>18</td><td>0.74</td><td>1.96</td><td>0.000</td><td>0.071</td><td>0.170</td><td>775</td><td>tags=56%, list=7%, signal=60%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HECKER_IFNB1_TARGETS'>HECKER_IFNB1_TARGETS</a></td><td><a href='HECKER_IFNB1_TARGETS.html'>Details ...</a></td><td>46</td><td>0.74</td><td>1.93</td><td>0.000</td><td>0.107</td><td>0.290</td><td>1660</td><td>tags=61%, list=15%, signal=72%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/RADAEVA_RESPONSE_TO_IFNA1_UP'>RADAEVA_RESPONSE_TO_IFNA1_UP</a></td><td><a href='RADAEVA_RESPONSE_TO_IFNA1_UP.html'>Details ...</a></td><td>28</td><td>0.59</td><td>1.93</td><td>0.000</td><td>0.085</td><td>0.290</td><td>943</td><td>tags=32%, list=9%, signal=35%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_PDE3B_TARGETS'>GAVIN_PDE3B_TARGETS</a></td><td><a href='GAVIN_PDE3B_TARGETS.html'>Details ...</a></td><td>18</td><td>0.73</td><td>1.90</td><td>0.000</td><td>0.103</td><td>0.370</td><td>1939</td><td>tags=61%, list=18%, signal=74%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/DAUER_STAT3_TARGETS_DN'>DAUER_STAT3_TARGETS_DN</a></td><td><a href='DAUER_STAT3_TARGETS_DN.html'>Details ...</a></td><td>30</td><td>0.69</td><td>1.90</td><td>0.000</td><td>0.095</td><td>0.390</td><td>1014</td><td>tags=47%, list=9%, signal=51%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP'>CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP</a></td><td><a href='CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP.html'>Details ...</a></td><td>51</td><td>0.55</td><td>1.90</td><td>0.000</td><td>0.083</td><td>0.390</td><td>1773</td><td>tags=43%, list=16%, signal=51%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LINDVALL_IMMORTALIZED_BY_TERT_DN'>LINDVALL_IMMORTALIZED_BY_TERT_DN</a></td><td><a href='LINDVALL_IMMORTALIZED_BY_TERT_DN.html'>Details ...</a></td><td>41</td><td>0.55</td><td>1.90</td><td>0.000</td><td>0.074</td><td>0.390</td><td>1936</td><td>tags=46%, list=18%, signal=56%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/GERHOLD_ADIPOGENESIS_UP'>GERHOLD_ADIPOGENESIS_UP</a></td><td><a href='GERHOLD_ADIPOGENESIS_UP.html'>Details ...</a></td><td>20</td><td>0.60</td><td>1.89</td><td>0.000</td><td>0.068</td><td>0.400</td><td>1952</td><td>tags=50%, list=18%, signal=61%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE'>BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE</a></td><td><a href='BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE.html'>Details ...</a></td><td>43</td><td>0.63</td><td>1.89</td><td>0.000</td><td>0.062</td><td>0.400</td><td>2061</td><td>tags=56%, list=19%, signal=69%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SANA_TNF_SIGNALING_DN'>SANA_TNF_SIGNALING_DN</a></td><td><a href='SANA_TNF_SIGNALING_DN.html'>Details ...</a></td><td>45</td><td>0.55</td><td>1.89</td><td>0.000</td><td>0.063</td><td>0.460</td><td>2430</td><td>tags=56%, list=22%, signal=71%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RESPONSE_TO_BEXAROTENE_DN'>WANG_RESPONSE_TO_BEXAROTENE_DN</a></td><td><a href='WANG_RESPONSE_TO_BEXAROTENE_DN.html'>Details ...</a></td><td>22</td><td>0.66</td><td>1.88</td><td>0.000</td><td>0.062</td><td>0.470</td><td>1720</td><td>tags=55%, list=16%, signal=65%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MARKEY_RB1_CHRONIC_LOF_DN'>MARKEY_RB1_CHRONIC_LOF_DN</a></td><td><a href='MARKEY_RB1_CHRONIC_LOF_DN.html'>Details ...</a></td><td>60</td><td>0.58</td><td>1.88</td><td>0.000</td><td>0.068</td><td>0.520</td><td>1539</td><td>tags=47%, list=14%, signal=54%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_INTERFERON_RESPONSIVE_GENES'>BROWNE_INTERFERON_RESPONSIVE_GENES</a></td><td><a href='BROWNE_INTERFERON_RESPONSIVE_GENES.html'>Details ...</a></td><td>28</td><td>0.70</td><td>1.86</td><td>0.000</td><td>0.076</td><td>0.580</td><td>1312</td><td>tags=54%, list=12%, signal=61%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP'>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP</a></td><td><a href='TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP.html'>Details ...</a></td><td>81</td><td>0.47</td><td>1.86</td><td>0.000</td><td>0.072</td><td>0.580</td><td>768</td><td>tags=26%, list=7%, signal=28%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_CIPROFIBRATE_UP'>LEE_LIVER_CANCER_CIPROFIBRATE_UP</a></td><td><a href='LEE_LIVER_CANCER_CIPROFIBRATE_UP.html'>Details ...</a></td><td>31</td><td>0.54</td><td>1.84</td><td>0.000</td><td>0.084</td><td>0.630</td><td>1565</td><td>tags=35%, list=14%, signal=41%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G2'>BOYAULT_LIVER_CANCER_SUBCLASS_G2</a></td><td><a href='BOYAULT_LIVER_CANCER_SUBCLASS_G2.html'>Details ...</a></td><td>16</td><td>0.63</td><td>1.84</td><td>0.000</td><td>0.084</td><td>0.640</td><td>1860</td><td>tags=50%, list=17%, signal=60%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_ASTROCYTE_MARKERS'>LEIN_ASTROCYTE_MARKERS</a></td><td><a href='LEIN_ASTROCYTE_MARKERS.html'>Details ...</a></td><td>24</td><td>0.63</td><td>1.83</td><td>0.000</td><td>0.085</td><td>0.650</td><td>1189</td><td>tags=46%, list=11%, signal=51%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/PETROVA_PROX1_TARGETS_DN'>PETROVA_PROX1_TARGETS_DN</a></td><td><a href='PETROVA_PROX1_TARGETS_DN.html'>Details ...</a></td><td>38</td><td>0.58</td><td>1.82</td><td>0.000</td><td>0.093</td><td>0.670</td><td>2141</td><td>tags=55%, list=20%, signal=69%</td></tr><tr><td class='lessen'>21</td><td>FARMER_BREAST_CANCER_CLUSTER_1</td><td></td><td>18</td><td>0.69</td><td>1.81</td><td>0.000</td><td>0.090</td><td>0.690</td><td>768</td><td>tags=44%, list=7%, signal=48%</td></tr><tr><td class='lessen'>22</td><td>JOHNSTONE_PARVB_TARGETS_2_UP</td><td></td><td>79</td><td>0.50</td><td>1.81</td><td>0.000</td><td>0.088</td><td>0.690</td><td>2231</td><td>tags=47%, list=20%, signal=58%</td></tr><tr><td class='lessen'>23</td><td>GOLDRATH_IMMUNE_MEMORY</td><td></td><td>34</td><td>0.53</td><td>1.81</td><td>0.000</td><td>0.087</td><td>0.690</td><td>1716</td><td>tags=44%, list=16%, signal=52%</td></tr><tr><td class='lessen'>24</td><td>MARKEY_RB1_ACUTE_LOF_DN</td><td></td><td>124</td><td>0.57</td><td>1.80</td><td>0.000</td><td>0.093</td><td>0.720</td><td>2445</td><td>tags=56%, list=22%, signal=71%</td></tr><tr><td class='lessen'>25</td><td>KANG_GIST_WITH_PDGFRA_UP</td><td></td><td>29</td><td>0.53</td><td>1.80</td><td>0.039</td><td>0.096</td><td>0.760</td><td>1440</td><td>tags=45%, list=13%, signal=52%</td></tr><tr><td class='lessen'>26</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0</td><td></td><td>44</td><td>0.57</td><td>1.79</td><td>0.000</td><td>0.093</td><td>0.770</td><td>1520</td><td>tags=43%, list=14%, signal=50%</td></tr><tr><td class='lessen'>27</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP</td><td></td><td>98</td><td>0.45</td><td>1.79</td><td>0.000</td><td>0.094</td><td>0.770</td><td>1436</td><td>tags=33%, list=13%, signal=37%</td></tr><tr><td class='lessen'>28</td><td>BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS</td><td></td><td>15</td><td>0.82</td><td>1.79</td><td>0.000</td><td>0.093</td><td>0.770</td><td>1014</td><td>tags=67%, list=9%, signal=73%</td></tr><tr><td class='lessen'>29</td><td>LIANG_SILENCED_BY_METHYLATION_UP</td><td></td><td>19</td><td>0.61</td><td>1.79</td><td>0.000</td><td>0.091</td><td>0.790</td><td>1652</td><td>tags=47%, list=15%, signal=56%</td></tr><tr><td class='lessen'>30</td><td>VALK_AML_CLUSTER_16</td><td></td><td>16</td><td>0.64</td><td>1.79</td><td>0.000</td><td>0.088</td><td>0.790</td><td>1734</td><td>tags=56%, list=16%, signal=67%</td></tr><tr><td class='lessen'>31</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN</td><td></td><td>85</td><td>0.50</td><td>1.77</td><td>0.000</td><td>0.099</td><td>0.830</td><td>2342</td><td>tags=48%, list=22%, signal=61%</td></tr><tr><td class='lessen'>32</td><td>HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP</td><td></td><td>137</td><td>0.50</td><td>1.77</td><td>0.000</td><td>0.104</td><td>0.840</td><td>2259</td><td>tags=47%, list=21%, signal=59%</td></tr><tr><td class='lessen'>33</td><td>ZHANG_TLX_TARGETS_UP</td><td></td><td>58</td><td>0.52</td><td>1.76</td><td>0.000</td><td>0.103</td><td>0.850</td><td>1637</td><td>tags=41%, list=15%, signal=48%</td></tr><tr><td class='lessen'>34</td><td>ZHU_CMV_8_HR_UP</td><td></td><td>27</td><td>0.55</td><td>1.75</td><td>0.000</td><td>0.113</td><td>0.870</td><td>691</td><td>tags=30%, list=6%, signal=32%</td></tr><tr><td class='lessen'>35</td><td>RUTELLA_RESPONSE_TO_HGF_UP</td><td></td><td>228</td><td>0.45</td><td>1.73</td><td>0.000</td><td>0.147</td><td>0.890</td><td>2071</td><td>tags=40%, list=19%, signal=48%</td></tr><tr><td class='lessen'>36</td><td>DEMAGALHAES_AGING_UP</td><td></td><td>29</td><td>0.59</td><td>1.72</td><td>0.059</td><td>0.154</td><td>0.910</td><td>2364</td><td>tags=62%, list=22%, signal=79%</td></tr><tr><td class='lessen'>37</td><td>MOSERLE_IFNA_RESPONSE</td><td></td><td>15</td><td>0.84</td><td>1.72</td><td>0.018</td><td>0.153</td><td>0.920</td><td>745</td><td>tags=67%, list=7%, signal=71%</td></tr><tr><td class='lessen'>38</td><td>TSENG_IRS1_TARGETS_DN</td><td></td><td>72</td><td>0.37</td><td>1.72</td><td>0.000</td><td>0.154</td><td>0.920</td><td>1567</td><td>tags=24%, list=14%, signal=27%</td></tr><tr><td class='lessen'>39</td><td>NAKAJIMA_MAST_CELL</td><td></td><td>25</td><td>0.53</td><td>1.72</td><td>0.018</td><td>0.158</td><td>0.940</td><td>1982</td><td>tags=44%, list=18%, signal=54%</td></tr><tr><td class='lessen'>40</td><td>TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN</td><td></td><td>20</td><td>0.62</td><td>1.72</td><td>0.000</td><td>0.155</td><td>0.940</td><td>2218</td><td>tags=45%, list=20%, signal=56%</td></tr><tr><td class='lessen'>41</td><td>JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN</td><td></td><td>34</td><td>0.49</td><td>1.71</td><td>0.000</td><td>0.154</td><td>0.940</td><td>1715</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>42</td><td>ZHU_CMV_8_HR_DN</td><td></td><td>29</td><td>0.49</td><td>1.71</td><td>0.000</td><td>0.156</td><td>0.940</td><td>1674</td><td>tags=38%, list=15%, signal=45%</td></tr><tr><td class='lessen'>43</td><td>UDAYAKUMAR_MED1_TARGETS_DN</td><td></td><td>134</td><td>0.36</td><td>1.71</td><td>0.000</td><td>0.153</td><td>0.940</td><td>1588</td><td>tags=28%, list=15%, signal=32%</td></tr><tr><td class='lessen'>44</td><td>WALLACE_PROSTATE_CANCER_RACE_UP</td><td></td><td>148</td><td>0.47</td><td>1.70</td><td>0.020</td><td>0.161</td><td>0.950</td><td>1425</td><td>tags=36%, list=13%, signal=41%</td></tr><tr><td class='lessen'>45</td><td>RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN</td><td></td><td>169</td><td>0.46</td><td>1.70</td><td>0.019</td><td>0.159</td><td>0.950</td><td>2828</td><td>tags=48%, list=26%, signal=64%</td></tr><tr><td class='lessen'>46</td><td>SANA_RESPONSE_TO_IFNG_UP</td><td></td><td>35</td><td>0.65</td><td>1.70</td><td>0.000</td><td>0.163</td><td>0.950</td><td>1379</td><td>tags=49%, list=13%, signal=55%</td></tr><tr><td class='lessen'>47</td><td>CHANG_CORE_SERUM_RESPONSE_DN</td><td></td><td>105</td><td>0.41</td><td>1.70</td><td>0.000</td><td>0.163</td><td>0.960</td><td>1841</td><td>tags=34%, list=17%, signal=41%</td></tr><tr><td class='lessen'>48</td><td>REN_ALVEOLAR_RHABDOMYOSARCOMA_DN</td><td></td><td>234</td><td>0.41</td><td>1.69</td><td>0.000</td><td>0.173</td><td>0.970</td><td>2404</td><td>tags=42%, list=22%, signal=53%</td></tr><tr><td class='lessen'>49</td><td>VALK_AML_CLUSTER_12</td><td></td><td>16</td><td>0.53</td><td>1.69</td><td>0.000</td><td>0.177</td><td>0.970</td><td>1338</td><td>tags=44%, list=12%, signal=50%</td></tr><tr><td class='lessen'>50</td><td>SMID_BREAST_CANCER_NORMAL_LIKE_UP</td><td></td><td>270</td><td>0.45</td><td>1.69</td><td>0.000</td><td>0.175</td><td>0.970</td><td>2199</td><td>tags=41%, list=20%, signal=50%</td></tr><tr><td class='lessen'>51</td><td>ELVIDGE_HYPOXIA_BY_DMOG_UP</td><td></td><td>72</td><td>0.49</td><td>1.68</td><td>0.036</td><td>0.185</td><td>0.980</td><td>1909</td><td>tags=44%, list=18%, signal=54%</td></tr><tr><td class='lessen'>52</td><td>SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP</td><td></td><td>196</td><td>0.42</td><td>1.68</td><td>0.000</td><td>0.184</td><td>0.980</td><td>2270</td><td>tags=42%, list=21%, signal=52%</td></tr><tr><td class='lessen'>53</td><td>ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN</td><td></td><td>25</td><td>0.49</td><td>1.68</td><td>0.021</td><td>0.183</td><td>0.990</td><td>1399</td><td>tags=32%, list=13%, signal=37%</td></tr><tr><td class='lessen'>54</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP</td><td></td><td>55</td><td>0.57</td><td>1.67</td><td>0.038</td><td>0.186</td><td>0.990</td><td>2302</td><td>tags=51%, list=21%, signal=64%</td></tr><tr><td class='lessen'>55</td><td>WIKMAN_ASBESTOS_LUNG_CANCER_DN</td><td></td><td>19</td><td>0.65</td><td>1.67</td><td>0.020</td><td>0.183</td><td>0.990</td><td>1761</td><td>tags=58%, list=16%, signal=69%</td></tr><tr><td class='lessen'>56</td><td>CHIBA_RESPONSE_TO_TSA_UP</td><td></td><td>34</td><td>0.50</td><td>1.67</td><td>0.000</td><td>0.180</td><td>0.990</td><td>1704</td><td>tags=35%, list=16%, signal=42%</td></tr><tr><td class='lessen'>57</td><td>DANG_REGULATED_BY_MYC_DN</td><td></td><td>147</td><td>0.38</td><td>1.67</td><td>0.000</td><td>0.181</td><td>0.990</td><td>1781</td><td>tags=33%, list=16%, signal=39%</td></tr><tr><td class='lessen'>58</td><td>NIKOLSKY_BREAST_CANCER_7P22_AMPLICON</td><td></td><td>15</td><td>0.61</td><td>1.67</td><td>0.037</td><td>0.181</td><td>0.990</td><td>3307</td><td>tags=80%, list=30%, signal=115%</td></tr><tr><td class='lessen'>59</td><td>THUM_SYSTOLIC_HEART_FAILURE_UP</td><td></td><td>249</td><td>0.40</td><td>1.67</td><td>0.021</td><td>0.181</td><td>1.000</td><td>1965</td><td>tags=37%, list=18%, signal=44%</td></tr><tr><td class='lessen'>60</td><td>KIM_GLIS2_TARGETS_UP</td><td></td><td>46</td><td>0.49</td><td>1.67</td><td>0.000</td><td>0.179</td><td>1.000</td><td>2574</td><td>tags=57%, list=24%, signal=74%</td></tr><tr><td class='lessen'>61</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN</td><td></td><td>24</td><td>0.54</td><td>1.67</td><td>0.000</td><td>0.177</td><td>1.000</td><td>1561</td><td>tags=46%, list=14%, signal=53%</td></tr><tr><td class='lessen'>62</td><td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP</td><td></td><td>48</td><td>0.60</td><td>1.66</td><td>0.000</td><td>0.176</td><td>1.000</td><td>1631</td><td>tags=54%, list=15%, signal=63%</td></tr><tr><td class='lessen'>63</td><td>GAURNIER_PSMD4_TARGETS</td><td></td><td>46</td><td>0.61</td><td>1.66</td><td>0.000</td><td>0.176</td><td>1.000</td><td>1874</td><td>tags=54%, list=17%, signal=65%</td></tr><tr><td class='lessen'>64</td><td>LIANG_SILENCED_BY_METHYLATION_2</td><td></td><td>35</td><td>0.61</td><td>1.66</td><td>0.021</td><td>0.173</td><td>1.000</td><td>1900</td><td>tags=34%, list=17%, signal=41%</td></tr><tr><td class='lessen'>65</td><td>RUAN_RESPONSE_TO_TROGLITAZONE_UP</td><td></td><td>15</td><td>0.54</td><td>1.65</td><td>0.000</td><td>0.188</td><td>1.000</td><td>1078</td><td>tags=33%, list=10%, signal=37%</td></tr><tr><td class='lessen'>66</td><td>BAKKER_FOXO3_TARGETS_UP</td><td></td><td>25</td><td>0.54</td><td>1.65</td><td>0.000</td><td>0.193</td><td>1.000</td><td>1867</td><td>tags=44%, list=17%, signal=53%</td></tr><tr><td class='lessen'>67</td><td>FRIDMAN_SENESCENCE_UP</td><td></td><td>46</td><td>0.50</td><td>1.65</td><td>0.000</td><td>0.193</td><td>1.000</td><td>1964</td><td>tags=43%, list=18%, signal=53%</td></tr><tr><td class='lessen'>68</td><td>BOSCO_TH1_CYTOTOXIC_MODULE</td><td></td><td>67</td><td>0.46</td><td>1.65</td><td>0.019</td><td>0.197</td><td>1.000</td><td>2171</td><td>tags=39%, list=20%, signal=48%</td></tr><tr><td class='lessen'>69</td><td>ROVERSI_GLIOMA_COPY_NUMBER_UP</td><td></td><td>49</td><td>0.39</td><td>1.64</td><td>0.000</td><td>0.200</td><td>1.000</td><td>1869</td><td>tags=33%, list=17%, signal=39%</td></tr><tr><td class='lessen'>70</td><td>STREICHER_LSM1_TARGETS_UP</td><td></td><td>21</td><td>0.47</td><td>1.64</td><td>0.019</td><td>0.198</td><td>1.000</td><td>1436</td><td>tags=29%, list=13%, signal=33%</td></tr><tr><td class='lessen'>71</td><td>ABBUD_LIF_SIGNALING_1_UP</td><td></td><td>29</td><td>0.61</td><td>1.64</td><td>0.000</td><td>0.197</td><td>1.000</td><td>2602</td><td>tags=59%, list=24%, signal=77%</td></tr><tr><td class='lessen'>72</td><td>BAUS_TFF2_TARGETS_UP</td><td></td><td>15</td><td>0.62</td><td>1.64</td><td>0.022</td><td>0.197</td><td>1.000</td><td>1815</td><td>tags=47%, list=17%, signal=56%</td></tr><tr><td class='lessen'>73</td><td>ROSS_AML_WITH_MLL_FUSIONS</td><td></td><td>44</td><td>0.46</td><td>1.64</td><td>0.000</td><td>0.195</td><td>1.000</td><td>2902</td><td>tags=48%, list=27%, signal=65%</td></tr><tr><td class='lessen'>74</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN</td><td></td><td>25</td><td>0.47</td><td>1.64</td><td>0.000</td><td>0.194</td><td>1.000</td><td>1436</td><td>tags=32%, list=13%, signal=37%</td></tr><tr><td class='lessen'>75</td><td>VARELA_ZMPSTE24_TARGETS_UP</td><td></td><td>23</td><td>0.55</td><td>1.64</td><td>0.024</td><td>0.192</td><td>1.000</td><td>2028</td><td>tags=48%, list=19%, signal=59%</td></tr><tr><td class='lessen'>76</td><td>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP</td><td></td><td>231</td><td>0.35</td><td>1.64</td><td>0.000</td><td>0.190</td><td>1.000</td><td>1765</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>77</td><td>ZHANG_TLX_TARGETS_60HR_UP</td><td></td><td>167</td><td>0.40</td><td>1.63</td><td>0.000</td><td>0.199</td><td>1.000</td><td>1894</td><td>tags=34%, list=17%, signal=40%</td></tr><tr><td class='lessen'>78</td><td>DOUGLAS_BMI1_TARGETS_DN</td><td></td><td>158</td><td>0.37</td><td>1.63</td><td>0.043</td><td>0.200</td><td>1.000</td><td>2336</td><td>tags=37%, list=21%, signal=47%</td></tr><tr><td class='lessen'>79</td><td>FRIDMAN_IMMORTALIZATION_DN</td><td></td><td>20</td><td>0.67</td><td>1.63</td><td>0.000</td><td>0.198</td><td>1.000</td><td>1783</td><td>tags=55%, list=16%, signal=66%</td></tr><tr><td class='lessen'>80</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_2B</td><td></td><td>203</td><td>0.41</td><td>1.63</td><td>0.000</td><td>0.195</td><td>1.000</td><td>2016</td><td>tags=36%, list=19%, signal=43%</td></tr><tr><td class='lessen'>81</td><td>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN</td><td></td><td>92</td><td>0.45</td><td>1.63</td><td>0.000</td><td>0.194</td><td>1.000</td><td>2143</td><td>tags=42%, list=20%, signal=52%</td></tr><tr><td class='lessen'>82</td><td>BALDWIN_PRKCI_TARGETS_UP</td><td></td><td>18</td><td>0.59</td><td>1.63</td><td>0.020</td><td>0.192</td><td>1.000</td><td>496</td><td>tags=33%, list=5%, signal=35%</td></tr><tr><td class='lessen'>83</td><td>SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER</td><td></td><td>28</td><td>0.55</td><td>1.63</td><td>0.020</td><td>0.193</td><td>1.000</td><td>2231</td><td>tags=54%, list=20%, signal=67%</td></tr><tr><td class='lessen'>84</td><td>FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP</td><td></td><td>27</td><td>0.49</td><td>1.63</td><td>0.000</td><td>0.192</td><td>1.000</td><td>2420</td><td>tags=48%, list=22%, signal=62%</td></tr><tr><td class='lessen'>85</td><td>ONGUSAHA_TP53_TARGETS</td><td></td><td>21</td><td>0.53</td><td>1.62</td><td>0.023</td><td>0.191</td><td>1.000</td><td>2352</td><td>tags=48%, list=22%, signal=61%</td></tr><tr><td class='lessen'>86</td><td>FIRESTEIN_CTNNB1_PATHWAY</td><td></td><td>22</td><td>0.46</td><td>1.62</td><td>0.020</td><td>0.190</td><td>1.000</td><td>1867</td><td>tags=27%, list=17%, signal=33%</td></tr><tr><td class='lessen'>87</td><td>SANA_TNF_SIGNALING_UP</td><td></td><td>48</td><td>0.55</td><td>1.62</td><td>0.000</td><td>0.190</td><td>1.000</td><td>1363</td><td>tags=40%, list=13%, signal=45%</td></tr><tr><td class='lessen'>88</td><td>STEGER_ADIPOGENESIS_DN</td><td></td><td>21</td><td>0.51</td><td>1.62</td><td>0.021</td><td>0.191</td><td>1.000</td><td>649</td><td>tags=33%, list=6%, signal=35%</td></tr><tr><td class='lessen'>89</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN</td><td></td><td>25</td><td>0.54</td><td>1.61</td><td>0.077</td><td>0.203</td><td>1.000</td><td>1790</td><td>tags=36%, list=16%, signal=43%</td></tr><tr><td class='lessen'>90</td><td>APPEL_IMATINIB_RESPONSE</td><td></td><td>16</td><td>0.64</td><td>1.61</td><td>0.000</td><td>0.207</td><td>1.000</td><td>2356</td><td>tags=56%, list=22%, signal=72%</td></tr><tr><td class='lessen'>91</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP</td><td></td><td>90</td><td>0.41</td><td>1.61</td><td>0.000</td><td>0.206</td><td>1.000</td><td>1056</td><td>tags=28%, list=10%, signal=31%</td></tr><tr><td class='lessen'>92</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP</td><td></td><td>76</td><td>0.54</td><td>1.61</td><td>0.043</td><td>0.204</td><td>1.000</td><td>2918</td><td>tags=55%, list=27%, signal=75%</td></tr><tr><td class='lessen'>93</td><td>RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP</td><td></td><td>216</td><td>0.43</td><td>1.61</td><td>0.000</td><td>0.206</td><td>1.000</td><td>2231</td><td>tags=41%, list=20%, signal=50%</td></tr><tr><td class='lessen'>94</td><td>LI_INDUCED_T_TO_NATURAL_KILLER_UP</td><td></td><td>145</td><td>0.46</td><td>1.61</td><td>0.000</td><td>0.204</td><td>1.000</td><td>3023</td><td>tags=53%, list=28%, signal=73%</td></tr><tr><td class='lessen'>95</td><td>DER_IFN_ALPHA_RESPONSE_UP</td><td></td><td>37</td><td>0.50</td><td>1.61</td><td>0.039</td><td>0.203</td><td>1.000</td><td>2685</td><td>tags=54%, list=25%, signal=72%</td></tr><tr><td class='lessen'>96</td><td>GALE_APL_WITH_FLT3_MUTATED_DN</td><td></td><td>16</td><td>0.59</td><td>1.61</td><td>0.071</td><td>0.202</td><td>1.000</td><td>1743</td><td>tags=69%, list=16%, signal=82%</td></tr><tr><td class='lessen'>97</td><td>BROWNE_HCMV_INFECTION_20HR_DN</td><td></td><td>62</td><td>0.39</td><td>1.60</td><td>0.020</td><td>0.202</td><td>1.000</td><td>1583</td><td>tags=35%, list=15%, signal=41%</td></tr><tr><td class='lessen'>98</td><td>ZHAN_MULTIPLE_MYELOMA_LB_DN</td><td></td><td>15</td><td>0.67</td><td>1.60</td><td>0.000</td><td>0.200</td><td>1.000</td><td>679</td><td>tags=40%, list=6%, signal=43%</td></tr><tr><td class='lessen'>99</td><td>ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN</td><td></td><td>156</td><td>0.36</td><td>1.60</td><td>0.000</td><td>0.206</td><td>1.000</td><td>1978</td><td>tags=29%, list=18%, signal=36%</td></tr><tr><td class='lessen'>100</td><td>RODWELL_AGING_KIDNEY_UP</td><td></td><td>228</td><td>0.39</td><td>1.60</td><td>0.021</td><td>0.206</td><td>1.000</td><td>2098</td><td>tags=36%, list=19%, signal=44%</td></tr><tr><td class='lessen'>101</td><td>CHOW_RASSF1_TARGETS_DN</td><td></td><td>16</td><td>0.60</td><td>1.60</td><td>0.021</td><td>0.207</td><td>1.000</td><td>1577</td><td>tags=56%, list=14%, signal=66%</td></tr><tr><td class='lessen'>102</td><td>VALK_AML_CLUSTER_11</td><td></td><td>19</td><td>0.57</td><td>1.60</td><td>0.000</td><td>0.207</td><td>1.000</td><td>1346</td><td>tags=47%, list=12%, signal=54%</td></tr><tr><td class='lessen'>103</td><td>NATSUME_RESPONSE_TO_INTERFERON_BETA_UP</td><td></td><td>45</td><td>0.47</td><td>1.60</td><td>0.000</td><td>0.207</td><td>1.000</td><td>1874</td><td>tags=38%, list=17%, signal=45%</td></tr><tr><td class='lessen'>104</td><td>GROSS_HYPOXIA_VIA_ELK3_ONLY_DN</td><td></td><td>24</td><td>0.49</td><td>1.60</td><td>0.000</td><td>0.206</td><td>1.000</td><td>1959</td><td>tags=38%, list=18%, signal=46%</td></tr><tr><td class='lessen'>105</td><td>COATES_MACROPHAGE_M1_VS_M2_UP</td><td></td><td>46</td><td>0.49</td><td>1.59</td><td>0.022</td><td>0.207</td><td>1.000</td><td>970</td><td>tags=33%, list=9%, signal=36%</td></tr><tr><td class='lessen'>106</td><td>FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN</td><td></td><td>33</td><td>0.47</td><td>1.59</td><td>0.000</td><td>0.205</td><td>1.000</td><td>2364</td><td>tags=52%, list=22%, signal=66%</td></tr><tr><td class='lessen'>107</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN</td><td></td><td>27</td><td>0.44</td><td>1.59</td><td>0.000</td><td>0.207</td><td>1.000</td><td>1306</td><td>tags=30%, list=12%, signal=34%</td></tr><tr><td class='lessen'>108</td><td>LEE_LIVER_CANCER_ACOX1_DN</td><td></td><td>37</td><td>0.44</td><td>1.59</td><td>0.000</td><td>0.208</td><td>1.000</td><td>2435</td><td>tags=41%, list=22%, signal=52%</td></tr><tr><td class='lessen'>109</td><td>LENAOUR_DENDRITIC_CELL_MATURATION_UP</td><td></td><td>63</td><td>0.45</td><td>1.59</td><td>0.000</td><td>0.210</td><td>1.000</td><td>2882</td><td>tags=49%, list=26%, signal=67%</td></tr><tr><td class='lessen'>110</td><td>VERHAAK_GLIOBLASTOMA_MESENCHYMAL</td><td></td><td>125</td><td>0.49</td><td>1.58</td><td>0.022</td><td>0.215</td><td>1.000</td><td>2401</td><td>tags=49%, list=22%, signal=62%</td></tr><tr><td class='lessen'>111</td><td>KIM_GERMINAL_CENTER_T_HELPER_UP</td><td></td><td>36</td><td>0.49</td><td>1.58</td><td>0.068</td><td>0.218</td><td>1.000</td><td>972</td><td>tags=31%, list=9%, signal=33%</td></tr><tr><td class='lessen'>112</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP</td><td></td><td>105</td><td>0.38</td><td>1.58</td><td>0.000</td><td>0.219</td><td>1.000</td><td>1930</td><td>tags=30%, list=18%, signal=36%</td></tr><tr><td class='lessen'>113</td><td>AKL_HTLV1_INFECTION_DN</td><td></td><td>42</td><td>0.44</td><td>1.58</td><td>0.058</td><td>0.218</td><td>1.000</td><td>3272</td><td>tags=60%, list=30%, signal=85%</td></tr><tr><td class='lessen'>114</td><td>ROY_WOUND_BLOOD_VESSEL_UP</td><td></td><td>23</td><td>0.48</td><td>1.58</td><td>0.020</td><td>0.220</td><td>1.000</td><td>2595</td><td>tags=57%, list=24%, signal=74%</td></tr><tr><td class='lessen'>115</td><td>LEE_LIVER_CANCER_ACOX1_UP</td><td></td><td>35</td><td>0.45</td><td>1.57</td><td>0.048</td><td>0.222</td><td>1.000</td><td>2365</td><td>tags=40%, list=22%, signal=51%</td></tr><tr><td class='lessen'>116</td><td>LEE_LIVER_CANCER_E2F1_UP</td><td></td><td>31</td><td>0.53</td><td>1.57</td><td>0.000</td><td>0.224</td><td>1.000</td><td>2270</td><td>tags=45%, list=21%, signal=57%</td></tr><tr><td class='lessen'>117</td><td>LIN_APC_TARGETS</td><td></td><td>36</td><td>0.44</td><td>1.57</td><td>0.038</td><td>0.222</td><td>1.000</td><td>1368</td><td>tags=28%, list=13%, signal=32%</td></tr><tr><td class='lessen'>118</td><td>DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN</td><td></td><td>64</td><td>0.44</td><td>1.57</td><td>0.087</td><td>0.220</td><td>1.000</td><td>2766</td><td>tags=44%, list=25%, signal=58%</td></tr><tr><td class='lessen'>119</td><td>SMID_BREAST_CANCER_LUMINAL_A_UP</td><td></td><td>51</td><td>0.41</td><td>1.57</td><td>0.000</td><td>0.220</td><td>1.000</td><td>1886</td><td>tags=37%, list=17%, signal=45%</td></tr><tr><td class='lessen'>120</td><td>SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP</td><td></td><td>82</td><td>0.47</td><td>1.57</td><td>0.000</td><td>0.228</td><td>1.000</td><td>2036</td><td>tags=35%, list=19%, signal=43%</td></tr><tr><td class='lessen'>121</td><td>CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP</td><td></td><td>24</td><td>0.51</td><td>1.57</td><td>0.000</td><td>0.226</td><td>1.000</td><td>1425</td><td>tags=38%, list=13%, signal=43%</td></tr><tr><td class='lessen'>122</td><td>EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP</td><td></td><td>120</td><td>0.37</td><td>1.57</td><td>0.019</td><td>0.230</td><td>1.000</td><td>1716</td><td>tags=28%, list=16%, signal=32%</td></tr><tr><td class='lessen'>123</td><td>WINTER_HYPOXIA_DN</td><td></td><td>27</td><td>0.56</td><td>1.56</td><td>0.135</td><td>0.237</td><td>1.000</td><td>2663</td><td>tags=67%, list=24%, signal=88%</td></tr><tr><td class='lessen'>124</td><td>JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN</td><td></td><td>28</td><td>0.46</td><td>1.56</td><td>0.071</td><td>0.235</td><td>1.000</td><td>641</td><td>tags=25%, list=6%, signal=26%</td></tr><tr><td class='lessen'>125</td><td>ZHANG_TLX_TARGETS_36HR_UP</td><td></td><td>123</td><td>0.41</td><td>1.56</td><td>0.000</td><td>0.234</td><td>1.000</td><td>1835</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>126</td><td>CAIRO_HEPATOBLASTOMA_CLASSES_DN</td><td></td><td>117</td><td>0.40</td><td>1.56</td><td>0.000</td><td>0.235</td><td>1.000</td><td>2093</td><td>tags=37%, list=19%, signal=45%</td></tr><tr><td class='lessen'>127</td><td>CAMPS_COLON_CANCER_COPY_NUMBER_DN</td><td></td><td>22</td><td>0.51</td><td>1.56</td><td>0.000</td><td>0.234</td><td>1.000</td><td>1789</td><td>tags=41%, list=16%, signal=49%</td></tr><tr><td class='lessen'>128</td><td>KOBAYASHI_EGFR_SIGNALING_24HR_UP</td><td></td><td>58</td><td>0.44</td><td>1.56</td><td>0.022</td><td>0.236</td><td>1.000</td><td>2473</td><td>tags=48%, list=23%, signal=62%</td></tr><tr><td class='lessen'>129</td><td>MILI_PSEUDOPODIA_CHEMOTAXIS_DN</td><td></td><td>251</td><td>0.31</td><td>1.56</td><td>0.020</td><td>0.236</td><td>1.000</td><td>2389</td><td>tags=35%, list=22%, signal=44%</td></tr><tr><td class='lessen'>130</td><td>ZUCCHI_METASTASIS_DN</td><td></td><td>22</td><td>0.54</td><td>1.55</td><td>0.068</td><td>0.237</td><td>1.000</td><td>821</td><td>tags=32%, list=8%, signal=34%</td></tr><tr><td class='lessen'>131</td><td>COWLING_MYCN_TARGETS</td><td></td><td>20</td><td>0.57</td><td>1.55</td><td>0.020</td><td>0.237</td><td>1.000</td><td>1737</td><td>tags=50%, list=16%, signal=59%</td></tr><tr><td class='lessen'>132</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP</td><td></td><td>101</td><td>0.37</td><td>1.55</td><td>0.000</td><td>0.237</td><td>1.000</td><td>1612</td><td>tags=27%, list=15%, signal=31%</td></tr><tr><td class='lessen'>133</td><td>HORIUCHI_WTAP_TARGETS_UP</td><td></td><td>164</td><td>0.35</td><td>1.55</td><td>0.000</td><td>0.238</td><td>1.000</td><td>2035</td><td>tags=32%, list=19%, signal=39%</td></tr><tr><td class='lessen'>134</td><td>WANG_CISPLATIN_RESPONSE_AND_XPC_DN</td><td></td><td>140</td><td>0.35</td><td>1.55</td><td>0.019</td><td>0.240</td><td>1.000</td><td>2290</td><td>tags=35%, list=21%, signal=44%</td></tr><tr><td class='lessen'>135</td><td>FOSTER_TOLERANT_MACROPHAGE_UP</td><td></td><td>83</td><td>0.38</td><td>1.55</td><td>0.000</td><td>0.239</td><td>1.000</td><td>1520</td><td>tags=30%, list=14%, signal=35%</td></tr><tr><td class='lessen'>136</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B</td><td></td><td>277</td><td>0.35</td><td>1.55</td><td>0.000</td><td>0.240</td><td>1.000</td><td>2364</td><td>tags=34%, list=22%, signal=43%</td></tr><tr><td class='lessen'>137</td><td>LUI_THYROID_CANCER_PAX8_PPARG_UP</td><td></td><td>28</td><td>0.40</td><td>1.55</td><td>0.000</td><td>0.244</td><td>1.000</td><td>2828</td><td>tags=54%, list=26%, signal=72%</td></tr><tr><td class='lessen'>138</td><td>INGRAM_SHH_TARGETS_UP</td><td></td><td>62</td><td>0.37</td><td>1.54</td><td>0.000</td><td>0.247</td><td>1.000</td><td>2174</td><td>tags=34%, list=20%, signal=42%</td></tr><tr><td class='lessen'>139</td><td>SEMENZA_HIF1_TARGETS</td><td></td><td>23</td><td>0.51</td><td>1.54</td><td>0.085</td><td>0.246</td><td>1.000</td><td>1198</td><td>tags=35%, list=11%, signal=39%</td></tr><tr><td class='lessen'>140</td><td>LANDIS_ERBB2_BREAST_TUMORS_324_DN</td><td></td><td>87</td><td>0.38</td><td>1.54</td><td>0.000</td><td>0.248</td><td>1.000</td><td>2430</td><td>tags=44%, list=22%, signal=56%</td></tr><tr><td class='lessen'>141</td><td>ONDER_CDH1_SIGNALING_VIA_CTNNB1</td><td></td><td>42</td><td>0.46</td><td>1.54</td><td>0.000</td><td>0.248</td><td>1.000</td><td>2178</td><td>tags=36%, list=20%, signal=44%</td></tr><tr><td class='lessen'>142</td><td>MULLIGHAN_MLL_SIGNATURE_1_UP</td><td></td><td>212</td><td>0.35</td><td>1.54</td><td>0.000</td><td>0.246</td><td>1.000</td><td>2449</td><td>tags=38%, list=23%, signal=48%</td></tr><tr><td class='lessen'>143</td><td>BASSO_CD40_SIGNALING_UP</td><td></td><td>48</td><td>0.55</td><td>1.54</td><td>0.000</td><td>0.248</td><td>1.000</td><td>1193</td><td>tags=31%, list=11%, signal=35%</td></tr><tr><td class='lessen'>144</td><td>LIU_PROSTATE_CANCER_DN</td><td></td><td>253</td><td>0.34</td><td>1.54</td><td>0.021</td><td>0.246</td><td>1.000</td><td>1592</td><td>tags=26%, list=15%, signal=30%</td></tr><tr><td class='lessen'>145</td><td>ZHANG_GATA6_TARGETS_DN</td><td></td><td>38</td><td>0.42</td><td>1.54</td><td>0.043</td><td>0.249</td><td>1.000</td><td>2303</td><td>tags=37%, list=21%, signal=47%</td></tr><tr><td class='lessen'>146</td><td>BURTON_ADIPOGENESIS_8</td><td></td><td>43</td><td>0.42</td><td>1.54</td><td>0.038</td><td>0.247</td><td>1.000</td><td>1025</td><td>tags=30%, list=9%, signal=33%</td></tr><tr><td class='lessen'>147</td><td>ONDER_CDH1_TARGETS_2_UP</td><td></td><td>128</td><td>0.36</td><td>1.53</td><td>0.000</td><td>0.246</td><td>1.000</td><td>1659</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>148</td><td>RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP</td><td></td><td>184</td><td>0.37</td><td>1.53</td><td>0.000</td><td>0.246</td><td>1.000</td><td>2066</td><td>tags=35%, list=19%, signal=42%</td></tr><tr><td class='lessen'>149</td><td>PEREZ_TP53_AND_TP63_TARGETS</td><td></td><td>106</td><td>0.34</td><td>1.53</td><td>0.039</td><td>0.251</td><td>1.000</td><td>1929</td><td>tags=29%, list=18%, signal=35%</td></tr><tr><td class='lessen'>150</td><td>MIKKELSEN_MEF_LCP_WITH_H3K4ME3</td><td></td><td>64</td><td>0.45</td><td>1.53</td><td>0.044</td><td>0.251</td><td>1.000</td><td>2270</td><td>tags=41%, list=21%, signal=51%</td></tr><tr><td class='lessen'>151</td><td>WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP</td><td></td><td>18</td><td>0.55</td><td>1.53</td><td>0.053</td><td>0.249</td><td>1.000</td><td>1874</td><td>tags=44%, list=17%, signal=54%</td></tr><tr><td class='lessen'>152</td><td>BOQUEST_STEM_CELL_DN</td><td></td><td>114</td><td>0.41</td><td>1.53</td><td>0.068</td><td>0.249</td><td>1.000</td><td>2355</td><td>tags=40%, list=22%, signal=51%</td></tr><tr><td class='lessen'>153</td><td>SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN</td><td></td><td>84</td><td>0.40</td><td>1.53</td><td>0.000</td><td>0.248</td><td>1.000</td><td>1783</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>154</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS</td><td></td><td>70</td><td>0.42</td><td>1.53</td><td>0.000</td><td>0.248</td><td>1.000</td><td>2048</td><td>tags=36%, list=19%, signal=44%</td></tr><tr><td class='lessen'>155</td><td>PEDRIOLI_MIR31_TARGETS_DN</td><td></td><td>215</td><td>0.32</td><td>1.53</td><td>0.000</td><td>0.250</td><td>1.000</td><td>2362</td><td>tags=33%, list=22%, signal=41%</td></tr><tr><td class='lessen'>156</td><td>COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP</td><td></td><td>19</td><td>0.42</td><td>1.53</td><td>0.000</td><td>0.251</td><td>1.000</td><td>1754</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>157</td><td>VALK_AML_CLUSTER_5</td><td></td><td>20</td><td>0.63</td><td>1.52</td><td>0.122</td><td>0.252</td><td>1.000</td><td>3254</td><td>tags=75%, list=30%, signal=107%</td></tr><tr><td class='lessen'>158</td><td>WU_HBX_TARGETS_2_UP</td><td></td><td>19</td><td>0.53</td><td>1.52</td><td>0.020</td><td>0.252</td><td>1.000</td><td>3497</td><td>tags=68%, list=32%, signal=101%</td></tr><tr><td class='lessen'>159</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP</td><td></td><td>94</td><td>0.42</td><td>1.52</td><td>0.020</td><td>0.255</td><td>1.000</td><td>1985</td><td>tags=36%, list=18%, signal=44%</td></tr><tr><td class='lessen'>160</td><td>MOREIRA_RESPONSE_TO_TSA_DN</td><td></td><td>15</td><td>0.46</td><td>1.52</td><td>0.018</td><td>0.256</td><td>1.000</td><td>1364</td><td>tags=40%, list=13%, signal=46%</td></tr><tr><td class='lessen'>161</td><td>CHESLER_BRAIN_QTL_CIS</td><td></td><td>37</td><td>0.40</td><td>1.52</td><td>0.059</td><td>0.258</td><td>1.000</td><td>1735</td><td>tags=30%, list=16%, signal=35%</td></tr><tr><td class='lessen'>162</td><td>NAKAYAMA_FRA2_TARGETS</td><td></td><td>24</td><td>0.45</td><td>1.52</td><td>0.042</td><td>0.258</td><td>1.000</td><td>1436</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>163</td><td>LEE_LIVER_CANCER_MYC_E2F1_UP</td><td></td><td>26</td><td>0.46</td><td>1.52</td><td>0.077</td><td>0.258</td><td>1.000</td><td>2251</td><td>tags=38%, list=21%, signal=48%</td></tr><tr><td class='lessen'>164</td><td>SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A</td><td></td><td>16</td><td>0.45</td><td>1.52</td><td>0.019</td><td>0.258</td><td>1.000</td><td>1287</td><td>tags=44%, list=12%, signal=50%</td></tr><tr><td class='lessen'>165</td><td>LIU_TARGETS_OF_VMYB_VS_CMYB_DN</td><td></td><td>26</td><td>0.56</td><td>1.51</td><td>0.085</td><td>0.258</td><td>1.000</td><td>1269</td><td>tags=35%, list=12%, signal=39%</td></tr><tr><td class='lessen'>166</td><td>AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G</td><td></td><td>51</td><td>0.40</td><td>1.51</td><td>0.000</td><td>0.259</td><td>1.000</td><td>2831</td><td>tags=51%, list=26%, signal=69%</td></tr><tr><td class='lessen'>167</td><td>FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP</td><td></td><td>24</td><td>0.43</td><td>1.51</td><td>0.000</td><td>0.261</td><td>1.000</td><td>3141</td><td>tags=63%, list=29%, signal=88%</td></tr><tr><td class='lessen'>168</td><td>BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN</td><td></td><td>19</td><td>0.56</td><td>1.51</td><td>0.065</td><td>0.262</td><td>1.000</td><td>1804</td><td>tags=47%, list=17%, signal=57%</td></tr><tr><td class='lessen'>169</td><td>ELVIDGE_HYPOXIA_UP</td><td></td><td>92</td><td>0.43</td><td>1.51</td><td>0.060</td><td>0.261</td><td>1.000</td><td>1909</td><td>tags=38%, list=18%, signal=46%</td></tr><tr><td class='lessen'>170</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP</td><td></td><td>94</td><td>0.37</td><td>1.51</td><td>0.074</td><td>0.266</td><td>1.000</td><td>1441</td><td>tags=26%, list=13%, signal=29%</td></tr><tr><td class='lessen'>171</td><td>BIDUS_METASTASIS_DN</td><td></td><td>93</td><td>0.40</td><td>1.51</td><td>0.000</td><td>0.265</td><td>1.000</td><td>1780</td><td>tags=34%, list=16%, signal=41%</td></tr><tr><td class='lessen'>172</td><td>AMIT_SERUM_RESPONSE_240_MCF10A</td><td></td><td>35</td><td>0.49</td><td>1.50</td><td>0.043</td><td>0.268</td><td>1.000</td><td>1733</td><td>tags=46%, list=16%, signal=54%</td></tr><tr><td class='lessen'>173</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD</td><td></td><td>20</td><td>0.46</td><td>1.50</td><td>0.064</td><td>0.270</td><td>1.000</td><td>1120</td><td>tags=30%, list=10%, signal=33%</td></tr><tr><td class='lessen'>174</td><td>ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN</td><td></td><td>56</td><td>0.45</td><td>1.50</td><td>0.113</td><td>0.268</td><td>1.000</td><td>1561</td><td>tags=36%, list=14%, signal=41%</td></tr><tr><td class='lessen'>175</td><td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN</td><td></td><td>25</td><td>0.42</td><td>1.50</td><td>0.023</td><td>0.267</td><td>1.000</td><td>1582</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>176</td><td>DAZARD_UV_RESPONSE_CLUSTER_G24</td><td></td><td>16</td><td>0.56</td><td>1.50</td><td>0.038</td><td>0.268</td><td>1.000</td><td>3057</td><td>tags=50%, list=28%, signal=69%</td></tr><tr><td class='lessen'>177</td><td>LEE_BMP2_TARGETS_UP</td><td></td><td>365</td><td>0.31</td><td>1.50</td><td>0.043</td><td>0.271</td><td>1.000</td><td>1862</td><td>tags=28%, list=17%, signal=33%</td></tr><tr><td class='lessen'>178</td><td>LIU_CMYB_TARGETS_UP</td><td></td><td>78</td><td>0.37</td><td>1.50</td><td>0.022</td><td>0.270</td><td>1.000</td><td>3188</td><td>tags=47%, list=29%, signal=67%</td></tr><tr><td class='lessen'>179</td><td>VECCHI_GASTRIC_CANCER_EARLY_DN</td><td></td><td>190</td><td>0.33</td><td>1.50</td><td>0.000</td><td>0.269</td><td>1.000</td><td>1860</td><td>tags=24%, list=17%, signal=29%</td></tr><tr><td class='lessen'>180</td><td>MARZEC_IL2_SIGNALING_DN</td><td></td><td>23</td><td>0.44</td><td>1.50</td><td>0.019</td><td>0.269</td><td>1.000</td><td>1983</td><td>tags=39%, list=18%, signal=48%</td></tr><tr><td class='lessen'>181</td><td>ROZANOV_MMP14_TARGETS_UP</td><td></td><td>132</td><td>0.35</td><td>1.50</td><td>0.021</td><td>0.268</td><td>1.000</td><td>1771</td><td>tags=31%, list=16%, signal=37%</td></tr><tr><td class='lessen'>182</td><td>MALONEY_RESPONSE_TO_17AAG_UP</td><td></td><td>21</td><td>0.49</td><td>1.49</td><td>0.047</td><td>0.269</td><td>1.000</td><td>1198</td><td>tags=38%, list=11%, signal=43%</td></tr><tr><td class='lessen'>183</td><td>CHICAS_RB1_TARGETS_CONFLUENT</td><td></td><td>288</td><td>0.29</td><td>1.49</td><td>0.000</td><td>0.268</td><td>1.000</td><td>1969</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>184</td><td>LIU_VAV3_PROSTATE_CARCINOGENESIS_UP</td><td></td><td>55</td><td>0.44</td><td>1.49</td><td>0.063</td><td>0.268</td><td>1.000</td><td>2218</td><td>tags=38%, list=20%, signal=48%</td></tr><tr><td class='lessen'>185</td><td>ZHU_CMV_ALL_DN</td><td></td><td>76</td><td>0.35</td><td>1.49</td><td>0.040</td><td>0.268</td><td>1.000</td><td>1691</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>186</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN</td><td></td><td>84</td><td>0.40</td><td>1.49</td><td>0.021</td><td>0.268</td><td>1.000</td><td>2342</td><td>tags=43%, list=22%, signal=54%</td></tr><tr><td class='lessen'>187</td><td>KUMAR_TARGETS_OF_MLL_AF9_FUSION</td><td></td><td>217</td><td>0.30</td><td>1.49</td><td>0.020</td><td>0.270</td><td>1.000</td><td>2611</td><td>tags=35%, list=24%, signal=46%</td></tr><tr><td class='lessen'>188</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN</td><td></td><td>39</td><td>0.40</td><td>1.49</td><td>0.000</td><td>0.270</td><td>1.000</td><td>2507</td><td>tags=36%, list=23%, signal=46%</td></tr><tr><td class='lessen'>189</td><td>BILBAN_B_CLL_LPL_UP</td><td></td><td>36</td><td>0.41</td><td>1.49</td><td>0.020</td><td>0.272</td><td>1.000</td><td>1965</td><td>tags=42%, list=18%, signal=51%</td></tr><tr><td class='lessen'>190</td><td>KIM_GASTRIC_CANCER_CHEMOSENSITIVITY</td><td></td><td>65</td><td>0.39</td><td>1.49</td><td>0.043</td><td>0.272</td><td>1.000</td><td>1632</td><td>tags=29%, list=15%, signal=34%</td></tr><tr><td class='lessen'>191</td><td>MORI_MATURE_B_LYMPHOCYTE_UP</td><td></td><td>52</td><td>0.43</td><td>1.49</td><td>0.063</td><td>0.271</td><td>1.000</td><td>2538</td><td>tags=48%, list=23%, signal=62%</td></tr><tr><td class='lessen'>192</td><td>MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP</td><td></td><td>15</td><td>0.52</td><td>1.49</td><td>0.064</td><td>0.270</td><td>1.000</td><td>1885</td><td>tags=47%, list=17%, signal=56%</td></tr><tr><td class='lessen'>193</td><td>HUTTMANN_B_CLL_POOR_SURVIVAL_UP</td><td></td><td>160</td><td>0.35</td><td>1.49</td><td>0.000</td><td>0.271</td><td>1.000</td><td>2932</td><td>tags=41%, list=27%, signal=55%</td></tr><tr><td class='lessen'>194</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_P3</td><td></td><td>88</td><td>0.39</td><td>1.48</td><td>0.022</td><td>0.272</td><td>1.000</td><td>1508</td><td>tags=32%, list=14%, signal=37%</td></tr><tr><td class='lessen'>195</td><td>BERNARD_PPAPDC1B_TARGETS_UP</td><td></td><td>21</td><td>0.52</td><td>1.48</td><td>0.048</td><td>0.270</td><td>1.000</td><td>1655</td><td>tags=48%, list=15%, signal=56%</td></tr><tr><td class='lessen'>196</td><td>TSENG_ADIPOGENIC_POTENTIAL_DN</td><td></td><td>22</td><td>0.47</td><td>1.48</td><td>0.064</td><td>0.272</td><td>1.000</td><td>284</td><td>tags=18%, list=3%, signal=19%</td></tr><tr><td class='lessen'>197</td><td>KIM_LRRC3B_TARGETS</td><td></td><td>20</td><td>0.56</td><td>1.48</td><td>0.093</td><td>0.272</td><td>1.000</td><td>2199</td><td>tags=45%, list=20%, signal=56%</td></tr><tr><td class='lessen'>198</td><td>BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING</td><td></td><td>130</td><td>0.31</td><td>1.48</td><td>0.040</td><td>0.271</td><td>1.000</td><td>2399</td><td>tags=33%, list=22%, signal=42%</td></tr><tr><td class='lessen'>199</td><td>KOHOUTEK_CCNT2_TARGETS</td><td></td><td>27</td><td>0.45</td><td>1.48</td><td>0.036</td><td>0.271</td><td>1.000</td><td>1816</td><td>tags=41%, list=17%, signal=49%</td></tr><tr><td class='lessen'>200</td><td>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN</td><td></td><td>227</td><td>0.40</td><td>1.48</td><td>0.048</td><td>0.274</td><td>1.000</td><td>2038</td><td>tags=36%, list=19%, signal=44%</td></tr><tr><td class='lessen'>201</td><td>WESTON_VEGFA_TARGETS_6HR</td><td></td><td>40</td><td>0.41</td><td>1.48</td><td>0.018</td><td>0.274</td><td>1.000</td><td>1363</td><td>tags=28%, list=13%, signal=31%</td></tr><tr><td class='lessen'>202</td><td>RODWELL_AGING_KIDNEY_NO_BLOOD_UP</td><td></td><td>109</td><td>0.32</td><td>1.48</td><td>0.000</td><td>0.272</td><td>1.000</td><td>2035</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>203</td><td>MISSIAGLIA_REGULATED_BY_METHYLATION_UP</td><td></td><td>64</td><td>0.47</td><td>1.48</td><td>0.089</td><td>0.273</td><td>1.000</td><td>1763</td><td>tags=39%, list=16%, signal=46%</td></tr><tr><td class='lessen'>204</td><td>LIAN_LIPA_TARGETS_6M</td><td></td><td>42</td><td>0.51</td><td>1.48</td><td>0.115</td><td>0.274</td><td>1.000</td><td>3233</td><td>tags=57%, list=30%, signal=81%</td></tr><tr><td class='lessen'>205</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN</td><td></td><td>26</td><td>0.47</td><td>1.48</td><td>0.056</td><td>0.273</td><td>1.000</td><td>1314</td><td>tags=27%, list=12%, signal=31%</td></tr><tr><td class='lessen'>206</td><td>RUAN_RESPONSE_TO_TNF_DN</td><td></td><td>42</td><td>0.41</td><td>1.48</td><td>0.023</td><td>0.272</td><td>1.000</td><td>2462</td><td>tags=43%, list=23%, signal=55%</td></tr><tr><td class='lessen'>207</td><td>KESHELAVA_MULTIPLE_DRUG_RESISTANCE</td><td></td><td>47</td><td>0.36</td><td>1.48</td><td>0.087</td><td>0.272</td><td>1.000</td><td>1638</td><td>tags=32%, list=15%, signal=37%</td></tr><tr><td class='lessen'>208</td><td>NEMETH_INFLAMMATORY_RESPONSE_LPS_UP</td><td></td><td>54</td><td>0.50</td><td>1.47</td><td>0.114</td><td>0.271</td><td>1.000</td><td>1901</td><td>tags=43%, list=17%, signal=51%</td></tr><tr><td class='lessen'>209</td><td>ZHENG_GLIOBLASTOMA_PLASTICITY_DN</td><td></td><td>35</td><td>0.41</td><td>1.47</td><td>0.025</td><td>0.271</td><td>1.000</td><td>1488</td><td>tags=29%, list=14%, signal=33%</td></tr><tr><td class='lessen'>210</td><td>LIM_MAMMARY_STEM_CELL_UP</td><td></td><td>263</td><td>0.32</td><td>1.47</td><td>0.021</td><td>0.276</td><td>1.000</td><td>1945</td><td>tags=29%, list=18%, signal=34%</td></tr><tr><td class='lessen'>211</td><td>MILI_PSEUDOPODIA_HAPTOTAXIS_DN</td><td></td><td>335</td><td>0.32</td><td>1.47</td><td>0.000</td><td>0.276</td><td>1.000</td><td>2513</td><td>tags=36%, list=23%, signal=46%</td></tr><tr><td class='lessen'>212</td><td>KHETCHOUMIAN_TRIM24_TARGETS_UP</td><td></td><td>23</td><td>0.48</td><td>1.47</td><td>0.040</td><td>0.277</td><td>1.000</td><td>2611</td><td>tags=39%, list=24%, signal=51%</td></tr><tr><td class='lessen'>213</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN</td><td></td><td>255</td><td>0.33</td><td>1.47</td><td>0.037</td><td>0.276</td><td>1.000</td><td>2301</td><td>tags=35%, list=21%, signal=43%</td></tr><tr><td class='lessen'>214</td><td>SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN</td><td></td><td>31</td><td>0.43</td><td>1.47</td><td>0.040</td><td>0.276</td><td>1.000</td><td>2538</td><td>tags=42%, list=23%, signal=55%</td></tr><tr><td class='lessen'>215</td><td>HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP</td><td></td><td>24</td><td>0.50</td><td>1.47</td><td>0.043</td><td>0.274</td><td>1.000</td><td>1680</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>216</td><td>NOJIMA_SFRP2_TARGETS_UP</td><td></td><td>17</td><td>0.60</td><td>1.47</td><td>0.067</td><td>0.274</td><td>1.000</td><td>1078</td><td>tags=35%, list=10%, signal=39%</td></tr><tr><td class='lessen'>217</td><td>MORI_PRE_BI_LYMPHOCYTE_DN</td><td></td><td>45</td><td>0.40</td><td>1.47</td><td>0.021</td><td>0.274</td><td>1.000</td><td>1883</td><td>tags=33%, list=17%, signal=40%</td></tr><tr><td class='lessen'>218</td><td>NOJIMA_SFRP2_TARGETS_DN</td><td></td><td>16</td><td>0.53</td><td>1.47</td><td>0.042</td><td>0.275</td><td>1.000</td><td>1778</td><td>tags=44%, list=16%, signal=52%</td></tr><tr><td class='lessen'>219</td><td>VALK_AML_CLUSTER_10</td><td></td><td>20</td><td>0.46</td><td>1.47</td><td>0.065</td><td>0.274</td><td>1.000</td><td>1231</td><td>tags=30%, list=11%, signal=34%</td></tr><tr><td class='lessen'>220</td><td>MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP</td><td></td><td>86</td><td>0.36</td><td>1.47</td><td>0.041</td><td>0.273</td><td>1.000</td><td>1507</td><td>tags=27%, list=14%, signal=31%</td></tr><tr><td class='lessen'>221</td><td>YAMASHITA_METHYLATED_IN_PROSTATE_CANCER</td><td></td><td>29</td><td>0.45</td><td>1.46</td><td>0.085</td><td>0.274</td><td>1.000</td><td>1156</td><td>tags=24%, list=11%, signal=27%</td></tr><tr><td class='lessen'>222</td><td>NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON</td><td></td><td>71</td><td>0.36</td><td>1.46</td><td>0.022</td><td>0.275</td><td>1.000</td><td>1967</td><td>tags=31%, list=18%, signal=38%</td></tr><tr><td class='lessen'>223</td><td>MORI_PLASMA_CELL_DN</td><td></td><td>19</td><td>0.48</td><td>1.46</td><td>0.159</td><td>0.276</td><td>1.000</td><td>1441</td><td>tags=37%, list=13%, signal=42%</td></tr><tr><td class='lessen'>224</td><td>ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP</td><td></td><td>21</td><td>0.50</td><td>1.46</td><td>0.063</td><td>0.278</td><td>1.000</td><td>920</td><td>tags=29%, list=8%, signal=31%</td></tr><tr><td class='lessen'>225</td><td>MCBRYAN_PUBERTAL_BREAST_3_4WK_UP</td><td></td><td>116</td><td>0.32</td><td>1.46</td><td>0.023</td><td>0.282</td><td>1.000</td><td>1837</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>226</td><td>NAKAMURA_METASTASIS</td><td></td><td>19</td><td>0.49</td><td>1.46</td><td>0.045</td><td>0.282</td><td>1.000</td><td>1019</td><td>tags=32%, list=9%, signal=35%</td></tr><tr><td class='lessen'>227</td><td>SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN</td><td></td><td>22</td><td>0.54</td><td>1.46</td><td>0.043</td><td>0.281</td><td>1.000</td><td>1674</td><td>tags=41%, list=15%, signal=48%</td></tr><tr><td class='lessen'>228</td><td>FARDIN_HYPOXIA_11</td><td></td><td>15</td><td>0.57</td><td>1.46</td><td>0.161</td><td>0.280</td><td>1.000</td><td>547</td><td>tags=27%, list=5%, signal=28%</td></tr><tr><td class='lessen'>229</td><td>SHEPARD_BMYB_MORPHOLINO_UP</td><td></td><td>109</td><td>0.31</td><td>1.46</td><td>0.000</td><td>0.280</td><td>1.000</td><td>1985</td><td>tags=30%, list=18%, signal=37%</td></tr><tr><td class='lessen'>230</td><td>YAMAZAKI_TCEB3_TARGETS_UP</td><td></td><td>94</td><td>0.35</td><td>1.45</td><td>0.043</td><td>0.281</td><td>1.000</td><td>1969</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>231</td><td>DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP</td><td></td><td>31</td><td>0.42</td><td>1.45</td><td>0.041</td><td>0.289</td><td>1.000</td><td>1384</td><td>tags=26%, list=13%, signal=29%</td></tr><tr><td class='lessen'>232</td><td>MULLIGHAN_MLL_SIGNATURE_2_UP</td><td></td><td>236</td><td>0.34</td><td>1.45</td><td>0.000</td><td>0.289</td><td>1.000</td><td>2449</td><td>tags=38%, list=23%, signal=48%</td></tr><tr><td class='lessen'>233</td><td>KIM_ALL_DISORDERS_CALB1_CORR_DN</td><td></td><td>28</td><td>0.53</td><td>1.45</td><td>0.093</td><td>0.289</td><td>1.000</td><td>1738</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>234</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN</td><td></td><td>246</td><td>0.35</td><td>1.45</td><td>0.021</td><td>0.289</td><td>1.000</td><td>1550</td><td>tags=30%, list=14%, signal=34%</td></tr><tr><td class='lessen'>235</td><td>KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN</td><td></td><td>172</td><td>0.31</td><td>1.45</td><td>0.024</td><td>0.288</td><td>1.000</td><td>2712</td><td>tags=37%, list=25%, signal=48%</td></tr><tr><td class='lessen'>236</td><td>INGRAM_SHH_TARGETS_DN</td><td></td><td>35</td><td>0.42</td><td>1.45</td><td>0.122</td><td>0.287</td><td>1.000</td><td>2425</td><td>tags=43%, list=22%, signal=55%</td></tr><tr><td class='lessen'>237</td><td>LEIN_PONS_MARKERS</td><td></td><td>52</td><td>0.39</td><td>1.45</td><td>0.022</td><td>0.286</td><td>1.000</td><td>1854</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>238</td><td>LEE_LIVER_CANCER_MYC_E2F1_DN</td><td></td><td>39</td><td>0.35</td><td>1.45</td><td>0.061</td><td>0.286</td><td>1.000</td><td>1539</td><td>tags=28%, list=14%, signal=33%</td></tr><tr><td class='lessen'>239</td><td>SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP</td><td></td><td>17</td><td>0.49</td><td>1.45</td><td>0.043</td><td>0.285</td><td>1.000</td><td>2436</td><td>tags=53%, list=22%, signal=68%</td></tr><tr><td class='lessen'>240</td><td>ASTIER_INTEGRIN_SIGNALING</td><td></td><td>22</td><td>0.47</td><td>1.45</td><td>0.073</td><td>0.284</td><td>1.000</td><td>1006</td><td>tags=32%, list=9%, signal=35%</td></tr><tr><td class='lessen'>241</td><td>YAGI_AML_WITH_11Q23_REARRANGED</td><td></td><td>202</td><td>0.30</td><td>1.45</td><td>0.000</td><td>0.284</td><td>1.000</td><td>2357</td><td>tags=33%, list=22%, signal=41%</td></tr><tr><td class='lessen'>242</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP</td><td></td><td>31</td><td>0.36</td><td>1.44</td><td>0.000</td><td>0.286</td><td>1.000</td><td>1120</td><td>tags=23%, list=10%, signal=25%</td></tr><tr><td class='lessen'>243</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP</td><td></td><td>98</td><td>0.33</td><td>1.44</td><td>0.043</td><td>0.285</td><td>1.000</td><td>2218</td><td>tags=32%, list=20%, signal=39%</td></tr><tr><td class='lessen'>244</td><td>EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION</td><td></td><td>35</td><td>0.45</td><td>1.44</td><td>0.115</td><td>0.285</td><td>1.000</td><td>2538</td><td>tags=40%, list=23%, signal=52%</td></tr><tr><td class='lessen'>245</td><td>YAGI_AML_WITH_T_8_21_TRANSLOCATION</td><td></td><td>204</td><td>0.29</td><td>1.44</td><td>0.000</td><td>0.285</td><td>1.000</td><td>2349</td><td>tags=32%, list=22%, signal=40%</td></tr><tr><td class='lessen'>246</td><td>HEIDENBLAD_AMPLICON_8Q24_UP</td><td></td><td>19</td><td>0.45</td><td>1.44</td><td>0.063</td><td>0.285</td><td>1.000</td><td>994</td><td>tags=32%, list=9%, signal=35%</td></tr><tr><td class='lessen'>247</td><td>JISON_SICKLE_CELL_DISEASE_UP</td><td></td><td>99</td><td>0.43</td><td>1.44</td><td>0.119</td><td>0.286</td><td>1.000</td><td>1790</td><td>tags=37%, list=16%, signal=44%</td></tr><tr><td class='lessen'>248</td><td>BURTON_ADIPOGENESIS_PEAK_AT_8HR</td><td></td><td>21</td><td>0.42</td><td>1.44</td><td>0.070</td><td>0.285</td><td>1.000</td><td>2231</td><td>tags=52%, list=20%, signal=66%</td></tr><tr><td class='lessen'>249</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP</td><td></td><td>80</td><td>0.33</td><td>1.44</td><td>0.018</td><td>0.287</td><td>1.000</td><td>1031</td><td>tags=23%, list=9%, signal=25%</td></tr><tr><td class='lessen'>250</td><td>GOZGIT_ESR1_TARGETS_UP</td><td></td><td>83</td><td>0.35</td><td>1.44</td><td>0.000</td><td>0.286</td><td>1.000</td><td>2141</td><td>tags=34%, list=20%, signal=42%</td></tr><tr><td class='lessen'>251</td><td>SWEET_KRAS_TARGETS_UP</td><td></td><td>37</td><td>0.40</td><td>1.44</td><td>0.040</td><td>0.288</td><td>1.000</td><td>1884</td><td>tags=32%, list=17%, signal=39%</td></tr><tr><td class='lessen'>252</td><td>ISSAEVA_MLL2_TARGETS</td><td></td><td>38</td><td>0.41</td><td>1.44</td><td>0.041</td><td>0.289</td><td>1.000</td><td>851</td><td>tags=24%, list=8%, signal=26%</td></tr><tr><td class='lessen'>253</td><td>TSAI_RESPONSE_TO_IONIZING_RADIATION</td><td></td><td>89</td><td>0.36</td><td>1.44</td><td>0.000</td><td>0.288</td><td>1.000</td><td>1952</td><td>tags=33%, list=18%, signal=39%</td></tr><tr><td class='lessen'>254</td><td>APPIERTO_RESPONSE_TO_FENRETINIDE_UP</td><td></td><td>25</td><td>0.44</td><td>1.44</td><td>0.064</td><td>0.287</td><td>1.000</td><td>1234</td><td>tags=28%, list=11%, signal=32%</td></tr><tr><td class='lessen'>255</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN</td><td></td><td>76</td><td>0.45</td><td>1.44</td><td>0.042</td><td>0.287</td><td>1.000</td><td>2023</td><td>tags=36%, list=19%, signal=43%</td></tr><tr><td class='lessen'>256</td><td>DER_IFN_GAMMA_RESPONSE_UP</td><td></td><td>33</td><td>0.40</td><td>1.43</td><td>0.047</td><td>0.294</td><td>1.000</td><td>1363</td><td>tags=27%, list=13%, signal=31%</td></tr><tr><td class='lessen'>257</td><td>KERLEY_RESPONSE_TO_CISPLATIN_UP</td><td></td><td>25</td><td>0.45</td><td>1.43</td><td>0.039</td><td>0.295</td><td>1.000</td><td>1406</td><td>tags=28%, list=13%, signal=32%</td></tr><tr><td class='lessen'>258</td><td>DURAND_STROMA_S_UP</td><td></td><td>162</td><td>0.30</td><td>1.43</td><td>0.020</td><td>0.295</td><td>1.000</td><td>1885</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>259</td><td>PROVENZANI_METASTASIS_DN</td><td></td><td>70</td><td>0.34</td><td>1.43</td><td>0.043</td><td>0.294</td><td>1.000</td><td>1616</td><td>tags=30%, list=15%, signal=35%</td></tr><tr><td class='lessen'>260</td><td>SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN</td><td></td><td>22</td><td>0.42</td><td>1.43</td><td>0.094</td><td>0.294</td><td>1.000</td><td>850</td><td>tags=23%, list=8%, signal=25%</td></tr><tr><td class='lessen'>261</td><td>PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP</td><td></td><td>113</td><td>0.36</td><td>1.43</td><td>0.104</td><td>0.297</td><td>1.000</td><td>2638</td><td>tags=40%, list=24%, signal=52%</td></tr><tr><td class='lessen'>262</td><td>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP</td><td></td><td>30</td><td>0.44</td><td>1.43</td><td>0.045</td><td>0.297</td><td>1.000</td><td>1955</td><td>tags=43%, list=18%, signal=53%</td></tr><tr><td class='lessen'>263</td><td>LIAN_LIPA_TARGETS_3M</td><td></td><td>34</td><td>0.54</td><td>1.43</td><td>0.163</td><td>0.297</td><td>1.000</td><td>2023</td><td>tags=47%, list=19%, signal=58%</td></tr><tr><td class='lessen'>264</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_DN</td><td></td><td>28</td><td>0.48</td><td>1.43</td><td>0.075</td><td>0.296</td><td>1.000</td><td>785</td><td>tags=29%, list=7%, signal=31%</td></tr><tr><td class='lessen'>265</td><td>SMID_BREAST_CANCER_LUMINAL_B_DN</td><td></td><td>318</td><td>0.34</td><td>1.43</td><td>0.083</td><td>0.296</td><td>1.000</td><td>2147</td><td>tags=31%, list=20%, signal=38%</td></tr><tr><td class='lessen'>266</td><td>JOHNSTONE_PARVB_TARGETS_3_UP</td><td></td><td>232</td><td>0.34</td><td>1.43</td><td>0.000</td><td>0.296</td><td>1.000</td><td>2715</td><td>tags=41%, list=25%, signal=53%</td></tr><tr><td class='lessen'>267</td><td>NADLER_HYPERGLYCEMIA_AT_OBESITY</td><td></td><td>42</td><td>0.41</td><td>1.43</td><td>0.078</td><td>0.297</td><td>1.000</td><td>1346</td><td>tags=29%, list=12%, signal=32%</td></tr><tr><td class='lessen'>268</td><td>FINAK_BREAST_CANCER_SDPP_SIGNATURE</td><td></td><td>16</td><td>0.58</td><td>1.42</td><td>0.125</td><td>0.297</td><td>1.000</td><td>792</td><td>tags=31%, list=7%, signal=34%</td></tr><tr><td class='lessen'>269</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP</td><td></td><td>32</td><td>0.37</td><td>1.42</td><td>0.065</td><td>0.298</td><td>1.000</td><td>1797</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>270</td><td>HELLER_SILENCED_BY_METHYLATION_UP</td><td></td><td>157</td><td>0.33</td><td>1.42</td><td>0.040</td><td>0.302</td><td>1.000</td><td>3264</td><td>tags=48%, list=30%, signal=67%</td></tr><tr><td class='lessen'>271</td><td>DELYS_THYROID_CANCER_DN</td><td></td><td>136</td><td>0.37</td><td>1.42</td><td>0.077</td><td>0.300</td><td>1.000</td><td>1936</td><td>tags=30%, list=18%, signal=36%</td></tr><tr><td class='lessen'>272</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1</td><td></td><td>47</td><td>0.35</td><td>1.42</td><td>0.041</td><td>0.299</td><td>1.000</td><td>570</td><td>tags=17%, list=5%, signal=18%</td></tr><tr><td class='lessen'>273</td><td>DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP</td><td></td><td>41</td><td>0.37</td><td>1.42</td><td>0.020</td><td>0.299</td><td>1.000</td><td>1543</td><td>tags=27%, list=14%, signal=31%</td></tr><tr><td class='lessen'>274</td><td>IVANOVA_HEMATOPOIESIS_MATURE_CELL</td><td></td><td>139</td><td>0.40</td><td>1.42</td><td>0.047</td><td>0.298</td><td>1.000</td><td>2643</td><td>tags=42%, list=24%, signal=55%</td></tr><tr><td class='lessen'>275</td><td>RIGGINS_TAMOXIFEN_RESISTANCE_UP</td><td></td><td>38</td><td>0.40</td><td>1.42</td><td>0.023</td><td>0.300</td><td>1.000</td><td>2005</td><td>tags=34%, list=18%, signal=42%</td></tr><tr><td class='lessen'>276</td><td>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP</td><td></td><td>138</td><td>0.32</td><td>1.42</td><td>0.000</td><td>0.302</td><td>1.000</td><td>1577</td><td>tags=25%, list=14%, signal=29%</td></tr><tr><td class='lessen'>277</td><td>ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION</td><td></td><td>42</td><td>0.40</td><td>1.42</td><td>0.023</td><td>0.304</td><td>1.000</td><td>1653</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>278</td><td>NADLER_OBESITY_UP</td><td></td><td>28</td><td>0.53</td><td>1.42</td><td>0.159</td><td>0.305</td><td>1.000</td><td>3033</td><td>tags=68%, list=28%, signal=94%</td></tr><tr><td class='lessen'>279</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP</td><td></td><td>38</td><td>0.54</td><td>1.42</td><td>0.093</td><td>0.304</td><td>1.000</td><td>1930</td><td>tags=50%, list=18%, signal=61%</td></tr><tr><td class='lessen'>280</td><td>ZHAN_V2_LATE_DIFFERENTIATION_GENES</td><td></td><td>25</td><td>0.47</td><td>1.41</td><td>0.113</td><td>0.303</td><td>1.000</td><td>1927</td><td>tags=44%, list=18%, signal=53%</td></tr><tr><td class='lessen'>281</td><td>BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN</td><td></td><td>23</td><td>0.45</td><td>1.41</td><td>0.073</td><td>0.304</td><td>1.000</td><td>2563</td><td>tags=52%, list=24%, signal=68%</td></tr><tr><td class='lessen'>282</td><td>LEE_LIVER_CANCER_CIPROFIBRATE_DN</td><td></td><td>46</td><td>0.40</td><td>1.41</td><td>0.149</td><td>0.303</td><td>1.000</td><td>2173</td><td>tags=35%, list=20%, signal=43%</td></tr><tr><td class='lessen'>283</td><td>CORRE_MULTIPLE_MYELOMA_UP</td><td></td><td>28</td><td>0.40</td><td>1.41</td><td>0.037</td><td>0.302</td><td>1.000</td><td>1621</td><td>tags=32%, list=15%, signal=38%</td></tr><tr><td class='lessen'>284</td><td>BOYLAN_MULTIPLE_MYELOMA_C_D_DN</td><td></td><td>122</td><td>0.37</td><td>1.41</td><td>0.042</td><td>0.303</td><td>1.000</td><td>1783</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>285</td><td>DIRMEIER_LMP1_RESPONSE_EARLY</td><td></td><td>39</td><td>0.46</td><td>1.41</td><td>0.170</td><td>0.302</td><td>1.000</td><td>1955</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>286</td><td>TSUNODA_CISPLATIN_RESISTANCE_DN</td><td></td><td>23</td><td>0.46</td><td>1.41</td><td>0.065</td><td>0.302</td><td>1.000</td><td>2199</td><td>tags=43%, list=20%, signal=54%</td></tr><tr><td class='lessen'>287</td><td>VERRECCHIA_EARLY_RESPONSE_TO_TGFB1</td><td></td><td>34</td><td>0.39</td><td>1.41</td><td>0.036</td><td>0.303</td><td>1.000</td><td>1565</td><td>tags=32%, list=14%, signal=38%</td></tr><tr><td class='lessen'>288</td><td>HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN</td><td></td><td>38</td><td>0.40</td><td>1.41</td><td>0.068</td><td>0.303</td><td>1.000</td><td>2270</td><td>tags=42%, list=21%, signal=53%</td></tr><tr><td class='lessen'>289</td><td>CHANG_IMMORTALIZED_BY_HPV31_DN</td><td></td><td>37</td><td>0.41</td><td>1.41</td><td>0.057</td><td>0.305</td><td>1.000</td><td>642</td><td>tags=22%, list=6%, signal=23%</td></tr><tr><td class='lessen'>290</td><td>SWEET_LUNG_CANCER_KRAS_DN</td><td></td><td>234</td><td>0.30</td><td>1.41</td><td>0.022</td><td>0.304</td><td>1.000</td><td>1938</td><td>tags=29%, list=18%, signal=35%</td></tr><tr><td class='lessen'>291</td><td>SENESE_HDAC2_TARGETS_DN</td><td></td><td>67</td><td>0.36</td><td>1.41</td><td>0.074</td><td>0.303</td><td>1.000</td><td>2005</td><td>tags=31%, list=18%, signal=38%</td></tr><tr><td class='lessen'>292</td><td>SAGIV_CD24_TARGETS_DN</td><td></td><td>33</td><td>0.45</td><td>1.41</td><td>0.149</td><td>0.308</td><td>1.000</td><td>539</td><td>tags=21%, list=5%, signal=22%</td></tr><tr><td class='lessen'>293</td><td>KONDO_EZH2_TARGETS</td><td></td><td>118</td><td>0.30</td><td>1.41</td><td>0.000</td><td>0.307</td><td>1.000</td><td>1968</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>294</td><td>MORI_IMMATURE_B_LYMPHOCYTE_UP</td><td></td><td>30</td><td>0.44</td><td>1.41</td><td>0.122</td><td>0.307</td><td>1.000</td><td>3623</td><td>tags=63%, list=33%, signal=95%</td></tr><tr><td class='lessen'>295</td><td>NAKAMURA_ADIPOGENESIS_EARLY_UP</td><td></td><td>33</td><td>0.41</td><td>1.40</td><td>0.022</td><td>0.309</td><td>1.000</td><td>1833</td><td>tags=36%, list=17%, signal=44%</td></tr><tr><td class='lessen'>296</td><td>BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP</td><td></td><td>40</td><td>0.42</td><td>1.40</td><td>0.114</td><td>0.311</td><td>1.000</td><td>534</td><td>tags=25%, list=5%, signal=26%</td></tr><tr><td class='lessen'>297</td><td>HUANG_DASATINIB_RESISTANCE_UP</td><td></td><td>51</td><td>0.45</td><td>1.40</td><td>0.045</td><td>0.311</td><td>1.000</td><td>3014</td><td>tags=53%, list=28%, signal=73%</td></tr><tr><td class='lessen'>298</td><td>QI_HYPOXIA</td><td></td><td>76</td><td>0.39</td><td>1.40</td><td>0.067</td><td>0.312</td><td>1.000</td><td>1941</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>299</td><td>KOHOUTEK_CCNT1_TARGETS</td><td></td><td>25</td><td>0.49</td><td>1.40</td><td>0.065</td><td>0.314</td><td>1.000</td><td>1837</td><td>tags=36%, list=17%, signal=43%</td></tr><tr><td class='lessen'>300</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN</td><td></td><td>75</td><td>0.38</td><td>1.40</td><td>0.044</td><td>0.314</td><td>1.000</td><td>2008</td><td>tags=33%, list=18%, signal=41%</td></tr><tr><td class='lessen'>301</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP</td><td></td><td>300</td><td>0.28</td><td>1.40</td><td>0.000</td><td>0.314</td><td>1.000</td><td>1867</td><td>tags=25%, list=17%, signal=29%</td></tr><tr><td class='lessen'>302</td><td>BURTON_ADIPOGENESIS_2</td><td></td><td>38</td><td>0.40</td><td>1.39</td><td>0.106</td><td>0.320</td><td>1.000</td><td>1521</td><td>tags=34%, list=14%, signal=40%</td></tr><tr><td class='lessen'>303</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP</td><td></td><td>27</td><td>0.43</td><td>1.39</td><td>0.098</td><td>0.320</td><td>1.000</td><td>1783</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>304</td><td>QI_PLASMACYTOMA_UP</td><td></td><td>152</td><td>0.40</td><td>1.39</td><td>0.167</td><td>0.319</td><td>1.000</td><td>2321</td><td>tags=41%, list=21%, signal=51%</td></tr><tr><td class='lessen'>305</td><td>WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN</td><td></td><td>15</td><td>0.51</td><td>1.39</td><td>0.102</td><td>0.319</td><td>1.000</td><td>2030</td><td>tags=47%, list=19%, signal=57%</td></tr><tr><td class='lessen'>306</td><td>ZHAN_MULTIPLE_MYELOMA_MS_UP</td><td></td><td>23</td><td>0.37</td><td>1.39</td><td>0.055</td><td>0.320</td><td>1.000</td><td>820</td><td>tags=22%, list=8%, signal=23%</td></tr><tr><td class='lessen'>307</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6</td><td></td><td>34</td><td>0.41</td><td>1.39</td><td>0.188</td><td>0.325</td><td>1.000</td><td>1387</td><td>tags=32%, list=13%, signal=37%</td></tr><tr><td class='lessen'>308</td><td>MARCHINI_TRABECTEDIN_RESISTANCE_DN</td><td></td><td>32</td><td>0.37</td><td>1.39</td><td>0.028</td><td>0.326</td><td>1.000</td><td>156</td><td>tags=16%, list=1%, signal=16%</td></tr><tr><td class='lessen'>309</td><td>BRUECKNER_TARGETS_OF_MIRLET7A3_UP</td><td></td><td>61</td><td>0.39</td><td>1.39</td><td>0.106</td><td>0.327</td><td>1.000</td><td>665</td><td>tags=21%, list=6%, signal=23%</td></tr><tr><td class='lessen'>310</td><td>HUANG_GATA2_TARGETS_UP</td><td></td><td>65</td><td>0.39</td><td>1.39</td><td>0.128</td><td>0.328</td><td>1.000</td><td>2339</td><td>tags=40%, list=21%, signal=51%</td></tr><tr><td class='lessen'>311</td><td>HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS</td><td></td><td>44</td><td>0.45</td><td>1.39</td><td>0.133</td><td>0.328</td><td>1.000</td><td>1382</td><td>tags=27%, list=13%, signal=31%</td></tr><tr><td class='lessen'>312</td><td>CHEN_LIVER_METABOLISM_QTL_CIS</td><td></td><td>52</td><td>0.37</td><td>1.38</td><td>0.095</td><td>0.331</td><td>1.000</td><td>1396</td><td>tags=29%, list=13%, signal=33%</td></tr><tr><td class='lessen'>313</td><td>ZHAN_MULTIPLE_MYELOMA_MF_DN</td><td></td><td>20</td><td>0.46</td><td>1.38</td><td>0.087</td><td>0.330</td><td>1.000</td><td>996</td><td>tags=35%, list=9%, signal=38%</td></tr><tr><td class='lessen'>314</td><td>ONO_FOXP3_TARGETS_UP</td><td></td><td>15</td><td>0.52</td><td>1.38</td><td>0.163</td><td>0.329</td><td>1.000</td><td>1246</td><td>tags=33%, list=11%, signal=38%</td></tr><tr><td class='lessen'>315</td><td>SERVITJA_ISLET_HNF1A_TARGETS_UP</td><td></td><td>104</td><td>0.32</td><td>1.38</td><td>0.025</td><td>0.330</td><td>1.000</td><td>2546</td><td>tags=37%, list=23%, signal=47%</td></tr><tr><td class='lessen'>316</td><td>BEIER_GLIOMA_STEM_CELL_DN</td><td></td><td>35</td><td>0.40</td><td>1.38</td><td>0.096</td><td>0.332</td><td>1.000</td><td>2920</td><td>tags=49%, list=27%, signal=66%</td></tr><tr><td class='lessen'>317</td><td>BAE_BRCA1_TARGETS_UP</td><td></td><td>43</td><td>0.38</td><td>1.38</td><td>0.070</td><td>0.334</td><td>1.000</td><td>2333</td><td>tags=42%, list=21%, signal=53%</td></tr><tr><td class='lessen'>318</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP</td><td></td><td>47</td><td>0.34</td><td>1.38</td><td>0.053</td><td>0.337</td><td>1.000</td><td>1318</td><td>tags=26%, list=12%, signal=29%</td></tr><tr><td class='lessen'>319</td><td>ZHAN_MULTIPLE_MYELOMA_HP_DN</td><td></td><td>22</td><td>0.47</td><td>1.38</td><td>0.063</td><td>0.340</td><td>1.000</td><td>3009</td><td>tags=55%, list=28%, signal=75%</td></tr><tr><td class='lessen'>320</td><td>LEE_LIVER_CANCER_MYC_TGFA_UP</td><td></td><td>31</td><td>0.43</td><td>1.38</td><td>0.159</td><td>0.341</td><td>1.000</td><td>1464</td><td>tags=26%, list=13%, signal=30%</td></tr><tr><td class='lessen'>321</td><td>PRAMOONJAGO_SOX4_TARGETS_UP</td><td></td><td>25</td><td>0.53</td><td>1.38</td><td>0.106</td><td>0.340</td><td>1.000</td><td>3487</td><td>tags=64%, list=32%, signal=94%</td></tr><tr><td class='lessen'>322</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP</td><td></td><td>395</td><td>0.30</td><td>1.37</td><td>0.078</td><td>0.341</td><td>1.000</td><td>2374</td><td>tags=33%, list=22%, signal=40%</td></tr><tr><td class='lessen'>323</td><td>HAN_JNK_SINGALING_UP</td><td></td><td>18</td><td>0.45</td><td>1.37</td><td>0.060</td><td>0.344</td><td>1.000</td><td>1436</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>324</td><td>JAATINEN_HEMATOPOIETIC_STEM_CELL_DN</td><td></td><td>115</td><td>0.42</td><td>1.37</td><td>0.049</td><td>0.345</td><td>1.000</td><td>2558</td><td>tags=41%, list=24%, signal=53%</td></tr><tr><td class='lessen'>325</td><td>FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN</td><td></td><td>55</td><td>0.38</td><td>1.37</td><td>0.143</td><td>0.345</td><td>1.000</td><td>2042</td><td>tags=33%, list=19%, signal=40%</td></tr><tr><td class='lessen'>326</td><td>VALK_AML_CLUSTER_9</td><td></td><td>18</td><td>0.48</td><td>1.37</td><td>0.143</td><td>0.344</td><td>1.000</td><td>1744</td><td>tags=44%, list=16%, signal=53%</td></tr><tr><td class='lessen'>327</td><td>LUCAS_HNF4A_TARGETS_UP</td><td></td><td>36</td><td>0.38</td><td>1.37</td><td>0.067</td><td>0.343</td><td>1.000</td><td>1234</td><td>tags=28%, list=11%, signal=31%</td></tr><tr><td class='lessen'>328</td><td>ELVIDGE_HIF1A_TARGETS_DN</td><td></td><td>50</td><td>0.41</td><td>1.37</td><td>0.104</td><td>0.347</td><td>1.000</td><td>1842</td><td>tags=38%, list=17%, signal=46%</td></tr><tr><td class='lessen'>329</td><td>WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP</td><td></td><td>168</td><td>0.29</td><td>1.37</td><td>0.053</td><td>0.347</td><td>1.000</td><td>2546</td><td>tags=36%, list=23%, signal=46%</td></tr><tr><td class='lessen'>330</td><td>CHIBA_RESPONSE_TO_TSA</td><td></td><td>20</td><td>0.36</td><td>1.37</td><td>0.067</td><td>0.349</td><td>1.000</td><td>1565</td><td>tags=30%, list=14%, signal=35%</td></tr><tr><td class='lessen'>331</td><td>LEE_EARLY_T_LYMPHOCYTE_DN</td><td></td><td>29</td><td>0.45</td><td>1.37</td><td>0.157</td><td>0.348</td><td>1.000</td><td>1322</td><td>tags=31%, list=12%, signal=35%</td></tr><tr><td class='lessen'>332</td><td>BURTON_ADIPOGENESIS_10</td><td></td><td>19</td><td>0.47</td><td>1.37</td><td>0.102</td><td>0.348</td><td>1.000</td><td>1467</td><td>tags=42%, list=13%, signal=49%</td></tr><tr><td class='lessen'>333</td><td>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN</td><td></td><td>32</td><td>0.38</td><td>1.37</td><td>0.061</td><td>0.348</td><td>1.000</td><td>1710</td><td>tags=41%, list=16%, signal=48%</td></tr><tr><td class='lessen'>334</td><td>RIZKI_TUMOR_INVASIVENESS_2D_UP</td><td></td><td>36</td><td>0.36</td><td>1.36</td><td>0.083</td><td>0.350</td><td>1.000</td><td>1929</td><td>tags=36%, list=18%, signal=44%</td></tr><tr><td class='lessen'>335</td><td>ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN</td><td></td><td>72</td><td>0.38</td><td>1.36</td><td>0.111</td><td>0.355</td><td>1.000</td><td>1797</td><td>tags=36%, list=17%, signal=43%</td></tr><tr><td class='lessen'>336</td><td>HAN_SATB1_TARGETS_DN</td><td></td><td>253</td><td>0.33</td><td>1.36</td><td>0.087</td><td>0.357</td><td>1.000</td><td>1629</td><td>tags=27%, list=15%, signal=31%</td></tr><tr><td class='lessen'>337</td><td>TAVOR_CEBPA_TARGETS_UP</td><td></td><td>25</td><td>0.50</td><td>1.36</td><td>0.156</td><td>0.356</td><td>1.000</td><td>2270</td><td>tags=52%, list=21%, signal=66%</td></tr><tr><td class='lessen'>338</td><td>ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP</td><td></td><td>109</td><td>0.34</td><td>1.36</td><td>0.083</td><td>0.357</td><td>1.000</td><td>2461</td><td>tags=38%, list=23%, signal=48%</td></tr><tr><td class='lessen'>339</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_D</td><td></td><td>44</td><td>0.46</td><td>1.36</td><td>0.205</td><td>0.358</td><td>1.000</td><td>2418</td><td>tags=43%, list=22%, signal=55%</td></tr><tr><td class='lessen'>340</td><td>VILIMAS_NOTCH1_TARGETS_UP</td><td></td><td>28</td><td>0.50</td><td>1.36</td><td>0.157</td><td>0.360</td><td>1.000</td><td>2199</td><td>tags=50%, list=20%, signal=62%</td></tr><tr><td class='lessen'>341</td><td>KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP</td><td></td><td>71</td><td>0.30</td><td>1.36</td><td>0.044</td><td>0.359</td><td>1.000</td><td>1883</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>342</td><td>SHIPP_DLBCL_CURED_VS_FATAL_UP</td><td></td><td>27</td><td>0.44</td><td>1.36</td><td>0.184</td><td>0.360</td><td>1.000</td><td>1693</td><td>tags=33%, list=16%, signal=39%</td></tr><tr><td class='lessen'>343</td><td>CHUANG_OXIDATIVE_STRESS_RESPONSE_UP</td><td></td><td>19</td><td>0.43</td><td>1.36</td><td>0.023</td><td>0.359</td><td>1.000</td><td>1595</td><td>tags=32%, list=15%, signal=37%</td></tr><tr><td class='lessen'>344</td><td>EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN</td><td></td><td>25</td><td>0.37</td><td>1.36</td><td>0.039</td><td>0.359</td><td>1.000</td><td>1645</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>345</td><td>GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN</td><td></td><td>29</td><td>0.45</td><td>1.36</td><td>0.104</td><td>0.358</td><td>1.000</td><td>3527</td><td>tags=55%, list=32%, signal=81%</td></tr><tr><td class='lessen'>346</td><td>JACKSON_DNMT1_TARGETS_UP</td><td></td><td>47</td><td>0.36</td><td>1.36</td><td>0.118</td><td>0.358</td><td>1.000</td><td>1550</td><td>tags=28%, list=14%, signal=32%</td></tr><tr><td class='lessen'>347</td><td>CUI_TCF21_TARGETS_UP</td><td></td><td>20</td><td>0.38</td><td>1.35</td><td>0.100</td><td>0.358</td><td>1.000</td><td>1198</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>348</td><td>BOYLAN_MULTIPLE_MYELOMA_D_UP</td><td></td><td>46</td><td>0.34</td><td>1.35</td><td>0.023</td><td>0.358</td><td>1.000</td><td>1595</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>349</td><td>KATSANOU_ELAVL1_TARGETS_UP</td><td></td><td>88</td><td>0.34</td><td>1.35</td><td>0.040</td><td>0.358</td><td>1.000</td><td>2828</td><td>tags=44%, list=26%, signal=59%</td></tr><tr><td class='lessen'>350</td><td>SCHOEN_NFKB_SIGNALING</td><td></td><td>20</td><td>0.47</td><td>1.35</td><td>0.132</td><td>0.360</td><td>1.000</td><td>1885</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>351</td><td>MATZUK_SPERMATOZOA</td><td></td><td>65</td><td>0.34</td><td>1.35</td><td>0.074</td><td>0.362</td><td>1.000</td><td>611</td><td>tags=17%, list=6%, signal=18%</td></tr><tr><td class='lessen'>352</td><td>LEONARD_HYPOXIA</td><td></td><td>21</td><td>0.52</td><td>1.35</td><td>0.173</td><td>0.362</td><td>1.000</td><td>2178</td><td>tags=52%, list=20%, signal=65%</td></tr><tr><td class='lessen'>353</td><td>LEIN_MIDBRAIN_MARKERS</td><td></td><td>40</td><td>0.41</td><td>1.35</td><td>0.082</td><td>0.362</td><td>1.000</td><td>1859</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>354</td><td>RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN</td><td></td><td>137</td><td>0.34</td><td>1.35</td><td>0.019</td><td>0.361</td><td>1.000</td><td>2302</td><td>tags=33%, list=21%, signal=41%</td></tr><tr><td class='lessen'>355</td><td>ROSS_AML_WITH_AML1_ETO_FUSION</td><td></td><td>47</td><td>0.36</td><td>1.35</td><td>0.125</td><td>0.361</td><td>1.000</td><td>2355</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>356</td><td>ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN</td><td></td><td>135</td><td>0.31</td><td>1.35</td><td>0.022</td><td>0.360</td><td>1.000</td><td>1846</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>357</td><td>GEORGANTAS_HSC_MARKERS</td><td></td><td>42</td><td>0.36</td><td>1.35</td><td>0.070</td><td>0.361</td><td>1.000</td><td>3029</td><td>tags=45%, list=28%, signal=62%</td></tr><tr><td class='lessen'>358</td><td>LEE_LIVER_CANCER_DENA_UP</td><td></td><td>35</td><td>0.36</td><td>1.35</td><td>0.116</td><td>0.361</td><td>1.000</td><td>2611</td><td>tags=37%, list=24%, signal=49%</td></tr><tr><td class='lessen'>359</td><td>CHYLA_CBFA2T3_TARGETS_DN</td><td></td><td>109</td><td>0.30</td><td>1.35</td><td>0.040</td><td>0.363</td><td>1.000</td><td>2558</td><td>tags=38%, list=24%, signal=49%</td></tr><tr><td class='lessen'>360</td><td>LIN_NPAS4_TARGETS_UP</td><td></td><td>79</td><td>0.34</td><td>1.35</td><td>0.082</td><td>0.362</td><td>1.000</td><td>2813</td><td>tags=37%, list=26%, signal=49%</td></tr><tr><td class='lessen'>361</td><td>SASSON_RESPONSE_TO_GONADOTROPHINS_DN</td><td></td><td>50</td><td>0.37</td><td>1.35</td><td>0.136</td><td>0.363</td><td>1.000</td><td>1507</td><td>tags=30%, list=14%, signal=35%</td></tr><tr><td class='lessen'>362</td><td>MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN</td><td></td><td>177</td><td>0.31</td><td>1.35</td><td>0.098</td><td>0.364</td><td>1.000</td><td>1886</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>363</td><td>WIERENGA_STAT5A_TARGETS_DN</td><td></td><td>98</td><td>0.34</td><td>1.34</td><td>0.083</td><td>0.366</td><td>1.000</td><td>2866</td><td>tags=38%, list=26%, signal=51%</td></tr><tr><td class='lessen'>364</td><td>BAELDE_DIABETIC_NEPHROPATHY_DN</td><td></td><td>221</td><td>0.31</td><td>1.34</td><td>0.083</td><td>0.366</td><td>1.000</td><td>2302</td><td>tags=35%, list=21%, signal=43%</td></tr><tr><td class='lessen'>365</td><td>JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP</td><td></td><td>62</td><td>0.38</td><td>1.34</td><td>0.163</td><td>0.366</td><td>1.000</td><td>3451</td><td>tags=58%, list=32%, signal=85%</td></tr><tr><td class='lessen'>366</td><td>PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP</td><td></td><td>67</td><td>0.35</td><td>1.34</td><td>0.091</td><td>0.366</td><td>1.000</td><td>1935</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>367</td><td>DIRMEIER_LMP1_RESPONSE_LATE_UP</td><td></td><td>30</td><td>0.46</td><td>1.34</td><td>0.163</td><td>0.366</td><td>1.000</td><td>1874</td><td>tags=43%, list=17%, signal=52%</td></tr><tr><td class='lessen'>368</td><td>ZHU_CMV_24_HR_DN</td><td></td><td>56</td><td>0.34</td><td>1.34</td><td>0.085</td><td>0.366</td><td>1.000</td><td>3247</td><td>tags=48%, list=30%, signal=68%</td></tr><tr><td class='lessen'>369</td><td>LIM_MAMMARY_LUMINAL_MATURE_DN</td><td></td><td>54</td><td>0.34</td><td>1.34</td><td>0.111</td><td>0.365</td><td>1.000</td><td>1260</td><td>tags=26%, list=12%, signal=29%</td></tr><tr><td class='lessen'>370</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_B</td><td></td><td>31</td><td>0.45</td><td>1.34</td><td>0.120</td><td>0.364</td><td>1.000</td><td>2175</td><td>tags=35%, list=20%, signal=44%</td></tr><tr><td class='lessen'>371</td><td>LANDIS_BREAST_CANCER_PROGRESSION_DN</td><td></td><td>39</td><td>0.40</td><td>1.34</td><td>0.083</td><td>0.364</td><td>1.000</td><td>2536</td><td>tags=49%, list=23%, signal=63%</td></tr><tr><td class='lessen'>372</td><td>NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER</td><td></td><td>49</td><td>0.36</td><td>1.34</td><td>0.039</td><td>0.363</td><td>1.000</td><td>2723</td><td>tags=39%, list=25%, signal=51%</td></tr><tr><td class='lessen'>373</td><td>COATES_MACROPHAGE_M1_VS_M2_DN</td><td></td><td>39</td><td>0.38</td><td>1.34</td><td>0.109</td><td>0.365</td><td>1.000</td><td>1258</td><td>tags=28%, list=12%, signal=32%</td></tr><tr><td class='lessen'>374</td><td>PATTERSON_DOCETAXEL_RESISTANCE</td><td></td><td>19</td><td>0.44</td><td>1.34</td><td>0.098</td><td>0.365</td><td>1.000</td><td>1914</td><td>tags=42%, list=18%, signal=51%</td></tr><tr><td class='lessen'>375</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP</td><td></td><td>52</td><td>0.35</td><td>1.34</td><td>0.111</td><td>0.365</td><td>1.000</td><td>1064</td><td>tags=25%, list=10%, signal=28%</td></tr><tr><td class='lessen'>376</td><td>PENG_RAPAMYCIN_RESPONSE_UP</td><td></td><td>110</td><td>0.33</td><td>1.34</td><td>0.041</td><td>0.365</td><td>1.000</td><td>2242</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>377</td><td>MORI_LARGE_PRE_BII_LYMPHOCYTE_DN</td><td></td><td>23</td><td>0.48</td><td>1.34</td><td>0.128</td><td>0.365</td><td>1.000</td><td>2199</td><td>tags=43%, list=20%, signal=54%</td></tr><tr><td class='lessen'>378</td><td>NAKAMURA_METASTASIS_MODEL_UP</td><td></td><td>21</td><td>0.45</td><td>1.34</td><td>0.179</td><td>0.365</td><td>1.000</td><td>2576</td><td>tags=43%, list=24%, signal=56%</td></tr><tr><td class='lessen'>379</td><td>PODAR_RESPONSE_TO_ADAPHOSTIN_UP</td><td></td><td>68</td><td>0.39</td><td>1.34</td><td>0.149</td><td>0.365</td><td>1.000</td><td>1765</td><td>tags=37%, list=16%, signal=44%</td></tr><tr><td class='lessen'>380</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_UP</td><td></td><td>83</td><td>0.31</td><td>1.34</td><td>0.104</td><td>0.364</td><td>1.000</td><td>2307</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>381</td><td>HOLLMANN_APOPTOSIS_VIA_CD40_DN</td><td></td><td>136</td><td>0.30</td><td>1.34</td><td>0.091</td><td>0.364</td><td>1.000</td><td>1978</td><td>tags=29%, list=18%, signal=35%</td></tr><tr><td class='lessen'>382</td><td>NAKAMURA_ADIPOGENESIS_EARLY_DN</td><td></td><td>20</td><td>0.40</td><td>1.34</td><td>0.102</td><td>0.364</td><td>1.000</td><td>1901</td><td>tags=40%, list=17%, signal=48%</td></tr><tr><td class='lessen'>383</td><td>GROSS_HYPOXIA_VIA_ELK3_ONLY_UP</td><td></td><td>22</td><td>0.45</td><td>1.34</td><td>0.179</td><td>0.363</td><td>1.000</td><td>1765</td><td>tags=41%, list=16%, signal=49%</td></tr><tr><td class='lessen'>384</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN</td><td></td><td>22</td><td>0.45</td><td>1.34</td><td>0.160</td><td>0.363</td><td>1.000</td><td>1787</td><td>tags=36%, list=16%, signal=43%</td></tr><tr><td class='lessen'>385</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_P2</td><td></td><td>39</td><td>0.34</td><td>1.34</td><td>0.074</td><td>0.363</td><td>1.000</td><td>1680</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>386</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN</td><td></td><td>27</td><td>0.43</td><td>1.34</td><td>0.154</td><td>0.362</td><td>1.000</td><td>2435</td><td>tags=41%, list=22%, signal=52%</td></tr><tr><td class='lessen'>387</td><td>VALK_AML_WITH_EVI1</td><td></td><td>16</td><td>0.44</td><td>1.33</td><td>0.085</td><td>0.363</td><td>1.000</td><td>1231</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>388</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_P4</td><td></td><td>49</td><td>0.35</td><td>1.33</td><td>0.151</td><td>0.364</td><td>1.000</td><td>1695</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>389</td><td>SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1</td><td></td><td>263</td><td>0.30</td><td>1.33</td><td>0.000</td><td>0.372</td><td>1.000</td><td>2900</td><td>tags=38%, list=27%, signal=50%</td></tr><tr><td class='lessen'>390</td><td>KARLSSON_TGFB1_TARGETS_DN</td><td></td><td>106</td><td>0.33</td><td>1.33</td><td>0.143</td><td>0.375</td><td>1.000</td><td>1780</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>391</td><td>WILENSKY_RESPONSE_TO_DARAPLADIB</td><td></td><td>15</td><td>0.57</td><td>1.33</td><td>0.170</td><td>0.376</td><td>1.000</td><td>3172</td><td>tags=67%, list=29%, signal=94%</td></tr><tr><td class='lessen'>392</td><td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE</td><td></td><td>35</td><td>0.36</td><td>1.33</td><td>0.143</td><td>0.378</td><td>1.000</td><td>1930</td><td>tags=34%, list=18%, signal=42%</td></tr><tr><td class='lessen'>393</td><td>WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP</td><td></td><td>33</td><td>0.49</td><td>1.33</td><td>0.159</td><td>0.378</td><td>1.000</td><td>1720</td><td>tags=45%, list=16%, signal=54%</td></tr><tr><td class='lessen'>394</td><td>LE_EGR2_TARGETS_DN</td><td></td><td>60</td><td>0.35</td><td>1.33</td><td>0.078</td><td>0.377</td><td>1.000</td><td>1941</td><td>tags=37%, list=18%, signal=44%</td></tr><tr><td class='lessen'>395</td><td>PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP</td><td></td><td>32</td><td>0.42</td><td>1.33</td><td>0.143</td><td>0.377</td><td>1.000</td><td>1754</td><td>tags=44%, list=16%, signal=52%</td></tr><tr><td class='lessen'>396</td><td>HUPER_BREAST_BASAL_VS_LUMINAL_DN</td><td></td><td>32</td><td>0.46</td><td>1.32</td><td>0.143</td><td>0.376</td><td>1.000</td><td>1324</td><td>tags=38%, list=12%, signal=43%</td></tr><tr><td class='lessen'>397</td><td>KASLER_HDAC7_TARGETS_1_UP</td><td></td><td>100</td><td>0.31</td><td>1.32</td><td>0.091</td><td>0.377</td><td>1.000</td><td>2356</td><td>tags=32%, list=22%, signal=40%</td></tr><tr><td class='lessen'>398</td><td>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP</td><td></td><td>45</td><td>0.41</td><td>1.32</td><td>0.125</td><td>0.377</td><td>1.000</td><td>2175</td><td>tags=40%, list=20%, signal=50%</td></tr><tr><td class='lessen'>399</td><td>VERHAAK_AML_WITH_NPM1_MUTATED_UP</td><td></td><td>105</td><td>0.41</td><td>1.32</td><td>0.209</td><td>0.377</td><td>1.000</td><td>2792</td><td>tags=48%, list=26%, signal=63%</td></tr><tr><td class='lessen'>400</td><td>CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN</td><td></td><td>21</td><td>0.43</td><td>1.32</td><td>0.083</td><td>0.377</td><td>1.000</td><td>1422</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>401</td><td>IKEDA_MIR1_TARGETS_UP</td><td></td><td>37</td><td>0.39</td><td>1.32</td><td>0.149</td><td>0.376</td><td>1.000</td><td>364</td><td>tags=19%, list=3%, signal=20%</td></tr><tr><td class='lessen'>402</td><td>AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP</td><td></td><td>63</td><td>0.38</td><td>1.32</td><td>0.087</td><td>0.377</td><td>1.000</td><td>2318</td><td>tags=35%, list=21%, signal=44%</td></tr><tr><td class='lessen'>403</td><td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP</td><td></td><td>103</td><td>0.36</td><td>1.32</td><td>0.111</td><td>0.376</td><td>1.000</td><td>2333</td><td>tags=38%, list=21%, signal=48%</td></tr><tr><td class='lessen'>404</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP</td><td></td><td>62</td><td>0.31</td><td>1.32</td><td>0.103</td><td>0.378</td><td>1.000</td><td>1592</td><td>tags=29%, list=15%, signal=34%</td></tr><tr><td class='lessen'>405</td><td>VERHAAK_AML_WITH_NPM1_MUTATED_DN</td><td></td><td>125</td><td>0.33</td><td>1.32</td><td>0.149</td><td>0.377</td><td>1.000</td><td>2576</td><td>tags=35%, list=24%, signal=46%</td></tr><tr><td class='lessen'>406</td><td>PEART_HDAC_PROLIFERATION_CLUSTER_UP</td><td></td><td>34</td><td>0.37</td><td>1.32</td><td>0.081</td><td>0.376</td><td>1.000</td><td>2224</td><td>tags=38%, list=20%, signal=48%</td></tr><tr><td class='lessen'>407</td><td>LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER</td><td></td><td>104</td><td>0.30</td><td>1.32</td><td>0.089</td><td>0.377</td><td>1.000</td><td>2456</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>408</td><td>BORCZUK_MALIGNANT_MESOTHELIOMA_DN</td><td></td><td>51</td><td>0.33</td><td>1.32</td><td>0.132</td><td>0.376</td><td>1.000</td><td>1735</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>409</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP</td><td></td><td>472</td><td>0.27</td><td>1.32</td><td>0.060</td><td>0.377</td><td>1.000</td><td>1506</td><td>tags=22%, list=14%, signal=24%</td></tr><tr><td class='lessen'>410</td><td>MAHAJAN_RESPONSE_TO_IL1A_UP</td><td></td><td>55</td><td>0.33</td><td>1.32</td><td>0.064</td><td>0.376</td><td>1.000</td><td>2951</td><td>tags=38%, list=27%, signal=52%</td></tr><tr><td class='lessen'>411</td><td>RAMALHO_STEMNESS_DN</td><td></td><td>41</td><td>0.44</td><td>1.32</td><td>0.158</td><td>0.379</td><td>1.000</td><td>2922</td><td>tags=51%, list=27%, signal=70%</td></tr><tr><td class='lessen'>412</td><td>GRABARCZYK_BCL11B_TARGETS_DN</td><td></td><td>31</td><td>0.43</td><td>1.32</td><td>0.116</td><td>0.378</td><td>1.000</td><td>2184</td><td>tags=35%, list=20%, signal=44%</td></tr><tr><td class='lessen'>413</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP</td><td></td><td>63</td><td>0.43</td><td>1.32</td><td>0.095</td><td>0.379</td><td>1.000</td><td>1661</td><td>tags=35%, list=15%, signal=41%</td></tr><tr><td class='lessen'>414</td><td>WIELAND_UP_BY_HBV_INFECTION</td><td></td><td>48</td><td>0.44</td><td>1.32</td><td>0.204</td><td>0.378</td><td>1.000</td><td>2918</td><td>tags=52%, list=27%, signal=71%</td></tr><tr><td class='lessen'>415</td><td>DURAND_STROMA_NS_UP</td><td></td><td>85</td><td>0.31</td><td>1.31</td><td>0.000</td><td>0.380</td><td>1.000</td><td>1844</td><td>tags=28%, list=17%, signal=34%</td></tr><tr><td class='lessen'>416</td><td>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN</td><td></td><td>115</td><td>0.33</td><td>1.31</td><td>0.064</td><td>0.382</td><td>1.000</td><td>2365</td><td>tags=35%, list=22%, signal=44%</td></tr><tr><td class='lessen'>417</td><td>KANG_GLIS3_TARGETS</td><td></td><td>19</td><td>0.43</td><td>1.31</td><td>0.146</td><td>0.382</td><td>1.000</td><td>1853</td><td>tags=26%, list=17%, signal=32%</td></tr><tr><td class='lessen'>418</td><td>ZHAN_MULTIPLE_MYELOMA_MF_UP</td><td></td><td>21</td><td>0.45</td><td>1.31</td><td>0.167</td><td>0.383</td><td>1.000</td><td>3457</td><td>tags=71%, list=32%, signal=104%</td></tr><tr><td class='lessen'>419</td><td>ROSS_ACUTE_MYELOID_LEUKEMIA_CBF</td><td></td><td>42</td><td>0.33</td><td>1.31</td><td>0.095</td><td>0.385</td><td>1.000</td><td>2423</td><td>tags=36%, list=22%, signal=46%</td></tr><tr><td class='lessen'>420</td><td>JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP</td><td></td><td>62</td><td>0.33</td><td>1.31</td><td>0.133</td><td>0.385</td><td>1.000</td><td>2469</td><td>tags=35%, list=23%, signal=46%</td></tr><tr><td class='lessen'>421</td><td>MCLACHLAN_DENTAL_CARIES_UP</td><td></td><td>129</td><td>0.45</td><td>1.31</td><td>0.333</td><td>0.386</td><td>1.000</td><td>2199</td><td>tags=42%, list=20%, signal=52%</td></tr><tr><td class='lessen'>422</td><td>WARTERS_RESPONSE_TO_IR_SKIN</td><td></td><td>36</td><td>0.35</td><td>1.31</td><td>0.136</td><td>0.385</td><td>1.000</td><td>1652</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>423</td><td>HSIAO_LIVER_SPECIFIC_GENES</td><td></td><td>144</td><td>0.35</td><td>1.31</td><td>0.098</td><td>0.387</td><td>1.000</td><td>2024</td><td>tags=31%, list=19%, signal=37%</td></tr><tr><td class='lessen'>424</td><td>HEIDENBLAD_AMPLICON_12P11_12_UP</td><td></td><td>19</td><td>0.41</td><td>1.31</td><td>0.073</td><td>0.387</td><td>1.000</td><td>1242</td><td>tags=26%, list=11%, signal=30%</td></tr><tr><td class='lessen'>425</td><td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST</td><td></td><td>68</td><td>0.32</td><td>1.31</td><td>0.080</td><td>0.388</td><td>1.000</td><td>1521</td><td>tags=26%, list=14%, signal=31%</td></tr><tr><td class='lessen'>426</td><td>MUNSHI_MULTIPLE_MYELOMA_UP</td><td></td><td>46</td><td>0.35</td><td>1.31</td><td>0.133</td><td>0.388</td><td>1.000</td><td>2697</td><td>tags=43%, list=25%, signal=58%</td></tr><tr><td class='lessen'>427</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S3</td><td></td><td>152</td><td>0.31</td><td>1.30</td><td>0.133</td><td>0.389</td><td>1.000</td><td>3069</td><td>tags=40%, list=28%, signal=55%</td></tr><tr><td class='lessen'>428</td><td>SENGUPTA_EBNA1_ANTICORRELATED</td><td></td><td>85</td><td>0.38</td><td>1.30</td><td>0.137</td><td>0.389</td><td>1.000</td><td>1644</td><td>tags=27%, list=15%, signal=32%</td></tr><tr><td class='lessen'>429</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C</td><td></td><td>40</td><td>0.35</td><td>1.30</td><td>0.118</td><td>0.391</td><td>1.000</td><td>1362</td><td>tags=28%, list=13%, signal=31%</td></tr><tr><td class='lessen'>430</td><td>LU_AGING_BRAIN_UP</td><td></td><td>146</td><td>0.30</td><td>1.30</td><td>0.140</td><td>0.391</td><td>1.000</td><td>2268</td><td>tags=34%, list=21%, signal=43%</td></tr><tr><td class='lessen'>431</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5</td><td></td><td>232</td><td>0.28</td><td>1.30</td><td>0.163</td><td>0.391</td><td>1.000</td><td>2238</td><td>tags=30%, list=21%, signal=37%</td></tr><tr><td class='lessen'>432</td><td>OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP</td><td></td><td>15</td><td>0.45</td><td>1.30</td><td>0.098</td><td>0.395</td><td>1.000</td><td>1282</td><td>tags=33%, list=12%, signal=38%</td></tr><tr><td class='lessen'>433</td><td>ALFANO_MYC_TARGETS</td><td></td><td>126</td><td>0.29</td><td>1.30</td><td>0.089</td><td>0.394</td><td>1.000</td><td>685</td><td>tags=14%, list=6%, signal=15%</td></tr><tr><td class='lessen'>434</td><td>HWANG_PROSTATE_CANCER_MARKERS</td><td></td><td>15</td><td>0.43</td><td>1.30</td><td>0.114</td><td>0.394</td><td>1.000</td><td>1300</td><td>tags=40%, list=12%, signal=45%</td></tr><tr><td class='lessen'>435</td><td>FINETTI_BREAST_CANCERS_KINOME_BLUE</td><td></td><td>15</td><td>0.45</td><td>1.30</td><td>0.176</td><td>0.394</td><td>1.000</td><td>54</td><td>tags=13%, list=0%, signal=13%</td></tr><tr><td class='lessen'>436</td><td>MARTINEZ_RB1_AND_TP53_TARGETS_UP</td><td></td><td>338</td><td>0.27</td><td>1.30</td><td>0.051</td><td>0.393</td><td>1.000</td><td>2285</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>437</td><td>LEIN_CHOROID_PLEXUS_MARKERS</td><td></td><td>45</td><td>0.33</td><td>1.30</td><td>0.098</td><td>0.393</td><td>1.000</td><td>1429</td><td>tags=27%, list=13%, signal=31%</td></tr><tr><td class='lessen'>438</td><td>SANA_RESPONSE_TO_IFNG_DN</td><td></td><td>42</td><td>0.34</td><td>1.30</td><td>0.149</td><td>0.393</td><td>1.000</td><td>2297</td><td>tags=36%, list=21%, signal=45%</td></tr><tr><td class='lessen'>439</td><td>BARRIER_COLON_CANCER_RECURRENCE_UP</td><td></td><td>23</td><td>0.44</td><td>1.30</td><td>0.200</td><td>0.393</td><td>1.000</td><td>2045</td><td>tags=39%, list=19%, signal=48%</td></tr><tr><td class='lessen'>440</td><td>DER_IFN_BETA_RESPONSE_UP</td><td></td><td>48</td><td>0.36</td><td>1.30</td><td>0.111</td><td>0.393</td><td>1.000</td><td>943</td><td>tags=21%, list=9%, signal=23%</td></tr><tr><td class='lessen'>441</td><td>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN</td><td></td><td>85</td><td>0.31</td><td>1.30</td><td>0.122</td><td>0.395</td><td>1.000</td><td>1321</td><td>tags=22%, list=12%, signal=25%</td></tr><tr><td class='lessen'>442</td><td>BROWN_MYELOID_CELL_DEVELOPMENT_UP</td><td></td><td>88</td><td>0.36</td><td>1.30</td><td>0.304</td><td>0.395</td><td>1.000</td><td>2558</td><td>tags=40%, list=24%, signal=52%</td></tr><tr><td class='lessen'>443</td><td>MILI_PSEUDOPODIA</td><td></td><td>23</td><td>0.39</td><td>1.30</td><td>0.133</td><td>0.394</td><td>1.000</td><td>875</td><td>tags=22%, list=8%, signal=24%</td></tr><tr><td class='lessen'>444</td><td>DELPUECH_FOXO3_TARGETS_UP</td><td></td><td>47</td><td>0.43</td><td>1.29</td><td>0.175</td><td>0.395</td><td>1.000</td><td>3248</td><td>tags=53%, list=30%, signal=75%</td></tr><tr><td class='lessen'>445</td><td>ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP</td><td></td><td>83</td><td>0.32</td><td>1.29</td><td>0.188</td><td>0.394</td><td>1.000</td><td>1279</td><td>tags=22%, list=12%, signal=24%</td></tr><tr><td class='lessen'>446</td><td>RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP</td><td></td><td>18</td><td>0.43</td><td>1.29</td><td>0.174</td><td>0.397</td><td>1.000</td><td>2270</td><td>tags=39%, list=21%, signal=49%</td></tr><tr><td class='lessen'>447</td><td>NUTT_GBM_VS_AO_GLIOMA_UP</td><td></td><td>26</td><td>0.37</td><td>1.29</td><td>0.122</td><td>0.396</td><td>1.000</td><td>2880</td><td>tags=50%, list=26%, signal=68%</td></tr><tr><td class='lessen'>448</td><td>YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN</td><td></td><td>35</td><td>0.36</td><td>1.29</td><td>0.167</td><td>0.396</td><td>1.000</td><td>1290</td><td>tags=26%, list=12%, signal=29%</td></tr><tr><td class='lessen'>449</td><td>PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP</td><td></td><td>26</td><td>0.35</td><td>1.29</td><td>0.098</td><td>0.396</td><td>1.000</td><td>1744</td><td>tags=31%, list=16%, signal=37%</td></tr><tr><td class='lessen'>450</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP</td><td></td><td>22</td><td>0.50</td><td>1.29</td><td>0.170</td><td>0.397</td><td>1.000</td><td>2725</td><td>tags=55%, list=25%, signal=73%</td></tr><tr><td class='lessen'>451</td><td>FOSTER_TOLERANT_MACROPHAGE_DN</td><td></td><td>229</td><td>0.31</td><td>1.29</td><td>0.167</td><td>0.398</td><td>1.000</td><td>2748</td><td>tags=37%, list=25%, signal=48%</td></tr><tr><td class='lessen'>452</td><td>LUI_THYROID_CANCER_CLUSTER_1</td><td></td><td>27</td><td>0.36</td><td>1.29</td><td>0.093</td><td>0.397</td><td>1.000</td><td>2477</td><td>tags=44%, list=23%, signal=57%</td></tr><tr><td class='lessen'>453</td><td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN</td><td></td><td>49</td><td>0.36</td><td>1.29</td><td>0.200</td><td>0.396</td><td>1.000</td><td>1885</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>454</td><td>RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP</td><td></td><td>61</td><td>0.33</td><td>1.29</td><td>0.043</td><td>0.396</td><td>1.000</td><td>2364</td><td>tags=41%, list=22%, signal=52%</td></tr><tr><td class='lessen'>455</td><td>GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB</td><td></td><td>86</td><td>0.31</td><td>1.29</td><td>0.125</td><td>0.395</td><td>1.000</td><td>1045</td><td>tags=19%, list=10%, signal=20%</td></tr><tr><td class='lessen'>456</td><td>WONG_ADULT_TISSUE_STEM_MODULE</td><td></td><td>403</td><td>0.28</td><td>1.29</td><td>0.103</td><td>0.396</td><td>1.000</td><td>2263</td><td>tags=28%, list=21%, signal=34%</td></tr><tr><td class='lessen'>457</td><td>DOANE_BREAST_CANCER_CLASSES_DN</td><td></td><td>21</td><td>0.38</td><td>1.29</td><td>0.119</td><td>0.396</td><td>1.000</td><td>1711</td><td>tags=33%, list=16%, signal=39%</td></tr><tr><td class='lessen'>458</td><td>HOWLIN_CITED1_TARGETS_1_DN</td><td></td><td>23</td><td>0.40</td><td>1.29</td><td>0.167</td><td>0.395</td><td>1.000</td><td>1923</td><td>tags=39%, list=18%, signal=47%</td></tr><tr><td class='lessen'>459</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_A</td><td></td><td>44</td><td>0.44</td><td>1.29</td><td>0.240</td><td>0.396</td><td>1.000</td><td>1754</td><td>tags=36%, list=16%, signal=43%</td></tr><tr><td class='lessen'>460</td><td>MANALO_HYPOXIA_UP</td><td></td><td>127</td><td>0.32</td><td>1.29</td><td>0.130</td><td>0.396</td><td>1.000</td><td>2268</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>461</td><td>BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING</td><td></td><td>290</td><td>0.27</td><td>1.29</td><td>0.098</td><td>0.395</td><td>1.000</td><td>1985</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>462</td><td>MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP</td><td></td><td>53</td><td>0.33</td><td>1.29</td><td>0.078</td><td>0.395</td><td>1.000</td><td>1936</td><td>tags=30%, list=18%, signal=37%</td></tr><tr><td class='lessen'>463</td><td>MOHANKUMAR_TLX1_TARGETS_DN</td><td></td><td>87</td><td>0.33</td><td>1.29</td><td>0.140</td><td>0.396</td><td>1.000</td><td>2934</td><td>tags=40%, list=27%, signal=55%</td></tr><tr><td class='lessen'>464</td><td>DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP</td><td></td><td>23</td><td>0.49</td><td>1.29</td><td>0.188</td><td>0.396</td><td>1.000</td><td>3626</td><td>tags=65%, list=33%, signal=98%</td></tr><tr><td class='lessen'>465</td><td>LEE_AGING_CEREBELLUM_UP</td><td></td><td>46</td><td>0.37</td><td>1.28</td><td>0.209</td><td>0.396</td><td>1.000</td><td>2790</td><td>tags=46%, list=26%, signal=61%</td></tr><tr><td class='lessen'>466</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP</td><td></td><td>41</td><td>0.40</td><td>1.28</td><td>0.116</td><td>0.396</td><td>1.000</td><td>1687</td><td>tags=34%, list=15%, signal=40%</td></tr><tr><td class='lessen'>467</td><td>MITSIADES_RESPONSE_TO_APLIDIN_UP</td><td></td><td>224</td><td>0.27</td><td>1.28</td><td>0.000</td><td>0.397</td><td>1.000</td><td>2175</td><td>tags=27%, list=20%, signal=33%</td></tr><tr><td class='lessen'>468</td><td>BOUDOUKHA_BOUND_BY_IGF2BP2</td><td></td><td>61</td><td>0.33</td><td>1.28</td><td>0.122</td><td>0.401</td><td>1.000</td><td>2667</td><td>tags=36%, list=25%, signal=48%</td></tr><tr><td class='lessen'>469</td><td>PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN</td><td></td><td>61</td><td>0.40</td><td>1.28</td><td>0.178</td><td>0.401</td><td>1.000</td><td>2129</td><td>tags=39%, list=20%, signal=49%</td></tr><tr><td class='lessen'>470</td><td>VANHARANTA_UTERINE_FIBROID_DN</td><td></td><td>36</td><td>0.41</td><td>1.28</td><td>0.132</td><td>0.402</td><td>1.000</td><td>1705</td><td>tags=36%, list=16%, signal=43%</td></tr><tr><td class='lessen'>471</td><td>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP</td><td></td><td>133</td><td>0.27</td><td>1.28</td><td>0.118</td><td>0.402</td><td>1.000</td><td>2206</td><td>tags=29%, list=20%, signal=35%</td></tr><tr><td class='lessen'>472</td><td>CROONQUIST_NRAS_SIGNALING_UP</td><td></td><td>23</td><td>0.41</td><td>1.28</td><td>0.173</td><td>0.402</td><td>1.000</td><td>1191</td><td>tags=26%, list=11%, signal=29%</td></tr><tr><td class='lessen'>473</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP</td><td></td><td>87</td><td>0.32</td><td>1.28</td><td>0.170</td><td>0.401</td><td>1.000</td><td>2115</td><td>tags=32%, list=19%, signal=40%</td></tr><tr><td class='lessen'>474</td><td>ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION</td><td></td><td>62</td><td>0.48</td><td>1.28</td><td>0.217</td><td>0.401</td><td>1.000</td><td>2019</td><td>tags=40%, list=19%, signal=49%</td></tr><tr><td class='lessen'>475</td><td>YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP</td><td></td><td>50</td><td>0.32</td><td>1.28</td><td>0.114</td><td>0.404</td><td>1.000</td><td>1930</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>476</td><td>GROSS_ELK3_TARGETS_UP</td><td></td><td>20</td><td>0.42</td><td>1.28</td><td>0.163</td><td>0.403</td><td>1.000</td><td>1293</td><td>tags=30%, list=12%, signal=34%</td></tr><tr><td class='lessen'>477</td><td>HUANG_GATA2_TARGETS_DN</td><td></td><td>48</td><td>0.36</td><td>1.28</td><td>0.085</td><td>0.404</td><td>1.000</td><td>2157</td><td>tags=35%, list=20%, signal=44%</td></tr><tr><td class='lessen'>478</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D</td><td></td><td>427</td><td>0.24</td><td>1.28</td><td>0.064</td><td>0.403</td><td>1.000</td><td>2113</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>479</td><td>ROME_INSULIN_TARGETS_IN_MUSCLE_UP</td><td></td><td>208</td><td>0.29</td><td>1.27</td><td>0.146</td><td>0.406</td><td>1.000</td><td>2179</td><td>tags=33%, list=20%, signal=41%</td></tr><tr><td class='lessen'>480</td><td>BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE</td><td></td><td>78</td><td>0.37</td><td>1.27</td><td>0.119</td><td>0.406</td><td>1.000</td><td>3054</td><td>tags=46%, list=28%, signal=64%</td></tr><tr><td class='lessen'>481</td><td>CHYLA_CBFA2T3_TARGETS_UP</td><td></td><td>207</td><td>0.31</td><td>1.27</td><td>0.222</td><td>0.408</td><td>1.000</td><td>2343</td><td>tags=31%, list=22%, signal=39%</td></tr><tr><td class='lessen'>482</td><td>BROCKE_APOPTOSIS_REVERSED_BY_IL6</td><td></td><td>85</td><td>0.35</td><td>1.27</td><td>0.156</td><td>0.413</td><td>1.000</td><td>3489</td><td>tags=51%, list=32%, signal=74%</td></tr><tr><td class='lessen'>483</td><td>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP</td><td></td><td>266</td><td>0.26</td><td>1.27</td><td>0.041</td><td>0.413</td><td>1.000</td><td>2035</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>484</td><td>RUTELLA_RESPONSE_TO_HGF_DN</td><td></td><td>125</td><td>0.34</td><td>1.27</td><td>0.143</td><td>0.412</td><td>1.000</td><td>2879</td><td>tags=42%, list=26%, signal=56%</td></tr><tr><td class='lessen'>485</td><td>RADMACHER_AML_PROGNOSIS</td><td></td><td>43</td><td>0.34</td><td>1.27</td><td>0.136</td><td>0.412</td><td>1.000</td><td>2456</td><td>tags=42%, list=23%, signal=54%</td></tr><tr><td class='lessen'>486</td><td>FORTSCHEGGER_PHF8_TARGETS_DN</td><td></td><td>388</td><td>0.27</td><td>1.27</td><td>0.024</td><td>0.412</td><td>1.000</td><td>1750</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>487</td><td>MA_MYELOID_DIFFERENTIATION_UP</td><td></td><td>21</td><td>0.42</td><td>1.27</td><td>0.160</td><td>0.411</td><td>1.000</td><td>2453</td><td>tags=38%, list=23%, signal=49%</td></tr><tr><td class='lessen'>488</td><td>WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2</td><td></td><td>32</td><td>0.38</td><td>1.27</td><td>0.216</td><td>0.411</td><td>1.000</td><td>1863</td><td>tags=38%, list=17%, signal=45%</td></tr><tr><td class='lessen'>489</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN</td><td></td><td>23</td><td>0.43</td><td>1.27</td><td>0.184</td><td>0.415</td><td>1.000</td><td>1485</td><td>tags=35%, list=14%, signal=40%</td></tr><tr><td class='lessen'>490</td><td>SMID_BREAST_CANCER_BASAL_DN</td><td></td><td>384</td><td>0.27</td><td>1.27</td><td>0.114</td><td>0.414</td><td>1.000</td><td>2152</td><td>tags=27%, list=20%, signal=33%</td></tr><tr><td class='lessen'>491</td><td>ZHANG_PROLIFERATING_VS_QUIESCENT</td><td></td><td>30</td><td>0.37</td><td>1.26</td><td>0.146</td><td>0.415</td><td>1.000</td><td>2042</td><td>tags=43%, list=19%, signal=53%</td></tr><tr><td class='lessen'>492</td><td>GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN</td><td></td><td>59</td><td>0.38</td><td>1.26</td><td>0.154</td><td>0.415</td><td>1.000</td><td>1178</td><td>tags=27%, list=11%, signal=30%</td></tr><tr><td class='lessen'>493</td><td>BRIDEAU_IMPRINTED_GENES</td><td></td><td>40</td><td>0.36</td><td>1.26</td><td>0.232</td><td>0.419</td><td>1.000</td><td>1686</td><td>tags=28%, list=15%, signal=32%</td></tr><tr><td class='lessen'>494</td><td>SENESE_HDAC1_AND_HDAC2_TARGETS_DN</td><td></td><td>121</td><td>0.28</td><td>1.26</td><td>0.171</td><td>0.419</td><td>1.000</td><td>1715</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>495</td><td>KEEN_RESPONSE_TO_ROSIGLITAZONE_DN</td><td></td><td>61</td><td>0.33</td><td>1.26</td><td>0.200</td><td>0.422</td><td>1.000</td><td>2364</td><td>tags=43%, list=22%, signal=54%</td></tr><tr><td class='lessen'>496</td><td>HAHTOLA_SEZARY_SYNDROM_DN</td><td></td><td>24</td><td>0.45</td><td>1.26</td><td>0.143</td><td>0.421</td><td>1.000</td><td>3296</td><td>tags=50%, list=30%, signal=72%</td></tr><tr><td class='lessen'>497</td><td>HUMMERICH_SKIN_CANCER_PROGRESSION_DN</td><td></td><td>62</td><td>0.32</td><td>1.26</td><td>0.113</td><td>0.422</td><td>1.000</td><td>2202</td><td>tags=37%, list=20%, signal=46%</td></tr><tr><td class='lessen'>498</td><td>LIN_NPAS4_TARGETS_DN</td><td></td><td>24</td><td>0.42</td><td>1.26</td><td>0.082</td><td>0.423</td><td>1.000</td><td>1558</td><td>tags=33%, list=14%, signal=39%</td></tr><tr><td class='lessen'>499</td><td>YAGI_AML_FAB_MARKERS</td><td></td><td>112</td><td>0.28</td><td>1.26</td><td>0.133</td><td>0.425</td><td>1.000</td><td>1873</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>500</td><td>ZHAN_MULTIPLE_MYELOMA_HP_UP</td><td></td><td>27</td><td>0.45</td><td>1.26</td><td>0.171</td><td>0.426</td><td>1.000</td><td>1334</td><td>tags=26%, list=12%, signal=29%</td></tr><tr><td class='lessen'>501</td><td>HOEGERKORP_CD44_TARGETS_TEMPORAL_DN</td><td></td><td>15</td><td>0.43</td><td>1.25</td><td>0.143</td><td>0.428</td><td>1.000</td><td>1146</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>502</td><td>NGUYEN_NOTCH1_TARGETS_UP</td><td></td><td>17</td><td>0.42</td><td>1.25</td><td>0.196</td><td>0.428</td><td>1.000</td><td>1563</td><td>tags=35%, list=14%, signal=41%</td></tr><tr><td class='lessen'>503</td><td>GRADE_COLON_AND_RECTAL_CANCER_DN</td><td></td><td>55</td><td>0.34</td><td>1.25</td><td>0.063</td><td>0.429</td><td>1.000</td><td>2000</td><td>tags=35%, list=18%, signal=42%</td></tr><tr><td class='lessen'>504</td><td>TARTE_PLASMA_CELL_VS_PLASMABLAST_UP</td><td></td><td>228</td><td>0.29</td><td>1.25</td><td>0.100</td><td>0.429</td><td>1.000</td><td>2507</td><td>tags=32%, list=23%, signal=40%</td></tr><tr><td class='lessen'>505</td><td>WENG_POR_TARGETS_LIVER_UP</td><td></td><td>21</td><td>0.38</td><td>1.25</td><td>0.170</td><td>0.429</td><td>1.000</td><td>160</td><td>tags=14%, list=1%, signal=14%</td></tr><tr><td class='lessen'>506</td><td>MIKKELSEN_NPC_LCP_WITH_H3K4ME3</td><td></td><td>31</td><td>0.38</td><td>1.25</td><td>0.125</td><td>0.432</td><td>1.000</td><td>2262</td><td>tags=42%, list=21%, signal=53%</td></tr><tr><td class='lessen'>507</td><td>VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP</td><td></td><td>91</td><td>0.30</td><td>1.25</td><td>0.173</td><td>0.432</td><td>1.000</td><td>2035</td><td>tags=34%, list=19%, signal=42%</td></tr><tr><td class='lessen'>508</td><td>WANG_SMARCE1_TARGETS_UP</td><td></td><td>131</td><td>0.28</td><td>1.25</td><td>0.160</td><td>0.431</td><td>1.000</td><td>1985</td><td>tags=27%, list=18%, signal=32%</td></tr><tr><td class='lessen'>509</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP</td><td></td><td>75</td><td>0.30</td><td>1.25</td><td>0.078</td><td>0.430</td><td>1.000</td><td>1455</td><td>tags=25%, list=13%, signal=29%</td></tr><tr><td class='lessen'>510</td><td>DAZARD_RESPONSE_TO_UV_NHEK_UP</td><td></td><td>125</td><td>0.29</td><td>1.25</td><td>0.163</td><td>0.430</td><td>1.000</td><td>2129</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>511</td><td>LEE_LIVER_CANCER_MYC_UP</td><td></td><td>31</td><td>0.34</td><td>1.25</td><td>0.140</td><td>0.431</td><td>1.000</td><td>2259</td><td>tags=32%, list=21%, signal=41%</td></tr><tr><td class='lessen'>512</td><td>AMIT_SERUM_RESPONSE_40_MCF10A</td><td></td><td>17</td><td>0.53</td><td>1.25</td><td>0.362</td><td>0.432</td><td>1.000</td><td>544</td><td>tags=35%, list=5%, signal=37%</td></tr><tr><td class='lessen'>513</td><td>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN</td><td></td><td>272</td><td>0.28</td><td>1.25</td><td>0.140</td><td>0.431</td><td>1.000</td><td>1936</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>514</td><td>LEE_AGING_NEOCORTEX_UP</td><td></td><td>55</td><td>0.32</td><td>1.25</td><td>0.083</td><td>0.434</td><td>1.000</td><td>1782</td><td>tags=31%, list=16%, signal=37%</td></tr><tr><td class='lessen'>515</td><td>KIM_WT1_TARGETS_12HR_UP</td><td></td><td>89</td><td>0.33</td><td>1.25</td><td>0.156</td><td>0.433</td><td>1.000</td><td>1212</td><td>tags=22%, list=11%, signal=25%</td></tr><tr><td class='lessen'>516</td><td>WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN</td><td></td><td>101</td><td>0.34</td><td>1.25</td><td>0.217</td><td>0.435</td><td>1.000</td><td>2129</td><td>tags=36%, list=20%, signal=44%</td></tr><tr><td class='lessen'>517</td><td>MODY_HIPPOCAMPUS_POSTNATAL</td><td></td><td>33</td><td>0.38</td><td>1.24</td><td>0.222</td><td>0.435</td><td>1.000</td><td>1943</td><td>tags=30%, list=18%, signal=37%</td></tr><tr><td class='lessen'>518</td><td>JIANG_HYPOXIA_NORMAL</td><td></td><td>147</td><td>0.30</td><td>1.24</td><td>0.196</td><td>0.436</td><td>1.000</td><td>2593</td><td>tags=35%, list=24%, signal=46%</td></tr><tr><td class='lessen'>519</td><td>FEVR_CTNNB1_TARGETS_UP</td><td></td><td>332</td><td>0.31</td><td>1.24</td><td>0.100</td><td>0.435</td><td>1.000</td><td>2909</td><td>tags=38%, list=27%, signal=50%</td></tr><tr><td class='lessen'>520</td><td>HAHTOLA_SEZARY_SYNDROM_UP</td><td></td><td>56</td><td>0.38</td><td>1.24</td><td>0.167</td><td>0.436</td><td>1.000</td><td>2710</td><td>tags=54%, list=25%, signal=71%</td></tr><tr><td class='lessen'>521</td><td>WANG_BARRETTS_ESOPHAGUS_UP</td><td></td><td>24</td><td>0.45</td><td>1.24</td><td>0.108</td><td>0.435</td><td>1.000</td><td>1720</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>522</td><td>PEREZ_TP63_TARGETS</td><td></td><td>189</td><td>0.29</td><td>1.24</td><td>0.140</td><td>0.441</td><td>1.000</td><td>2167</td><td>tags=28%, list=20%, signal=34%</td></tr><tr><td class='lessen'>523</td><td>TRACEY_RESISTANCE_TO_IFNA2_DN</td><td></td><td>17</td><td>0.49</td><td>1.24</td><td>0.225</td><td>0.440</td><td>1.000</td><td>3183</td><td>tags=71%, list=29%, signal=100%</td></tr><tr><td class='lessen'>524</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_T4</td><td></td><td>41</td><td>0.34</td><td>1.24</td><td>0.176</td><td>0.441</td><td>1.000</td><td>1787</td><td>tags=29%, list=16%, signal=35%</td></tr><tr><td class='lessen'>525</td><td>WEST_ADRENOCORTICAL_TUMOR_DN</td><td></td><td>310</td><td>0.26</td><td>1.24</td><td>0.119</td><td>0.441</td><td>1.000</td><td>1788</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>526</td><td>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP</td><td></td><td>243</td><td>0.25</td><td>1.24</td><td>0.041</td><td>0.441</td><td>1.000</td><td>1436</td><td>tags=19%, list=13%, signal=21%</td></tr><tr><td class='lessen'>527</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP</td><td></td><td>98</td><td>0.30</td><td>1.24</td><td>0.122</td><td>0.444</td><td>1.000</td><td>1936</td><td>tags=26%, list=18%, signal=31%</td></tr><tr><td class='lessen'>528</td><td>MARSON_BOUND_BY_FOXP3_STIMULATED</td><td></td><td>467</td><td>0.23</td><td>1.24</td><td>0.019</td><td>0.444</td><td>1.000</td><td>1425</td><td>tags=19%, list=13%, signal=21%</td></tr><tr><td class='lessen'>529</td><td>PARENT_MTOR_SIGNALING_UP</td><td></td><td>309</td><td>0.26</td><td>1.24</td><td>0.093</td><td>0.444</td><td>1.000</td><td>1379</td><td>tags=18%, list=13%, signal=20%</td></tr><tr><td class='lessen'>530</td><td>ZHOU_TNF_SIGNALING_4HR</td><td></td><td>24</td><td>0.38</td><td>1.24</td><td>0.260</td><td>0.444</td><td>1.000</td><td>2554</td><td>tags=50%, list=23%, signal=65%</td></tr><tr><td class='lessen'>531</td><td>ZHAN_MULTIPLE_MYELOMA_CD2_UP</td><td></td><td>30</td><td>0.39</td><td>1.23</td><td>0.190</td><td>0.445</td><td>1.000</td><td>3053</td><td>tags=50%, list=28%, signal=69%</td></tr><tr><td class='lessen'>532</td><td>WESTON_VEGFA_TARGETS_12HR</td><td></td><td>24</td><td>0.35</td><td>1.23</td><td>0.220</td><td>0.448</td><td>1.000</td><td>1307</td><td>tags=25%, list=12%, signal=28%</td></tr><tr><td class='lessen'>533</td><td>LENAOUR_DENDRITIC_CELL_MATURATION_DN</td><td></td><td>76</td><td>0.40</td><td>1.23</td><td>0.239</td><td>0.451</td><td>1.000</td><td>1785</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>534</td><td>MCCABE_HOXC6_TARGETS_DN</td><td></td><td>16</td><td>0.41</td><td>1.23</td><td>0.245</td><td>0.451</td><td>1.000</td><td>2700</td><td>tags=38%, list=25%, signal=50%</td></tr><tr><td class='lessen'>535</td><td>SEKI_INFLAMMATORY_RESPONSE_LPS_DN</td><td></td><td>17</td><td>0.39</td><td>1.23</td><td>0.192</td><td>0.450</td><td>1.000</td><td>2435</td><td>tags=41%, list=22%, signal=53%</td></tr><tr><td class='lessen'>536</td><td>MARSON_FOXP3_TARGETS_UP</td><td></td><td>42</td><td>0.33</td><td>1.23</td><td>0.196</td><td>0.450</td><td>1.000</td><td>2904</td><td>tags=40%, list=27%, signal=55%</td></tr><tr><td class='lessen'>537</td><td>COLINA_TARGETS_OF_4EBP1_AND_4EBP2</td><td></td><td>184</td><td>0.26</td><td>1.23</td><td>0.170</td><td>0.450</td><td>1.000</td><td>1614</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>538</td><td>CUI_TCF21_TARGETS_2_DN</td><td></td><td>441</td><td>0.29</td><td>1.23</td><td>0.167</td><td>0.450</td><td>1.000</td><td>1792</td><td>tags=25%, list=16%, signal=29%</td></tr><tr><td class='lessen'>539</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_1_UP</td><td></td><td>56</td><td>0.33</td><td>1.23</td><td>0.156</td><td>0.450</td><td>1.000</td><td>3037</td><td>tags=48%, list=28%, signal=67%</td></tr><tr><td class='lessen'>540</td><td>BERENJENO_TRANSFORMED_BY_RHOA_DN</td><td></td><td>202</td><td>0.26</td><td>1.23</td><td>0.143</td><td>0.449</td><td>1.000</td><td>1941</td><td>tags=26%, list=18%, signal=31%</td></tr><tr><td class='lessen'>541</td><td>FOSTER_KDM1A_TARGETS_UP</td><td></td><td>129</td><td>0.30</td><td>1.23</td><td>0.128</td><td>0.449</td><td>1.000</td><td>2860</td><td>tags=36%, list=26%, signal=49%</td></tr><tr><td class='lessen'>542</td><td>FURUKAWA_DUSP6_TARGETS_PCI35_UP</td><td></td><td>35</td><td>0.32</td><td>1.23</td><td>0.163</td><td>0.449</td><td>1.000</td><td>1779</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>543</td><td>WANG_HCP_PROSTATE_CANCER</td><td></td><td>67</td><td>0.31</td><td>1.23</td><td>0.178</td><td>0.450</td><td>1.000</td><td>1969</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>544</td><td>RIGGI_EWING_SARCOMA_PROGENITOR_UP</td><td></td><td>226</td><td>0.25</td><td>1.23</td><td>0.070</td><td>0.450</td><td>1.000</td><td>1854</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>545</td><td>LEIN_NEURON_MARKERS</td><td></td><td>32</td><td>0.38</td><td>1.23</td><td>0.207</td><td>0.450</td><td>1.000</td><td>1767</td><td>tags=31%, list=16%, signal=37%</td></tr><tr><td class='lessen'>546</td><td>LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN</td><td></td><td>33</td><td>0.39</td><td>1.23</td><td>0.231</td><td>0.452</td><td>1.000</td><td>2536</td><td>tags=48%, list=23%, signal=63%</td></tr><tr><td class='lessen'>547</td><td>PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN</td><td></td><td>16</td><td>0.43</td><td>1.23</td><td>0.281</td><td>0.451</td><td>1.000</td><td>1528</td><td>tags=25%, list=14%, signal=29%</td></tr><tr><td class='lessen'>548</td><td>HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP</td><td></td><td>47</td><td>0.36</td><td>1.22</td><td>0.191</td><td>0.451</td><td>1.000</td><td>1903</td><td>tags=36%, list=17%, signal=44%</td></tr><tr><td class='lessen'>549</td><td>SANSOM_APC_TARGETS_DN</td><td></td><td>196</td><td>0.30</td><td>1.22</td><td>0.109</td><td>0.452</td><td>1.000</td><td>2502</td><td>tags=34%, list=23%, signal=44%</td></tr><tr><td class='lessen'>550</td><td>BOQUEST_STEM_CELL_UP</td><td></td><td>137</td><td>0.29</td><td>1.22</td><td>0.178</td><td>0.453</td><td>1.000</td><td>2035</td><td>tags=30%, list=19%, signal=36%</td></tr><tr><td class='lessen'>551</td><td>STONER_ESOPHAGEAL_CARCINOGENESIS_UP</td><td></td><td>16</td><td>0.42</td><td>1.22</td><td>0.184</td><td>0.453</td><td>1.000</td><td>1810</td><td>tags=38%, list=17%, signal=45%</td></tr><tr><td class='lessen'>552</td><td>LINDVALL_IMMORTALIZED_BY_TERT_UP</td><td></td><td>51</td><td>0.29</td><td>1.22</td><td>0.120</td><td>0.454</td><td>1.000</td><td>1324</td><td>tags=25%, list=12%, signal=29%</td></tr><tr><td class='lessen'>553</td><td>MARTINEZ_TP53_TARGETS_UP</td><td></td><td>336</td><td>0.24</td><td>1.22</td><td>0.132</td><td>0.455</td><td>1.000</td><td>2285</td><td>tags=29%, list=21%, signal=35%</td></tr><tr><td class='lessen'>554</td><td>PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN</td><td></td><td>18</td><td>0.40</td><td>1.22</td><td>0.174</td><td>0.460</td><td>1.000</td><td>1406</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>555</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN</td><td></td><td>179</td><td>0.25</td><td>1.22</td><td>0.071</td><td>0.459</td><td>1.000</td><td>2212</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>556</td><td>KYNG_RESPONSE_TO_H2O2</td><td></td><td>30</td><td>0.29</td><td>1.22</td><td>0.098</td><td>0.459</td><td>1.000</td><td>2263</td><td>tags=37%, list=21%, signal=46%</td></tr><tr><td class='lessen'>557</td><td>CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY</td><td></td><td>17</td><td>0.42</td><td>1.22</td><td>0.234</td><td>0.459</td><td>1.000</td><td>728</td><td>tags=24%, list=7%, signal=25%</td></tr><tr><td class='lessen'>558</td><td>HENDRICKS_SMARCA4_TARGETS_UP</td><td></td><td>31</td><td>0.37</td><td>1.22</td><td>0.233</td><td>0.458</td><td>1.000</td><td>2709</td><td>tags=42%, list=25%, signal=56%</td></tr><tr><td class='lessen'>559</td><td>SASSON_RESPONSE_TO_FORSKOLIN_DN</td><td></td><td>49</td><td>0.32</td><td>1.22</td><td>0.233</td><td>0.459</td><td>1.000</td><td>1507</td><td>tags=29%, list=14%, signal=33%</td></tr><tr><td class='lessen'>560</td><td>MCCABE_BOUND_BY_HOXC6</td><td></td><td>198</td><td>0.26</td><td>1.22</td><td>0.091</td><td>0.458</td><td>1.000</td><td>2327</td><td>tags=27%, list=21%, signal=33%</td></tr><tr><td class='lessen'>561</td><td>BOYLAN_MULTIPLE_MYELOMA_PCA1_UP</td><td></td><td>45</td><td>0.39</td><td>1.22</td><td>0.209</td><td>0.458</td><td>1.000</td><td>1783</td><td>tags=31%, list=16%, signal=37%</td></tr><tr><td class='lessen'>562</td><td>GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION</td><td></td><td>17</td><td>0.43</td><td>1.22</td><td>0.180</td><td>0.459</td><td>1.000</td><td>2932</td><td>tags=47%, list=27%, signal=64%</td></tr><tr><td class='lessen'>563</td><td>HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN</td><td></td><td>41</td><td>0.43</td><td>1.22</td><td>0.293</td><td>0.458</td><td>1.000</td><td>2558</td><td>tags=49%, list=24%, signal=64%</td></tr><tr><td class='lessen'>564</td><td>KAAB_HEART_ATRIUM_VS_VENTRICLE_UP</td><td></td><td>131</td><td>0.29</td><td>1.21</td><td>0.178</td><td>0.461</td><td>1.000</td><td>2042</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>565</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S1</td><td></td><td>121</td><td>0.29</td><td>1.21</td><td>0.204</td><td>0.466</td><td>1.000</td><td>2430</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>566</td><td>ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF</td><td></td><td>252</td><td>0.28</td><td>1.21</td><td>0.192</td><td>0.465</td><td>1.000</td><td>1923</td><td>tags=26%, list=18%, signal=31%</td></tr><tr><td class='lessen'>567</td><td>SMIRNOV_RESPONSE_TO_IR_6HR_UP</td><td></td><td>79</td><td>0.29</td><td>1.21</td><td>0.098</td><td>0.464</td><td>1.000</td><td>2174</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>568</td><td>LEIN_MEDULLA_MARKERS</td><td></td><td>43</td><td>0.32</td><td>1.21</td><td>0.151</td><td>0.466</td><td>1.000</td><td>2611</td><td>tags=40%, list=24%, signal=52%</td></tr><tr><td class='lessen'>569</td><td>SUMI_HNF4A_TARGETS</td><td></td><td>15</td><td>0.42</td><td>1.21</td><td>0.315</td><td>0.469</td><td>1.000</td><td>2365</td><td>tags=27%, list=22%, signal=34%</td></tr><tr><td class='lessen'>570</td><td>LEIN_OLIGODENDROCYTE_MARKERS</td><td></td><td>36</td><td>0.32</td><td>1.21</td><td>0.231</td><td>0.469</td><td>1.000</td><td>2268</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>571</td><td>GENTILE_UV_LOW_DOSE_UP</td><td></td><td>17</td><td>0.45</td><td>1.21</td><td>0.277</td><td>0.469</td><td>1.000</td><td>209</td><td>tags=18%, list=2%, signal=18%</td></tr><tr><td class='lessen'>572</td><td>RICKMAN_METASTASIS_DN</td><td></td><td>132</td><td>0.33</td><td>1.21</td><td>0.283</td><td>0.470</td><td>1.000</td><td>1783</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>573</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP</td><td></td><td>242</td><td>0.27</td><td>1.20</td><td>0.217</td><td>0.472</td><td>1.000</td><td>2014</td><td>tags=25%, list=19%, signal=30%</td></tr><tr><td class='lessen'>574</td><td>ONKEN_UVEAL_MELANOMA_UP</td><td></td><td>409</td><td>0.24</td><td>1.20</td><td>0.171</td><td>0.473</td><td>1.000</td><td>1941</td><td>tags=25%, list=18%, signal=29%</td></tr><tr><td class='lessen'>575</td><td>HOEGERKORP_CD44_TARGETS_DIRECT_UP</td><td></td><td>17</td><td>0.36</td><td>1.20</td><td>0.179</td><td>0.473</td><td>1.000</td><td>426</td><td>tags=18%, list=4%, signal=18%</td></tr><tr><td class='lessen'>576</td><td>SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER</td><td></td><td>17</td><td>0.42</td><td>1.20</td><td>0.259</td><td>0.472</td><td>1.000</td><td>4203</td><td>tags=53%, list=39%, signal=86%</td></tr><tr><td class='lessen'>577</td><td>SABATES_COLORECTAL_ADENOMA_DN</td><td></td><td>151</td><td>0.30</td><td>1.20</td><td>0.159</td><td>0.473</td><td>1.000</td><td>1982</td><td>tags=26%, list=18%, signal=31%</td></tr><tr><td class='lessen'>578</td><td>GENTILE_UV_RESPONSE_CLUSTER_D7</td><td></td><td>26</td><td>0.34</td><td>1.20</td><td>0.149</td><td>0.472</td><td>1.000</td><td>1452</td><td>tags=31%, list=13%, signal=35%</td></tr><tr><td class='lessen'>579</td><td>HALMOS_CEBPA_TARGETS_UP</td><td></td><td>33</td><td>0.38</td><td>1.20</td><td>0.273</td><td>0.475</td><td>1.000</td><td>1384</td><td>tags=30%, list=13%, signal=35%</td></tr><tr><td class='lessen'>580</td><td>BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP</td><td></td><td>94</td><td>0.28</td><td>1.20</td><td>0.196</td><td>0.478</td><td>1.000</td><td>2032</td><td>tags=29%, list=19%, signal=35%</td></tr><tr><td class='lessen'>581</td><td>SAFFORD_T_LYMPHOCYTE_ANERGY</td><td></td><td>51</td><td>0.34</td><td>1.20</td><td>0.233</td><td>0.479</td><td>1.000</td><td>1888</td><td>tags=27%, list=17%, signal=33%</td></tr><tr><td class='lessen'>582</td><td>WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN</td><td></td><td>57</td><td>0.28</td><td>1.20</td><td>0.170</td><td>0.479</td><td>1.000</td><td>2231</td><td>tags=32%, list=20%, signal=40%</td></tr><tr><td class='lessen'>583</td><td>BASSO_HAIRY_CELL_LEUKEMIA_DN</td><td></td><td>50</td><td>0.36</td><td>1.20</td><td>0.279</td><td>0.479</td><td>1.000</td><td>3116</td><td>tags=44%, list=29%, signal=61%</td></tr><tr><td class='lessen'>584</td><td>DITTMER_PTHLH_TARGETS_DN</td><td></td><td>39</td><td>0.34</td><td>1.20</td><td>0.191</td><td>0.480</td><td>1.000</td><td>1372</td><td>tags=26%, list=13%, signal=29%</td></tr><tr><td class='lessen'>585</td><td>ONO_AML1_TARGETS_UP</td><td></td><td>15</td><td>0.41</td><td>1.20</td><td>0.275</td><td>0.482</td><td>1.000</td><td>1657</td><td>tags=27%, list=15%, signal=31%</td></tr><tr><td class='lessen'>586</td><td>LANDIS_ERBB2_BREAST_TUMORS_65_DN</td><td></td><td>23</td><td>0.37</td><td>1.19</td><td>0.268</td><td>0.482</td><td>1.000</td><td>2177</td><td>tags=48%, list=20%, signal=60%</td></tr><tr><td class='lessen'>587</td><td>ZHENG_BOUND_BY_FOXP3</td><td></td><td>277</td><td>0.26</td><td>1.19</td><td>0.235</td><td>0.481</td><td>1.000</td><td>1690</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>588</td><td>OSADA_ASCL1_TARGETS_UP</td><td></td><td>29</td><td>0.40</td><td>1.19</td><td>0.306</td><td>0.481</td><td>1.000</td><td>1645</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>589</td><td>SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2</td><td></td><td>32</td><td>0.35</td><td>1.19</td><td>0.245</td><td>0.483</td><td>1.000</td><td>1287</td><td>tags=25%, list=12%, signal=28%</td></tr><tr><td class='lessen'>590</td><td>GRUETZMANN_PANCREATIC_CANCER_UP</td><td></td><td>191</td><td>0.26</td><td>1.19</td><td>0.191</td><td>0.482</td><td>1.000</td><td>1455</td><td>tags=23%, list=13%, signal=26%</td></tr><tr><td class='lessen'>591</td><td>CROMER_TUMORIGENESIS_UP</td><td></td><td>37</td><td>0.38</td><td>1.19</td><td>0.276</td><td>0.482</td><td>1.000</td><td>2611</td><td>tags=41%, list=24%, signal=53%</td></tr><tr><td class='lessen'>592</td><td>GAJATE_RESPONSE_TO_TRABECTEDIN_UP</td><td></td><td>37</td><td>0.31</td><td>1.19</td><td>0.227</td><td>0.484</td><td>1.000</td><td>1982</td><td>tags=38%, list=18%, signal=46%</td></tr><tr><td class='lessen'>593</td><td>WINZEN_DEGRADED_VIA_KHSRP</td><td></td><td>56</td><td>0.38</td><td>1.19</td><td>0.346</td><td>0.489</td><td>1.000</td><td>1403</td><td>tags=21%, list=13%, signal=24%</td></tr><tr><td class='lessen'>594</td><td>PETRETTO_CARDIAC_HYPERTROPHY</td><td></td><td>25</td><td>0.38</td><td>1.19</td><td>0.205</td><td>0.494</td><td>1.000</td><td>2270</td><td>tags=40%, list=21%, signal=50%</td></tr><tr><td class='lessen'>595</td><td>KAN_RESPONSE_TO_ARSENIC_TRIOXIDE</td><td></td><td>73</td><td>0.29</td><td>1.19</td><td>0.283</td><td>0.493</td><td>1.000</td><td>704</td><td>tags=18%, list=6%, signal=19%</td></tr><tr><td class='lessen'>596</td><td>TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP</td><td></td><td>36</td><td>0.38</td><td>1.19</td><td>0.233</td><td>0.492</td><td>1.000</td><td>1268</td><td>tags=28%, list=12%, signal=31%</td></tr><tr><td class='lessen'>597</td><td>BLUM_RESPONSE_TO_SALIRASIB_UP</td><td></td><td>127</td><td>0.29</td><td>1.19</td><td>0.186</td><td>0.492</td><td>1.000</td><td>2432</td><td>tags=37%, list=22%, signal=47%</td></tr><tr><td class='lessen'>598</td><td>NAKAMURA_METASTASIS_MODEL_DN</td><td></td><td>23</td><td>0.38</td><td>1.18</td><td>0.173</td><td>0.494</td><td>1.000</td><td>1397</td><td>tags=26%, list=13%, signal=30%</td></tr><tr><td class='lessen'>599</td><td>HARRIS_BRAIN_CANCER_PROGENITORS</td><td></td><td>24</td><td>0.35</td><td>1.18</td><td>0.257</td><td>0.494</td><td>1.000</td><td>3014</td><td>tags=50%, list=28%, signal=69%</td></tr><tr><td class='lessen'>600</td><td>GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN</td><td></td><td>21</td><td>0.42</td><td>1.18</td><td>0.283</td><td>0.495</td><td>1.000</td><td>3159</td><td>tags=57%, list=29%, signal=80%</td></tr><tr><td class='lessen'>601</td><td>WIERENGA_STAT5A_TARGETS_GROUP1</td><td></td><td>62</td><td>0.32</td><td>1.18</td><td>0.283</td><td>0.496</td><td>1.000</td><td>2366</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>602</td><td>XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP</td><td></td><td>24</td><td>0.38</td><td>1.18</td><td>0.333</td><td>0.497</td><td>1.000</td><td>1742</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>603</td><td>ROSS_AML_WITH_PML_RARA_FUSION</td><td></td><td>36</td><td>0.33</td><td>1.18</td><td>0.250</td><td>0.497</td><td>1.000</td><td>1695</td><td>tags=33%, list=16%, signal=39%</td></tr><tr><td class='lessen'>604</td><td>PASINI_SUZ12_TARGETS_DN</td><td></td><td>185</td><td>0.27</td><td>1.18</td><td>0.244</td><td>0.497</td><td>1.000</td><td>2365</td><td>tags=30%, list=22%, signal=38%</td></tr><tr><td class='lessen'>605</td><td>CHUNG_BLISTER_CYTOTOXICITY_DN</td><td></td><td>21</td><td>0.40</td><td>1.18</td><td>0.271</td><td>0.497</td><td>1.000</td><td>3958</td><td>tags=57%, list=36%, signal=90%</td></tr><tr><td class='lessen'>606</td><td>TENEDINI_MEGAKARYOCYTE_MARKERS</td><td></td><td>47</td><td>0.34</td><td>1.18</td><td>0.302</td><td>0.496</td><td>1.000</td><td>1334</td><td>tags=23%, list=12%, signal=27%</td></tr><tr><td class='lessen'>607</td><td>COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN</td><td></td><td>17</td><td>0.41</td><td>1.18</td><td>0.288</td><td>0.497</td><td>1.000</td><td>1982</td><td>tags=47%, list=18%, signal=57%</td></tr><tr><td class='lessen'>608</td><td>GROSS_HYPOXIA_VIA_ELK3_UP</td><td></td><td>117</td><td>0.28</td><td>1.18</td><td>0.184</td><td>0.497</td><td>1.000</td><td>2011</td><td>tags=31%, list=18%, signal=37%</td></tr><tr><td class='lessen'>609</td><td>MARTENS_BOUND_BY_PML_RARA_FUSION</td><td></td><td>225</td><td>0.28</td><td>1.18</td><td>0.244</td><td>0.497</td><td>1.000</td><td>2709</td><td>tags=34%, list=25%, signal=44%</td></tr><tr><td class='lessen'>610</td><td>RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP</td><td></td><td>44</td><td>0.34</td><td>1.18</td><td>0.235</td><td>0.496</td><td>1.000</td><td>1787</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>611</td><td>PARK_APL_PATHOGENESIS_DN</td><td></td><td>23</td><td>0.37</td><td>1.18</td><td>0.235</td><td>0.496</td><td>1.000</td><td>3033</td><td>tags=43%, list=28%, signal=60%</td></tr><tr><td class='lessen'>612</td><td>LEE_AGING_CEREBELLUM_DN</td><td></td><td>55</td><td>0.31</td><td>1.18</td><td>0.283</td><td>0.495</td><td>1.000</td><td>1590</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>613</td><td>AMIT_EGF_RESPONSE_60_HELA</td><td></td><td>23</td><td>0.40</td><td>1.18</td><td>0.292</td><td>0.495</td><td>1.000</td><td>1956</td><td>tags=43%, list=18%, signal=53%</td></tr><tr><td class='lessen'>614</td><td>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP</td><td></td><td>88</td><td>0.29</td><td>1.18</td><td>0.292</td><td>0.494</td><td>1.000</td><td>2047</td><td>tags=30%, list=19%, signal=36%</td></tr><tr><td class='lessen'>615</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_5_DN</td><td></td><td>26</td><td>0.34</td><td>1.18</td><td>0.244</td><td>0.494</td><td>1.000</td><td>1183</td><td>tags=19%, list=11%, signal=22%</td></tr><tr><td class='lessen'>616</td><td>LEE_INTRATHYMIC_T_PROGENITOR</td><td></td><td>15</td><td>0.35</td><td>1.18</td><td>0.283</td><td>0.495</td><td>1.000</td><td>1965</td><td>tags=33%, list=18%, signal=41%</td></tr><tr><td class='lessen'>617</td><td>PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN</td><td></td><td>79</td><td>0.29</td><td>1.18</td><td>0.169</td><td>0.495</td><td>1.000</td><td>1313</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>618</td><td>MENSE_HYPOXIA_UP</td><td></td><td>47</td><td>0.40</td><td>1.18</td><td>0.279</td><td>0.498</td><td>1.000</td><td>2212</td><td>tags=43%, list=20%, signal=53%</td></tr><tr><td class='lessen'>619</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN</td><td></td><td>23</td><td>0.35</td><td>1.17</td><td>0.205</td><td>0.499</td><td>1.000</td><td>3081</td><td>tags=48%, list=28%, signal=67%</td></tr><tr><td class='lessen'>620</td><td>WINTER_HYPOXIA_METAGENE</td><td></td><td>131</td><td>0.31</td><td>1.17</td><td>0.217</td><td>0.498</td><td>1.000</td><td>2361</td><td>tags=34%, list=22%, signal=42%</td></tr><tr><td class='lessen'>621</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_6</td><td></td><td>49</td><td>0.30</td><td>1.17</td><td>0.200</td><td>0.499</td><td>1.000</td><td>1213</td><td>tags=18%, list=11%, signal=21%</td></tr><tr><td class='lessen'>622</td><td>MEDINA_SMARCA4_TARGETS</td><td></td><td>29</td><td>0.32</td><td>1.17</td><td>0.260</td><td>0.498</td><td>1.000</td><td>2222</td><td>tags=34%, list=20%, signal=43%</td></tr><tr><td class='lessen'>623</td><td>POOLA_INVASIVE_BREAST_CANCER_UP</td><td></td><td>150</td><td>0.31</td><td>1.17</td><td>0.283</td><td>0.498</td><td>1.000</td><td>2199</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>624</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_3</td><td></td><td>20</td><td>0.43</td><td>1.17</td><td>0.261</td><td>0.497</td><td>1.000</td><td>1893</td><td>tags=40%, list=17%, signal=48%</td></tr><tr><td class='lessen'>625</td><td>KRIGE_AMINO_ACID_DEPRIVATION</td><td></td><td>17</td><td>0.43</td><td>1.17</td><td>0.229</td><td>0.497</td><td>1.000</td><td>1765</td><td>tags=53%, list=16%, signal=63%</td></tr><tr><td class='lessen'>626</td><td>MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN</td><td></td><td>15</td><td>0.35</td><td>1.17</td><td>0.302</td><td>0.498</td><td>1.000</td><td>1917</td><td>tags=40%, list=18%, signal=48%</td></tr><tr><td class='lessen'>627</td><td>ABBUD_LIF_SIGNALING_1_DN</td><td></td><td>18</td><td>0.36</td><td>1.17</td><td>0.175</td><td>0.498</td><td>1.000</td><td>2041</td><td>tags=50%, list=19%, signal=61%</td></tr><tr><td class='lessen'>628</td><td>NUYTTEN_NIPP1_TARGETS_UP</td><td></td><td>355</td><td>0.26</td><td>1.17</td><td>0.224</td><td>0.498</td><td>1.000</td><td>2306</td><td>tags=28%, list=21%, signal=34%</td></tr><tr><td class='lessen'>629</td><td>LEE_LIVER_CANCER_DENA_DN</td><td></td><td>51</td><td>0.32</td><td>1.17</td><td>0.220</td><td>0.497</td><td>1.000</td><td>1866</td><td>tags=25%, list=17%, signal=31%</td></tr><tr><td class='lessen'>630</td><td>DOANE_RESPONSE_TO_ANDROGEN_UP</td><td></td><td>109</td><td>0.27</td><td>1.17</td><td>0.167</td><td>0.497</td><td>1.000</td><td>2880</td><td>tags=32%, list=26%, signal=43%</td></tr><tr><td class='lessen'>631</td><td>LASTOWSKA_COAMPLIFIED_WITH_MYCN</td><td></td><td>23</td><td>0.37</td><td>1.17</td><td>0.293</td><td>0.499</td><td>1.000</td><td>985</td><td>tags=22%, list=9%, signal=24%</td></tr><tr><td class='lessen'>632</td><td>GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP</td><td></td><td>34</td><td>0.36</td><td>1.17</td><td>0.250</td><td>0.499</td><td>1.000</td><td>2175</td><td>tags=38%, list=20%, signal=48%</td></tr><tr><td class='lessen'>633</td><td>DURCHDEWALD_SKIN_CARCINOGENESIS_UP</td><td></td><td>39</td><td>0.34</td><td>1.17</td><td>0.250</td><td>0.502</td><td>1.000</td><td>2608</td><td>tags=36%, list=24%, signal=47%</td></tr><tr><td class='lessen'>634</td><td>DELACROIX_RAR_BOUND_ES</td><td></td><td>219</td><td>0.28</td><td>1.17</td><td>0.233</td><td>0.503</td><td>1.000</td><td>1675</td><td>tags=21%, list=15%, signal=24%</td></tr><tr><td class='lessen'>635</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN</td><td></td><td>24</td><td>0.37</td><td>1.17</td><td>0.317</td><td>0.503</td><td>1.000</td><td>1836</td><td>tags=38%, list=17%, signal=45%</td></tr><tr><td class='lessen'>636</td><td>BURTON_ADIPOGENESIS_9</td><td></td><td>54</td><td>0.32</td><td>1.17</td><td>0.195</td><td>0.503</td><td>1.000</td><td>1468</td><td>tags=24%, list=13%, signal=28%</td></tr><tr><td class='lessen'>637</td><td>LABBE_TGFB1_TARGETS_DN</td><td></td><td>53</td><td>0.30</td><td>1.17</td><td>0.180</td><td>0.504</td><td>1.000</td><td>1231</td><td>tags=21%, list=11%, signal=23%</td></tr><tr><td class='lessen'>638</td><td>YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN</td><td></td><td>52</td><td>0.28</td><td>1.17</td><td>0.140</td><td>0.504</td><td>1.000</td><td>1985</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>639</td><td>MCBRYAN_PUBERTAL_BREAST_4_5WK_DN</td><td></td><td>97</td><td>0.25</td><td>1.17</td><td>0.108</td><td>0.503</td><td>1.000</td><td>1838</td><td>tags=24%, list=17%, signal=28%</td></tr><tr><td class='lessen'>640</td><td>MIKKELSEN_MCV6_LCP_WITH_H3K4ME3</td><td></td><td>72</td><td>0.35</td><td>1.16</td><td>0.340</td><td>0.503</td><td>1.000</td><td>2270</td><td>tags=31%, list=21%, signal=38%</td></tr><tr><td class='lessen'>641</td><td>RIZKI_TUMOR_INVASIVENESS_3D_DN</td><td></td><td>146</td><td>0.25</td><td>1.16</td><td>0.260</td><td>0.503</td><td>1.000</td><td>3074</td><td>tags=39%, list=28%, signal=54%</td></tr><tr><td class='lessen'>642</td><td>HINATA_NFKB_TARGETS_KERATINOCYTE_UP</td><td></td><td>53</td><td>0.40</td><td>1.16</td><td>0.360</td><td>0.504</td><td>1.000</td><td>1931</td><td>tags=34%, list=18%, signal=41%</td></tr><tr><td class='lessen'>643</td><td>CAIRO_HEPATOBLASTOMA_DN</td><td></td><td>159</td><td>0.28</td><td>1.16</td><td>0.260</td><td>0.503</td><td>1.000</td><td>2947</td><td>tags=32%, list=27%, signal=43%</td></tr><tr><td class='lessen'>644</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN</td><td></td><td>102</td><td>0.33</td><td>1.16</td><td>0.273</td><td>0.505</td><td>1.000</td><td>1631</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>645</td><td>LEE_CALORIE_RESTRICTION_MUSCLE_DN</td><td></td><td>28</td><td>0.33</td><td>1.16</td><td>0.280</td><td>0.505</td><td>1.000</td><td>1023</td><td>tags=21%, list=9%, signal=24%</td></tr><tr><td class='lessen'>646</td><td>PENG_GLUCOSE_DEPRIVATION_UP</td><td></td><td>22</td><td>0.37</td><td>1.16</td><td>0.226</td><td>0.504</td><td>1.000</td><td>1802</td><td>tags=36%, list=17%, signal=43%</td></tr><tr><td class='lessen'>647</td><td>VALK_AML_CLUSTER_15</td><td></td><td>16</td><td>0.39</td><td>1.16</td><td>0.288</td><td>0.504</td><td>1.000</td><td>1321</td><td>tags=31%, list=12%, signal=36%</td></tr><tr><td class='lessen'>648</td><td>SCHRAETS_MLL_TARGETS_UP</td><td></td><td>19</td><td>0.39</td><td>1.16</td><td>0.268</td><td>0.506</td><td>1.000</td><td>2210</td><td>tags=53%, list=20%, signal=66%</td></tr><tr><td class='lessen'>649</td><td>XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN</td><td></td><td>61</td><td>0.34</td><td>1.16</td><td>0.265</td><td>0.505</td><td>1.000</td><td>3060</td><td>tags=46%, list=28%, signal=63%</td></tr><tr><td class='lessen'>650</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN</td><td></td><td>197</td><td>0.30</td><td>1.16</td><td>0.227</td><td>0.506</td><td>1.000</td><td>2475</td><td>tags=33%, list=23%, signal=42%</td></tr><tr><td class='lessen'>651</td><td>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN</td><td></td><td>61</td><td>0.31</td><td>1.16</td><td>0.260</td><td>0.506</td><td>1.000</td><td>1401</td><td>tags=26%, list=13%, signal=30%</td></tr><tr><td class='lessen'>652</td><td>COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP</td><td></td><td>61</td><td>0.29</td><td>1.16</td><td>0.345</td><td>0.506</td><td>1.000</td><td>1630</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>653</td><td>IGLESIAS_E2F_TARGETS_UP</td><td></td><td>77</td><td>0.28</td><td>1.16</td><td>0.244</td><td>0.507</td><td>1.000</td><td>2430</td><td>tags=36%, list=22%, signal=46%</td></tr><tr><td class='lessen'>654</td><td>LIU_SMARCA4_TARGETS</td><td></td><td>35</td><td>0.33</td><td>1.16</td><td>0.286</td><td>0.508</td><td>1.000</td><td>2561</td><td>tags=31%, list=24%, signal=41%</td></tr><tr><td class='lessen'>655</td><td>MIKKELSEN_MCV6_ICP_WITH_H3K27ME3</td><td></td><td>31</td><td>0.40</td><td>1.16</td><td>0.320</td><td>0.508</td><td>1.000</td><td>2095</td><td>tags=32%, list=19%, signal=40%</td></tr><tr><td class='lessen'>656</td><td>PLASARI_TGFB1_TARGETS_10HR_DN</td><td></td><td>146</td><td>0.28</td><td>1.15</td><td>0.255</td><td>0.514</td><td>1.000</td><td>1419</td><td>tags=18%, list=13%, signal=21%</td></tr><tr><td class='lessen'>657</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_3_DN</td><td></td><td>21</td><td>0.40</td><td>1.15</td><td>0.286</td><td>0.514</td><td>1.000</td><td>1787</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>658</td><td>HELLER_HDAC_TARGETS_UP</td><td></td><td>171</td><td>0.26</td><td>1.15</td><td>0.163</td><td>0.513</td><td>1.000</td><td>2678</td><td>tags=32%, list=25%, signal=41%</td></tr><tr><td class='lessen'>659</td><td>CASTELLANO_NRAS_TARGETS_UP</td><td></td><td>37</td><td>0.31</td><td>1.15</td><td>0.208</td><td>0.513</td><td>1.000</td><td>1885</td><td>tags=27%, list=17%, signal=33%</td></tr><tr><td class='lessen'>660</td><td>KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP</td><td></td><td>33</td><td>0.32</td><td>1.15</td><td>0.280</td><td>0.514</td><td>1.000</td><td>1313</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>661</td><td>ENK_UV_RESPONSE_EPIDERMIS_DN</td><td></td><td>276</td><td>0.24</td><td>1.15</td><td>0.222</td><td>0.515</td><td>1.000</td><td>1968</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>662</td><td>TOMLINS_METASTASIS_DN</td><td></td><td>15</td><td>0.45</td><td>1.15</td><td>0.341</td><td>0.518</td><td>1.000</td><td>333</td><td>tags=13%, list=3%, signal=14%</td></tr><tr><td class='lessen'>663</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN</td><td></td><td>44</td><td>0.31</td><td>1.15</td><td>0.255</td><td>0.518</td><td>1.000</td><td>700</td><td>tags=18%, list=6%, signal=19%</td></tr><tr><td class='lessen'>664</td><td>MASSARWEH_TAMOXIFEN_RESISTANCE_UP</td><td></td><td>286</td><td>0.25</td><td>1.15</td><td>0.308</td><td>0.519</td><td>1.000</td><td>1884</td><td>tags=25%, list=17%, signal=29%</td></tr><tr><td class='lessen'>665</td><td>GROSS_HYPOXIA_VIA_HIF1A_DN</td><td></td><td>51</td><td>0.35</td><td>1.15</td><td>0.302</td><td>0.519</td><td>1.000</td><td>3014</td><td>tags=41%, list=28%, signal=57%</td></tr><tr><td class='lessen'>666</td><td>PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN</td><td></td><td>237</td><td>0.23</td><td>1.15</td><td>0.149</td><td>0.518</td><td>1.000</td><td>1690</td><td>tags=20%, list=16%, signal=23%</td></tr><tr><td class='lessen'>667</td><td>GROSS_HYPOXIA_VIA_ELK3_DN</td><td></td><td>90</td><td>0.32</td><td>1.15</td><td>0.260</td><td>0.518</td><td>1.000</td><td>1783</td><td>tags=30%, list=16%, signal=36%</td></tr><tr><td class='lessen'>668</td><td>ENK_UV_RESPONSE_KERATINOCYTE_UP</td><td></td><td>290</td><td>0.27</td><td>1.15</td><td>0.318</td><td>0.518</td><td>1.000</td><td>2407</td><td>tags=31%, list=22%, signal=39%</td></tr><tr><td class='lessen'>669</td><td>EPPERT_CE_HSC_LSC</td><td></td><td>26</td><td>0.34</td><td>1.15</td><td>0.386</td><td>0.520</td><td>1.000</td><td>716</td><td>tags=23%, list=7%, signal=25%</td></tr><tr><td class='lessen'>670</td><td>PLASARI_TGFB1_TARGETS_10HR_UP</td><td></td><td>117</td><td>0.32</td><td>1.15</td><td>0.283</td><td>0.520</td><td>1.000</td><td>1903</td><td>tags=27%, list=17%, signal=33%</td></tr><tr><td class='lessen'>671</td><td>MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3</td><td></td><td>24</td><td>0.36</td><td>1.15</td><td>0.298</td><td>0.520</td><td>1.000</td><td>1223</td><td>tags=21%, list=11%, signal=23%</td></tr><tr><td class='lessen'>672</td><td>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP</td><td></td><td>169</td><td>0.30</td><td>1.15</td><td>0.348</td><td>0.519</td><td>1.000</td><td>1815</td><td>tags=24%, list=17%, signal=29%</td></tr><tr><td class='lessen'>673</td><td>HARRIS_HYPOXIA</td><td></td><td>48</td><td>0.33</td><td>1.14</td><td>0.264</td><td>0.520</td><td>1.000</td><td>1978</td><td>tags=31%, list=18%, signal=38%</td></tr><tr><td class='lessen'>674</td><td>RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN</td><td></td><td>21</td><td>0.38</td><td>1.14</td><td>0.308</td><td>0.519</td><td>1.000</td><td>885</td><td>tags=19%, list=8%, signal=21%</td></tr><tr><td class='lessen'>675</td><td>CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN</td><td></td><td>18</td><td>0.41</td><td>1.14</td><td>0.280</td><td>0.520</td><td>1.000</td><td>2611</td><td>tags=56%, list=24%, signal=73%</td></tr><tr><td class='lessen'>676</td><td>CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP</td><td></td><td>20</td><td>0.40</td><td>1.14</td><td>0.280</td><td>0.519</td><td>1.000</td><td>4053</td><td>tags=60%, list=37%, signal=95%</td></tr><tr><td class='lessen'>677</td><td>BAELDE_DIABETIC_NEPHROPATHY_UP</td><td></td><td>51</td><td>0.33</td><td>1.14</td><td>0.286</td><td>0.522</td><td>1.000</td><td>2397</td><td>tags=37%, list=22%, signal=48%</td></tr><tr><td class='lessen'>678</td><td>BURTON_ADIPOGENESIS_7</td><td></td><td>30</td><td>0.37</td><td>1.14</td><td>0.349</td><td>0.524</td><td>1.000</td><td>1382</td><td>tags=30%, list=13%, signal=34%</td></tr><tr><td class='lessen'>679</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS</td><td></td><td>24</td><td>0.32</td><td>1.14</td><td>0.250</td><td>0.524</td><td>1.000</td><td>664</td><td>tags=17%, list=6%, signal=18%</td></tr><tr><td class='lessen'>680</td><td>NAKAMURA_ADIPOGENESIS_LATE_DN</td><td></td><td>22</td><td>0.34</td><td>1.14</td><td>0.241</td><td>0.524</td><td>1.000</td><td>1901</td><td>tags=36%, list=17%, signal=44%</td></tr><tr><td class='lessen'>681</td><td>AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G</td><td></td><td>88</td><td>0.27</td><td>1.14</td><td>0.277</td><td>0.525</td><td>1.000</td><td>1908</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>682</td><td>TIEN_INTESTINE_PROBIOTICS_6HR_DN</td><td></td><td>92</td><td>0.29</td><td>1.14</td><td>0.340</td><td>0.529</td><td>1.000</td><td>2822</td><td>tags=38%, list=26%, signal=51%</td></tr><tr><td class='lessen'>683</td><td>HOFMANN_CELL_LYMPHOMA_UP</td><td></td><td>32</td><td>0.32</td><td>1.14</td><td>0.288</td><td>0.529</td><td>1.000</td><td>1334</td><td>tags=25%, list=12%, signal=28%</td></tr><tr><td class='lessen'>684</td><td>TOOKER_GEMCITABINE_RESISTANCE_UP</td><td></td><td>37</td><td>0.31</td><td>1.14</td><td>0.260</td><td>0.529</td><td>1.000</td><td>1293</td><td>tags=24%, list=12%, signal=28%</td></tr><tr><td class='lessen'>685</td><td>KANNAN_TP53_TARGETS_UP</td><td></td><td>26</td><td>0.38</td><td>1.14</td><td>0.333</td><td>0.530</td><td>1.000</td><td>2404</td><td>tags=46%, list=22%, signal=59%</td></tr><tr><td class='lessen'>686</td><td>ZHAN_MULTIPLE_MYELOMA_DN</td><td></td><td>22</td><td>0.36</td><td>1.14</td><td>0.311</td><td>0.530</td><td>1.000</td><td>2814</td><td>tags=45%, list=26%, signal=61%</td></tr><tr><td class='lessen'>687</td><td>KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN</td><td></td><td>29</td><td>0.39</td><td>1.14</td><td>0.333</td><td>0.530</td><td>1.000</td><td>1625</td><td>tags=28%, list=15%, signal=32%</td></tr><tr><td class='lessen'>688</td><td>MIKKELSEN_IPS_LCP_WITH_H3K4ME3</td><td></td><td>71</td><td>0.34</td><td>1.13</td><td>0.320</td><td>0.533</td><td>1.000</td><td>3398</td><td>tags=42%, list=31%, signal=61%</td></tr><tr><td class='lessen'>689</td><td>ROSS_LEUKEMIA_WITH_MLL_FUSIONS</td><td></td><td>38</td><td>0.32</td><td>1.13</td><td>0.264</td><td>0.533</td><td>1.000</td><td>1653</td><td>tags=32%, list=15%, signal=37%</td></tr><tr><td class='lessen'>690</td><td>LU_EZH2_TARGETS_UP</td><td></td><td>129</td><td>0.26</td><td>1.13</td><td>0.271</td><td>0.533</td><td>1.000</td><td>2161</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>691</td><td>JIANG_TIP30_TARGETS_UP</td><td></td><td>26</td><td>0.34</td><td>1.13</td><td>0.295</td><td>0.533</td><td>1.000</td><td>1836</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>692</td><td>SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP</td><td></td><td>18</td><td>0.47</td><td>1.13</td><td>0.273</td><td>0.532</td><td>1.000</td><td>2231</td><td>tags=50%, list=20%, signal=63%</td></tr><tr><td class='lessen'>693</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN</td><td></td><td>339</td><td>0.26</td><td>1.13</td><td>0.267</td><td>0.535</td><td>1.000</td><td>2009</td><td>tags=26%, list=18%, signal=31%</td></tr><tr><td class='lessen'>694</td><td>BROWNE_HCMV_INFECTION_48HR_UP</td><td></td><td>99</td><td>0.26</td><td>1.13</td><td>0.279</td><td>0.535</td><td>1.000</td><td>1547</td><td>tags=21%, list=14%, signal=25%</td></tr><tr><td class='lessen'>695</td><td>FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP</td><td></td><td>39</td><td>0.30</td><td>1.13</td><td>0.289</td><td>0.535</td><td>1.000</td><td>1978</td><td>tags=26%, list=18%, signal=31%</td></tr><tr><td class='lessen'>696</td><td>CADWELL_ATG16L1_TARGETS_UP</td><td></td><td>44</td><td>0.33</td><td>1.13</td><td>0.233</td><td>0.534</td><td>1.000</td><td>2134</td><td>tags=32%, list=20%, signal=39%</td></tr><tr><td class='lessen'>697</td><td>EHLERS_ANEUPLOIDY_UP</td><td></td><td>28</td><td>0.39</td><td>1.13</td><td>0.320</td><td>0.533</td><td>1.000</td><td>2409</td><td>tags=39%, list=22%, signal=50%</td></tr><tr><td class='lessen'>698</td><td>KAYO_CALORIE_RESTRICTION_MUSCLE_UP</td><td></td><td>54</td><td>0.32</td><td>1.13</td><td>0.293</td><td>0.534</td><td>1.000</td><td>2218</td><td>tags=33%, list=20%, signal=42%</td></tr><tr><td class='lessen'>699</td><td>KYNG_DNA_DAMAGE_DN</td><td></td><td>105</td><td>0.25</td><td>1.13</td><td>0.184</td><td>0.534</td><td>1.000</td><td>2318</td><td>tags=30%, list=21%, signal=37%</td></tr><tr><td class='lessen'>700</td><td>HALMOS_CEBPA_TARGETS_DN</td><td></td><td>22</td><td>0.33</td><td>1.13</td><td>0.273</td><td>0.533</td><td>1.000</td><td>15</td><td>tags=9%, list=0%, signal=9%</td></tr><tr><td class='lessen'>701</td><td>LEE_DIFFERENTIATING_T_LYMPHOCYTE</td><td></td><td>104</td><td>0.30</td><td>1.13</td><td>0.315</td><td>0.536</td><td>1.000</td><td>2410</td><td>tags=38%, list=22%, signal=49%</td></tr><tr><td class='lessen'>702</td><td>PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN</td><td></td><td>85</td><td>0.26</td><td>1.13</td><td>0.300</td><td>0.535</td><td>1.000</td><td>2092</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>703</td><td>MARZEC_IL2_SIGNALING_UP</td><td></td><td>64</td><td>0.31</td><td>1.13</td><td>0.341</td><td>0.535</td><td>1.000</td><td>1842</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>704</td><td>GYORFFY_DOXORUBICIN_RESISTANCE</td><td></td><td>24</td><td>0.36</td><td>1.13</td><td>0.404</td><td>0.534</td><td>1.000</td><td>2753</td><td>tags=42%, list=25%, signal=56%</td></tr><tr><td class='lessen'>705</td><td>WINNEPENNINCKX_MELANOMA_METASTASIS_DN</td><td></td><td>26</td><td>0.36</td><td>1.13</td><td>0.319</td><td>0.535</td><td>1.000</td><td>3223</td><td>tags=46%, list=30%, signal=65%</td></tr><tr><td class='lessen'>706</td><td>ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP</td><td></td><td>47</td><td>0.30</td><td>1.13</td><td>0.268</td><td>0.536</td><td>1.000</td><td>2924</td><td>tags=40%, list=27%, signal=55%</td></tr><tr><td class='lessen'>707</td><td>HOUSTIS_ROS</td><td></td><td>18</td><td>0.39</td><td>1.13</td><td>0.340</td><td>0.537</td><td>1.000</td><td>1922</td><td>tags=39%, list=18%, signal=47%</td></tr><tr><td class='lessen'>708</td><td>STEARMAN_TUMOR_FIELD_EFFECT_UP</td><td></td><td>21</td><td>0.42</td><td>1.13</td><td>0.367</td><td>0.536</td><td>1.000</td><td>3033</td><td>tags=57%, list=28%, signal=79%</td></tr><tr><td class='lessen'>709</td><td>MIKKELSEN_ES_ICP_WITH_H3K4ME3</td><td></td><td>340</td><td>0.22</td><td>1.13</td><td>0.182</td><td>0.535</td><td>1.000</td><td>1917</td><td>tags=21%, list=18%, signal=25%</td></tr><tr><td class='lessen'>710</td><td>SASSON_RESPONSE_TO_FORSKOLIN_UP</td><td></td><td>53</td><td>0.28</td><td>1.12</td><td>0.261</td><td>0.535</td><td>1.000</td><td>2685</td><td>tags=42%, list=25%, signal=55%</td></tr><tr><td class='lessen'>711</td><td>JIANG_HYPOXIA_CANCER</td><td></td><td>42</td><td>0.31</td><td>1.12</td><td>0.288</td><td>0.534</td><td>1.000</td><td>1235</td><td>tags=21%, list=11%, signal=24%</td></tr><tr><td class='lessen'>712</td><td>HOLLMANN_APOPTOSIS_VIA_CD40_UP</td><td></td><td>108</td><td>0.26</td><td>1.12</td><td>0.275</td><td>0.534</td><td>1.000</td><td>1846</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>713</td><td>BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP</td><td></td><td>20</td><td>0.36</td><td>1.12</td><td>0.321</td><td>0.534</td><td>1.000</td><td>140</td><td>tags=15%, list=1%, signal=15%</td></tr><tr><td class='lessen'>714</td><td>PACHER_TARGETS_OF_IGF1_AND_IGF2_UP</td><td></td><td>16</td><td>0.41</td><td>1.12</td><td>0.353</td><td>0.537</td><td>1.000</td><td>1595</td><td>tags=44%, list=15%, signal=51%</td></tr><tr><td class='lessen'>715</td><td>WU_HBX_TARGETS_1_DN</td><td></td><td>15</td><td>0.42</td><td>1.12</td><td>0.357</td><td>0.537</td><td>1.000</td><td>2684</td><td>tags=53%, list=25%, signal=71%</td></tr><tr><td class='lessen'>716</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS</td><td></td><td>20</td><td>0.38</td><td>1.12</td><td>0.244</td><td>0.540</td><td>1.000</td><td>664</td><td>tags=20%, list=6%, signal=21%</td></tr><tr><td class='lessen'>717</td><td>WEINMANN_ADAPTATION_TO_HYPOXIA_DN</td><td></td><td>26</td><td>0.35</td><td>1.12</td><td>0.327</td><td>0.544</td><td>1.000</td><td>2115</td><td>tags=38%, list=19%, signal=48%</td></tr><tr><td class='lessen'>718</td><td>DELACROIX_RARG_BOUND_MEF</td><td></td><td>198</td><td>0.25</td><td>1.12</td><td>0.289</td><td>0.544</td><td>1.000</td><td>2356</td><td>tags=28%, list=22%, signal=35%</td></tr><tr><td class='lessen'>719</td><td>WESTON_VEGFA_TARGETS</td><td></td><td>66</td><td>0.28</td><td>1.12</td><td>0.276</td><td>0.544</td><td>1.000</td><td>1363</td><td>tags=23%, list=13%, signal=26%</td></tr><tr><td class='lessen'>720</td><td>DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN</td><td></td><td>172</td><td>0.28</td><td>1.12</td><td>0.370</td><td>0.544</td><td>1.000</td><td>1455</td><td>tags=26%, list=13%, signal=29%</td></tr><tr><td class='lessen'>721</td><td>ZHENG_FOXP3_TARGETS_UP</td><td></td><td>18</td><td>0.37</td><td>1.12</td><td>0.320</td><td>0.545</td><td>1.000</td><td>2102</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>722</td><td>DORSAM_HOXA9_TARGETS_DN</td><td></td><td>21</td><td>0.34</td><td>1.11</td><td>0.347</td><td>0.547</td><td>1.000</td><td>2500</td><td>tags=43%, list=23%, signal=56%</td></tr><tr><td class='lessen'>723</td><td>VERRECCHIA_RESPONSE_TO_TGFB1_C2</td><td></td><td>16</td><td>0.37</td><td>1.11</td><td>0.292</td><td>0.547</td><td>1.000</td><td>1417</td><td>tags=31%, list=13%, signal=36%</td></tr><tr><td class='lessen'>724</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP</td><td></td><td>27</td><td>0.31</td><td>1.11</td><td>0.289</td><td>0.547</td><td>1.000</td><td>2263</td><td>tags=37%, list=21%, signal=47%</td></tr><tr><td class='lessen'>725</td><td>NAKAJIMA_EOSINOPHIL</td><td></td><td>16</td><td>0.44</td><td>1.11</td><td>0.375</td><td>0.546</td><td>1.000</td><td>1109</td><td>tags=25%, list=10%, signal=28%</td></tr><tr><td class='lessen'>726</td><td>GUO_HEX_TARGETS_DN</td><td></td><td>36</td><td>0.31</td><td>1.11</td><td>0.326</td><td>0.546</td><td>1.000</td><td>2036</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>727</td><td>ZHANG_BREAST_CANCER_PROGENITORS_DN</td><td></td><td>77</td><td>0.26</td><td>1.11</td><td>0.260</td><td>0.546</td><td>1.000</td><td>1354</td><td>tags=22%, list=12%, signal=25%</td></tr><tr><td class='lessen'>728</td><td>KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP</td><td></td><td>66</td><td>0.33</td><td>1.11</td><td>0.442</td><td>0.546</td><td>1.000</td><td>1345</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>729</td><td>PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP</td><td></td><td>142</td><td>0.27</td><td>1.11</td><td>0.317</td><td>0.546</td><td>1.000</td><td>1447</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>730</td><td>WARTERS_IR_RESPONSE_5GY</td><td></td><td>21</td><td>0.35</td><td>1.11</td><td>0.261</td><td>0.546</td><td>1.000</td><td>1810</td><td>tags=33%, list=17%, signal=40%</td></tr><tr><td class='lessen'>731</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP</td><td></td><td>18</td><td>0.38</td><td>1.11</td><td>0.367</td><td>0.547</td><td>1.000</td><td>932</td><td>tags=22%, list=9%, signal=24%</td></tr><tr><td class='lessen'>732</td><td>VALK_AML_WITH_CEBPA</td><td></td><td>22</td><td>0.34</td><td>1.11</td><td>0.295</td><td>0.551</td><td>1.000</td><td>2619</td><td>tags=41%, list=24%, signal=54%</td></tr><tr><td class='lessen'>733</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP</td><td></td><td>36</td><td>0.31</td><td>1.11</td><td>0.255</td><td>0.550</td><td>1.000</td><td>1720</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>734</td><td>DASU_IL6_SIGNALING_UP</td><td></td><td>28</td><td>0.38</td><td>1.11</td><td>0.349</td><td>0.550</td><td>1.000</td><td>2678</td><td>tags=39%, list=25%, signal=52%</td></tr><tr><td class='lessen'>735</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_C</td><td></td><td>44</td><td>0.31</td><td>1.11</td><td>0.326</td><td>0.552</td><td>1.000</td><td>1488</td><td>tags=30%, list=14%, signal=34%</td></tr><tr><td class='lessen'>736</td><td>DELASERNA_MYOD_TARGETS_UP</td><td></td><td>50</td><td>0.30</td><td>1.11</td><td>0.311</td><td>0.553</td><td>1.000</td><td>3204</td><td>tags=46%, list=29%, signal=65%</td></tr><tr><td class='lessen'>737</td><td>LEE_LIVER_CANCER_E2F1_DN</td><td></td><td>37</td><td>0.29</td><td>1.11</td><td>0.267</td><td>0.553</td><td>1.000</td><td>2500</td><td>tags=32%, list=23%, signal=42%</td></tr><tr><td class='lessen'>738</td><td>CERVERA_SDHB_TARGETS_1_UP</td><td></td><td>52</td><td>0.32</td><td>1.11</td><td>0.333</td><td>0.554</td><td>1.000</td><td>2560</td><td>tags=33%, list=24%, signal=43%</td></tr><tr><td class='lessen'>739</td><td>BURTON_ADIPOGENESIS_4</td><td></td><td>23</td><td>0.33</td><td>1.11</td><td>0.277</td><td>0.555</td><td>1.000</td><td>1444</td><td>tags=22%, list=13%, signal=25%</td></tr><tr><td class='lessen'>740</td><td>ACEVEDO_LIVER_CANCER_DN</td><td></td><td>263</td><td>0.26</td><td>1.10</td><td>0.277</td><td>0.556</td><td>1.000</td><td>2867</td><td>tags=32%, list=26%, signal=43%</td></tr><tr><td class='lessen'>741</td><td>CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70</td><td></td><td>38</td><td>0.31</td><td>1.10</td><td>0.308</td><td>0.556</td><td>1.000</td><td>1931</td><td>tags=29%, list=18%, signal=35%</td></tr><tr><td class='lessen'>742</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4</td><td></td><td>62</td><td>0.31</td><td>1.10</td><td>0.298</td><td>0.556</td><td>1.000</td><td>1379</td><td>tags=21%, list=13%, signal=24%</td></tr><tr><td class='lessen'>743</td><td>MA_MYELOID_DIFFERENTIATION_DN</td><td></td><td>27</td><td>0.33</td><td>1.10</td><td>0.308</td><td>0.556</td><td>1.000</td><td>2900</td><td>tags=41%, list=27%, signal=55%</td></tr><tr><td class='lessen'>744</td><td>HU_GENOTOXIC_DAMAGE_4HR</td><td></td><td>18</td><td>0.42</td><td>1.10</td><td>0.367</td><td>0.561</td><td>1.000</td><td>819</td><td>tags=22%, list=8%, signal=24%</td></tr><tr><td class='lessen'>745</td><td>JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP</td><td></td><td>43</td><td>0.32</td><td>1.10</td><td>0.264</td><td>0.564</td><td>1.000</td><td>468</td><td>tags=14%, list=4%, signal=15%</td></tr><tr><td class='lessen'>746</td><td>VANLOO_SP3_TARGETS_DN</td><td></td><td>44</td><td>0.30</td><td>1.10</td><td>0.340</td><td>0.564</td><td>1.000</td><td>1314</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>747</td><td>CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY</td><td></td><td>16</td><td>0.38</td><td>1.10</td><td>0.375</td><td>0.564</td><td>1.000</td><td>1264</td><td>tags=19%, list=12%, signal=21%</td></tr><tr><td class='lessen'>748</td><td>SUNG_METASTASIS_STROMA_UP</td><td></td><td>62</td><td>0.26</td><td>1.10</td><td>0.308</td><td>0.564</td><td>1.000</td><td>1841</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>749</td><td>NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP</td><td></td><td>84</td><td>0.27</td><td>1.10</td><td>0.316</td><td>0.564</td><td>1.000</td><td>981</td><td>tags=18%, list=9%, signal=19%</td></tr><tr><td class='lessen'>750</td><td>KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP</td><td></td><td>79</td><td>0.25</td><td>1.10</td><td>0.279</td><td>0.563</td><td>1.000</td><td>1883</td><td>tags=28%, list=17%, signal=33%</td></tr><tr><td class='lessen'>751</td><td>RIZKI_TUMOR_INVASIVENESS_2D_DN</td><td></td><td>38</td><td>0.30</td><td>1.10</td><td>0.275</td><td>0.564</td><td>1.000</td><td>1867</td><td>tags=26%, list=17%, signal=32%</td></tr><tr><td class='lessen'>752</td><td>ALCALA_APOPTOSIS</td><td></td><td>43</td><td>0.36</td><td>1.10</td><td>0.317</td><td>0.567</td><td>1.000</td><td>1849</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>753</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16</td><td></td><td>38</td><td>0.29</td><td>1.09</td><td>0.255</td><td>0.567</td><td>1.000</td><td>2418</td><td>tags=34%, list=22%, signal=44%</td></tr><tr><td class='lessen'>754</td><td>TAVAZOIE_METASTASIS</td><td></td><td>64</td><td>0.27</td><td>1.09</td><td>0.200</td><td>0.567</td><td>1.000</td><td>2748</td><td>tags=36%, list=25%, signal=48%</td></tr><tr><td class='lessen'>755</td><td>KRASNOSELSKAYA_ILF3_TARGETS_DN</td><td></td><td>30</td><td>0.34</td><td>1.09</td><td>0.367</td><td>0.567</td><td>1.000</td><td>1863</td><td>tags=33%, list=17%, signal=40%</td></tr><tr><td class='lessen'>756</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_8</td><td></td><td>23</td><td>0.36</td><td>1.09</td><td>0.340</td><td>0.568</td><td>1.000</td><td>2135</td><td>tags=43%, list=20%, signal=54%</td></tr><tr><td class='lessen'>757</td><td>BROWNE_HCMV_INFECTION_12HR_UP</td><td></td><td>52</td><td>0.28</td><td>1.09</td><td>0.302</td><td>0.567</td><td>1.000</td><td>1507</td><td>tags=27%, list=14%, signal=31%</td></tr><tr><td class='lessen'>758</td><td>WINTER_HYPOXIA_UP</td><td></td><td>44</td><td>0.33</td><td>1.09</td><td>0.404</td><td>0.567</td><td>1.000</td><td>2595</td><td>tags=36%, list=24%, signal=48%</td></tr><tr><td class='lessen'>759</td><td>HOFMANN_CELL_LYMPHOMA_DN</td><td></td><td>24</td><td>0.37</td><td>1.09</td><td>0.364</td><td>0.567</td><td>1.000</td><td>2708</td><td>tags=46%, list=25%, signal=61%</td></tr><tr><td class='lessen'>760</td><td>THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN</td><td></td><td>137</td><td>0.24</td><td>1.09</td><td>0.320</td><td>0.567</td><td>1.000</td><td>2258</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>761</td><td>SWEET_KRAS_ONCOGENIC_SIGNATURE</td><td></td><td>42</td><td>0.32</td><td>1.09</td><td>0.372</td><td>0.568</td><td>1.000</td><td>2976</td><td>tags=45%, list=27%, signal=62%</td></tr><tr><td class='lessen'>762</td><td>BOYLAN_MULTIPLE_MYELOMA_D_DN</td><td></td><td>39</td><td>0.27</td><td>1.09</td><td>0.341</td><td>0.568</td><td>1.000</td><td>2410</td><td>tags=26%, list=22%, signal=33%</td></tr><tr><td class='lessen'>763</td><td>SESTO_RESPONSE_TO_UV_C0</td><td></td><td>56</td><td>0.30</td><td>1.09</td><td>0.370</td><td>0.568</td><td>1.000</td><td>1271</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>764</td><td>CERVERA_SDHB_TARGETS_2</td><td></td><td>60</td><td>0.26</td><td>1.09</td><td>0.333</td><td>0.568</td><td>1.000</td><td>1978</td><td>tags=27%, list=18%, signal=32%</td></tr><tr><td class='lessen'>765</td><td>ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF</td><td></td><td>118</td><td>0.31</td><td>1.09</td><td>0.391</td><td>0.567</td><td>1.000</td><td>2175</td><td>tags=30%, list=20%, signal=37%</td></tr><tr><td class='lessen'>766</td><td>DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN</td><td></td><td>15</td><td>0.36</td><td>1.09</td><td>0.304</td><td>0.567</td><td>1.000</td><td>735</td><td>tags=20%, list=7%, signal=21%</td></tr><tr><td class='lessen'>767</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP</td><td></td><td>39</td><td>0.31</td><td>1.09</td><td>0.302</td><td>0.568</td><td>1.000</td><td>2178</td><td>tags=33%, list=20%, signal=42%</td></tr><tr><td class='lessen'>768</td><td>BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER</td><td></td><td>16</td><td>0.35</td><td>1.09</td><td>0.294</td><td>0.567</td><td>1.000</td><td>2218</td><td>tags=44%, list=20%, signal=55%</td></tr><tr><td class='lessen'>769</td><td>BROWNE_HCMV_INFECTION_6HR_UP</td><td></td><td>44</td><td>0.29</td><td>1.09</td><td>0.381</td><td>0.571</td><td>1.000</td><td>1487</td><td>tags=20%, list=14%, signal=24%</td></tr><tr><td class='lessen'>770</td><td>IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR</td><td></td><td>251</td><td>0.23</td><td>1.09</td><td>0.333</td><td>0.570</td><td>1.000</td><td>2082</td><td>tags=26%, list=19%, signal=31%</td></tr><tr><td class='lessen'>771</td><td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP</td><td></td><td>22</td><td>0.35</td><td>1.09</td><td>0.279</td><td>0.570</td><td>1.000</td><td>3076</td><td>tags=50%, list=28%, signal=70%</td></tr><tr><td class='lessen'>772</td><td>HINATA_NFKB_TARGETS_FIBROBLAST_UP</td><td></td><td>52</td><td>0.35</td><td>1.09</td><td>0.311</td><td>0.571</td><td>1.000</td><td>2110</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>773</td><td>MCBRYAN_PUBERTAL_BREAST_3_4WK_DN</td><td></td><td>18</td><td>0.34</td><td>1.09</td><td>0.358</td><td>0.571</td><td>1.000</td><td>1111</td><td>tags=22%, list=10%, signal=25%</td></tr><tr><td class='lessen'>774</td><td>PAL_PRMT5_TARGETS_DN</td><td></td><td>17</td><td>0.40</td><td>1.08</td><td>0.383</td><td>0.574</td><td>1.000</td><td>2129</td><td>tags=29%, list=20%, signal=37%</td></tr><tr><td class='lessen'>775</td><td>AMIT_SERUM_RESPONSE_120_MCF10A</td><td></td><td>29</td><td>0.38</td><td>1.08</td><td>0.408</td><td>0.575</td><td>1.000</td><td>261</td><td>tags=17%, list=2%, signal=18%</td></tr><tr><td class='lessen'>776</td><td>KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3</td><td></td><td>453</td><td>0.23</td><td>1.08</td><td>0.348</td><td>0.576</td><td>1.000</td><td>1889</td><td>tags=25%, list=17%, signal=28%</td></tr><tr><td class='lessen'>777</td><td>NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON</td><td></td><td>66</td><td>0.26</td><td>1.08</td><td>0.346</td><td>0.576</td><td>1.000</td><td>2205</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>778</td><td>LEE_AGING_MUSCLE_DN</td><td></td><td>30</td><td>0.31</td><td>1.08</td><td>0.417</td><td>0.577</td><td>1.000</td><td>1686</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>779</td><td>BRUINS_UVC_RESPONSE_EARLY_LATE</td><td></td><td>155</td><td>0.22</td><td>1.08</td><td>0.327</td><td>0.580</td><td>1.000</td><td>2085</td><td>tags=26%, list=19%, signal=31%</td></tr><tr><td class='lessen'>780</td><td>SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN</td><td></td><td>16</td><td>0.37</td><td>1.08</td><td>0.400</td><td>0.582</td><td>1.000</td><td>2389</td><td>tags=38%, list=22%, signal=48%</td></tr><tr><td class='lessen'>781</td><td>LEE_LIVER_CANCER_MYC_DN</td><td></td><td>37</td><td>0.30</td><td>1.08</td><td>0.354</td><td>0.583</td><td>1.000</td><td>1539</td><td>tags=24%, list=14%, signal=28%</td></tr><tr><td class='lessen'>782</td><td>STAEGE_EWING_FAMILY_TUMOR</td><td></td><td>17</td><td>0.33</td><td>1.07</td><td>0.361</td><td>0.588</td><td>1.000</td><td>1652</td><td>tags=29%, list=15%, signal=35%</td></tr><tr><td class='lessen'>783</td><td>LEE_CALORIE_RESTRICTION_MUSCLE_UP</td><td></td><td>26</td><td>0.35</td><td>1.07</td><td>0.367</td><td>0.588</td><td>1.000</td><td>1930</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>784</td><td>MATSUDA_NATURAL_KILLER_DIFFERENTIATION</td><td></td><td>264</td><td>0.20</td><td>1.07</td><td>0.300</td><td>0.590</td><td>1.000</td><td>2136</td><td>tags=24%, list=20%, signal=29%</td></tr><tr><td class='lessen'>785</td><td>FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN</td><td></td><td>33</td><td>0.33</td><td>1.07</td><td>0.367</td><td>0.594</td><td>1.000</td><td>2706</td><td>tags=39%, list=25%, signal=52%</td></tr><tr><td class='lessen'>786</td><td>HAN_SATB1_TARGETS_UP</td><td></td><td>197</td><td>0.23</td><td>1.07</td><td>0.333</td><td>0.596</td><td>1.000</td><td>1769</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>787</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN</td><td></td><td>15</td><td>0.42</td><td>1.07</td><td>0.455</td><td>0.599</td><td>1.000</td><td>2470</td><td>tags=27%, list=23%, signal=34%</td></tr><tr><td class='lessen'>788</td><td>BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN</td><td></td><td>29</td><td>0.32</td><td>1.07</td><td>0.333</td><td>0.599</td><td>1.000</td><td>626</td><td>tags=21%, list=6%, signal=22%</td></tr><tr><td class='lessen'>789</td><td>JIANG_AGING_CEREBRAL_CORTEX_DN</td><td></td><td>26</td><td>0.31</td><td>1.07</td><td>0.277</td><td>0.599</td><td>1.000</td><td>1943</td><td>tags=31%, list=18%, signal=37%</td></tr><tr><td class='lessen'>790</td><td>AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP</td><td></td><td>154</td><td>0.23</td><td>1.07</td><td>0.375</td><td>0.600</td><td>1.000</td><td>2635</td><td>tags=32%, list=24%, signal=41%</td></tr><tr><td class='lessen'>791</td><td>ONDER_CDH1_TARGETS_1_UP</td><td></td><td>86</td><td>0.24</td><td>1.06</td><td>0.295</td><td>0.602</td><td>1.000</td><td>1773</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>792</td><td>AIYAR_COBRA1_TARGETS_UP</td><td></td><td>15</td><td>0.41</td><td>1.06</td><td>0.415</td><td>0.603</td><td>1.000</td><td>1743</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>793</td><td>DAIRKEE_TERT_TARGETS_DN</td><td></td><td>59</td><td>0.27</td><td>1.06</td><td>0.366</td><td>0.604</td><td>1.000</td><td>3692</td><td>tags=46%, list=34%, signal=69%</td></tr><tr><td class='lessen'>794</td><td>VALK_AML_WITH_FLT3_ITD</td><td></td><td>20</td><td>0.33</td><td>1.06</td><td>0.380</td><td>0.604</td><td>1.000</td><td>1860</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>795</td><td>AMIT_EGF_RESPONSE_120_HELA</td><td></td><td>38</td><td>0.34</td><td>1.06</td><td>0.409</td><td>0.604</td><td>1.000</td><td>1061</td><td>tags=18%, list=10%, signal=20%</td></tr><tr><td class='lessen'>796</td><td>ZHU_CMV_ALL_UP</td><td></td><td>65</td><td>0.27</td><td>1.06</td><td>0.378</td><td>0.604</td><td>1.000</td><td>800</td><td>tags=15%, list=7%, signal=17%</td></tr><tr><td class='lessen'>797</td><td>ODONNELL_TFRC_TARGETS_UP</td><td></td><td>229</td><td>0.24</td><td>1.06</td><td>0.400</td><td>0.606</td><td>1.000</td><td>1968</td><td>tags=23%, list=18%, signal=27%</td></tr><tr><td class='lessen'>798</td><td>KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS</td><td></td><td>25</td><td>0.41</td><td>1.06</td><td>0.451</td><td>0.605</td><td>1.000</td><td>4207</td><td>tags=64%, list=39%, signal=104%</td></tr><tr><td class='lessen'>799</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_UP</td><td></td><td>165</td><td>0.25</td><td>1.06</td><td>0.364</td><td>0.606</td><td>1.000</td><td>1824</td><td>tags=23%, list=17%, signal=27%</td></tr><tr><td class='lessen'>800</td><td>RAGHAVACHARI_PLATELET_SPECIFIC_GENES</td><td></td><td>33</td><td>0.29</td><td>1.06</td><td>0.389</td><td>0.606</td><td>1.000</td><td>1077</td><td>tags=18%, list=10%, signal=20%</td></tr><tr><td class='lessen'>801</td><td>CONRAD_STEM_CELL</td><td></td><td>18</td><td>0.38</td><td>1.06</td><td>0.400</td><td>0.608</td><td>1.000</td><td>1732</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>802</td><td>LUI_THYROID_CANCER_CLUSTER_2</td><td></td><td>25</td><td>0.29</td><td>1.06</td><td>0.388</td><td>0.608</td><td>1.000</td><td>2642</td><td>tags=40%, list=24%, signal=53%</td></tr><tr><td class='lessen'>803</td><td>LABBE_WNT3A_TARGETS_DN</td><td></td><td>55</td><td>0.31</td><td>1.06</td><td>0.404</td><td>0.608</td><td>1.000</td><td>2500</td><td>tags=35%, list=23%, signal=45%</td></tr><tr><td class='lessen'>804</td><td>VALK_AML_CLUSTER_8</td><td></td><td>20</td><td>0.35</td><td>1.06</td><td>0.346</td><td>0.609</td><td>1.000</td><td>2435</td><td>tags=40%, list=22%, signal=51%</td></tr><tr><td class='lessen'>805</td><td>NIELSEN_GIST</td><td></td><td>56</td><td>0.27</td><td>1.06</td><td>0.308</td><td>0.608</td><td>1.000</td><td>2177</td><td>tags=27%, list=20%, signal=33%</td></tr><tr><td class='lessen'>806</td><td>KIM_ALL_DISORDERS_CALB1_CORR_UP</td><td></td><td>284</td><td>0.22</td><td>1.06</td><td>0.333</td><td>0.608</td><td>1.000</td><td>1767</td><td>tags=21%, list=16%, signal=24%</td></tr><tr><td class='lessen'>807</td><td>MATZUK_MALE_REPRODUCTION_SERTOLI</td><td></td><td>19</td><td>0.32</td><td>1.06</td><td>0.393</td><td>0.608</td><td>1.000</td><td>202</td><td>tags=16%, list=2%, signal=16%</td></tr><tr><td class='lessen'>808</td><td>ZHAN_MULTIPLE_MYELOMA_CD2_DN</td><td></td><td>20</td><td>0.37</td><td>1.06</td><td>0.386</td><td>0.610</td><td>1.000</td><td>2356</td><td>tags=50%, list=22%, signal=64%</td></tr><tr><td class='lessen'>809</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_6_UP</td><td></td><td>69</td><td>0.26</td><td>1.06</td><td>0.356</td><td>0.609</td><td>1.000</td><td>3719</td><td>tags=48%, list=34%, signal=72%</td></tr><tr><td class='lessen'>810</td><td>KRIEG_KDM3A_TARGETS_NOT_HYPOXIA</td><td></td><td>103</td><td>0.27</td><td>1.05</td><td>0.439</td><td>0.610</td><td>1.000</td><td>2482</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>811</td><td>BRUNO_HEMATOPOIESIS</td><td></td><td>33</td><td>0.28</td><td>1.05</td><td>0.400</td><td>0.611</td><td>1.000</td><td>2561</td><td>tags=39%, list=24%, signal=51%</td></tr><tr><td class='lessen'>812</td><td>SASSON_RESPONSE_TO_GONADOTROPHINS_UP</td><td></td><td>52</td><td>0.24</td><td>1.05</td><td>0.352</td><td>0.615</td><td>1.000</td><td>2685</td><td>tags=40%, list=25%, signal=53%</td></tr><tr><td class='lessen'>813</td><td>PHONG_TNF_RESPONSE_NOT_VIA_P38</td><td></td><td>192</td><td>0.28</td><td>1.05</td><td>0.409</td><td>0.614</td><td>1.000</td><td>1894</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>814</td><td>LEE_RECENT_THYMIC_EMIGRANT</td><td></td><td>121</td><td>0.24</td><td>1.05</td><td>0.447</td><td>0.614</td><td>1.000</td><td>2168</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>815</td><td>ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP</td><td></td><td>22</td><td>0.31</td><td>1.05</td><td>0.457</td><td>0.615</td><td>1.000</td><td>1335</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>816</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td><td></td><td>79</td><td>0.25</td><td>1.05</td><td>0.333</td><td>0.614</td><td>1.000</td><td>3063</td><td>tags=41%, list=28%, signal=56%</td></tr><tr><td class='lessen'>817</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN</td><td></td><td>116</td><td>0.30</td><td>1.05</td><td>0.452</td><td>0.615</td><td>1.000</td><td>2410</td><td>tags=30%, list=22%, signal=38%</td></tr><tr><td class='lessen'>818</td><td>YANG_BREAST_CANCER_ESR1_UP</td><td></td><td>20</td><td>0.34</td><td>1.05</td><td>0.352</td><td>0.618</td><td>1.000</td><td>1787</td><td>tags=30%, list=16%, signal=36%</td></tr><tr><td class='lessen'>819</td><td>LEIN_CEREBELLUM_MARKERS</td><td></td><td>50</td><td>0.27</td><td>1.05</td><td>0.426</td><td>0.618</td><td>1.000</td><td>1323</td><td>tags=22%, list=12%, signal=25%</td></tr><tr><td class='lessen'>820</td><td>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP</td><td></td><td>74</td><td>0.29</td><td>1.05</td><td>0.458</td><td>0.619</td><td>1.000</td><td>1687</td><td>tags=24%, list=15%, signal=29%</td></tr><tr><td class='lessen'>821</td><td>VALK_AML_CLUSTER_13</td><td></td><td>17</td><td>0.31</td><td>1.05</td><td>0.396</td><td>0.619</td><td>1.000</td><td>1588</td><td>tags=35%, list=15%, signal=41%</td></tr><tr><td class='lessen'>822</td><td>OKUMURA_INFLAMMATORY_RESPONSE_LPS</td><td></td><td>98</td><td>0.25</td><td>1.05</td><td>0.296</td><td>0.619</td><td>1.000</td><td>1582</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>823</td><td>KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP</td><td></td><td>306</td><td>0.23</td><td>1.05</td><td>0.286</td><td>0.618</td><td>1.000</td><td>1743</td><td>tags=22%, list=16%, signal=25%</td></tr><tr><td class='lessen'>824</td><td>ZWANG_EGF_PERSISTENTLY_DN</td><td></td><td>26</td><td>0.34</td><td>1.05</td><td>0.551</td><td>0.620</td><td>1.000</td><td>998</td><td>tags=19%, list=9%, signal=21%</td></tr><tr><td class='lessen'>825</td><td>GERY_CEBP_TARGETS</td><td></td><td>75</td><td>0.27</td><td>1.04</td><td>0.439</td><td>0.619</td><td>1.000</td><td>2231</td><td>tags=29%, list=20%, signal=37%</td></tr><tr><td class='lessen'>826</td><td>HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR</td><td></td><td>25</td><td>0.33</td><td>1.04</td><td>0.383</td><td>0.620</td><td>1.000</td><td>1498</td><td>tags=28%, list=14%, signal=32%</td></tr><tr><td class='lessen'>827</td><td>ELVIDGE_HIF1A_TARGETS_UP</td><td></td><td>36</td><td>0.31</td><td>1.04</td><td>0.354</td><td>0.619</td><td>1.000</td><td>920</td><td>tags=19%, list=8%, signal=21%</td></tr><tr><td class='lessen'>828</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK</td><td></td><td>74</td><td>0.25</td><td>1.04</td><td>0.421</td><td>0.619</td><td>1.000</td><td>1923</td><td>tags=26%, list=18%, signal=31%</td></tr><tr><td class='lessen'>829</td><td>WORSCHECH_TUMOR_REJECTION_UP</td><td></td><td>34</td><td>0.35</td><td>1.04</td><td>0.449</td><td>0.618</td><td>1.000</td><td>2331</td><td>tags=38%, list=21%, signal=49%</td></tr><tr><td class='lessen'>830</td><td>GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11</td><td></td><td>30</td><td>0.30</td><td>1.04</td><td>0.419</td><td>0.621</td><td>1.000</td><td>1840</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>831</td><td>GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN</td><td></td><td>33</td><td>0.30</td><td>1.04</td><td>0.404</td><td>0.622</td><td>1.000</td><td>3087</td><td>tags=48%, list=28%, signal=67%</td></tr><tr><td class='lessen'>832</td><td>FRASOR_RESPONSE_TO_ESTRADIOL_DN</td><td></td><td>47</td><td>0.28</td><td>1.04</td><td>0.367</td><td>0.622</td><td>1.000</td><td>530</td><td>tags=13%, list=5%, signal=13%</td></tr><tr><td class='lessen'>833</td><td>BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN</td><td></td><td>23</td><td>0.34</td><td>1.04</td><td>0.353</td><td>0.623</td><td>1.000</td><td>2616</td><td>tags=43%, list=24%, signal=57%</td></tr><tr><td class='lessen'>834</td><td>NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON</td><td></td><td>80</td><td>0.28</td><td>1.04</td><td>0.382</td><td>0.623</td><td>1.000</td><td>2191</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>835</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN</td><td></td><td>160</td><td>0.22</td><td>1.04</td><td>0.373</td><td>0.623</td><td>1.000</td><td>1596</td><td>tags=22%, list=15%, signal=25%</td></tr><tr><td class='lessen'>836</td><td>KRIEG_HYPOXIA_NOT_VIA_KDM3A</td><td></td><td>351</td><td>0.22</td><td>1.04</td><td>0.462</td><td>0.623</td><td>1.000</td><td>2411</td><td>tags=28%, list=22%, signal=35%</td></tr><tr><td class='lessen'>837</td><td>ELVIDGE_HYPOXIA_BY_DMOG_DN</td><td></td><td>32</td><td>0.32</td><td>1.04</td><td>0.383</td><td>0.623</td><td>1.000</td><td>920</td><td>tags=16%, list=8%, signal=17%</td></tr><tr><td class='lessen'>838</td><td>DANG_MYC_TARGETS_DN</td><td></td><td>15</td><td>0.35</td><td>1.04</td><td>0.357</td><td>0.625</td><td>1.000</td><td>2184</td><td>tags=40%, list=20%, signal=50%</td></tr><tr><td class='lessen'>839</td><td>MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP</td><td></td><td>48</td><td>0.27</td><td>1.04</td><td>0.442</td><td>0.625</td><td>1.000</td><td>2196</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>840</td><td>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN</td><td></td><td>121</td><td>0.25</td><td>1.04</td><td>0.432</td><td>0.626</td><td>1.000</td><td>1742</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>841</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7</td><td></td><td>212</td><td>0.22</td><td>1.04</td><td>0.382</td><td>0.625</td><td>1.000</td><td>1854</td><td>tags=21%, list=17%, signal=25%</td></tr><tr><td class='lessen'>842</td><td>BROWNE_HCMV_INFECTION_48HR_DN</td><td></td><td>300</td><td>0.22</td><td>1.04</td><td>0.370</td><td>0.625</td><td>1.000</td><td>2235</td><td>tags=26%, list=21%, signal=31%</td></tr><tr><td class='lessen'>843</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP</td><td></td><td>150</td><td>0.24</td><td>1.04</td><td>0.432</td><td>0.624</td><td>1.000</td><td>2174</td><td>tags=23%, list=20%, signal=29%</td></tr><tr><td class='lessen'>844</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS</td><td></td><td>35</td><td>0.32</td><td>1.04</td><td>0.447</td><td>0.624</td><td>1.000</td><td>2095</td><td>tags=34%, list=19%, signal=42%</td></tr><tr><td class='lessen'>845</td><td>ZWANG_EGF_INTERVAL_DN</td><td></td><td>108</td><td>0.24</td><td>1.04</td><td>0.422</td><td>0.625</td><td>1.000</td><td>1750</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>846</td><td>SIMBULAN_UV_RESPONSE_NORMAL_DN</td><td></td><td>15</td><td>0.35</td><td>1.04</td><td>0.455</td><td>0.624</td><td>1.000</td><td>2680</td><td>tags=40%, list=25%, signal=53%</td></tr><tr><td class='lessen'>847</td><td>AMIT_EGF_RESPONSE_480_MCF10A</td><td></td><td>28</td><td>0.33</td><td>1.03</td><td>0.422</td><td>0.627</td><td>1.000</td><td>2897</td><td>tags=32%, list=27%, signal=44%</td></tr><tr><td class='lessen'>848</td><td>FALVELLA_SMOKERS_WITH_LUNG_CANCER</td><td></td><td>42</td><td>0.30</td><td>1.03</td><td>0.381</td><td>0.627</td><td>1.000</td><td>2200</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>849</td><td>GOLDRATH_ANTIGEN_RESPONSE</td><td></td><td>195</td><td>0.25</td><td>1.03</td><td>0.435</td><td>0.628</td><td>1.000</td><td>2406</td><td>tags=31%, list=22%, signal=39%</td></tr><tr><td class='lessen'>850</td><td>BILBAN_B_CLL_LPL_DN</td><td></td><td>16</td><td>0.39</td><td>1.03</td><td>0.417</td><td>0.627</td><td>1.000</td><td>3036</td><td>tags=63%, list=28%, signal=87%</td></tr><tr><td class='lessen'>851</td><td>JIANG_TIP30_TARGETS_DN</td><td></td><td>17</td><td>0.38</td><td>1.03</td><td>0.489</td><td>0.628</td><td>1.000</td><td>3033</td><td>tags=47%, list=28%, signal=65%</td></tr><tr><td class='lessen'>852</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4</td><td></td><td>140</td><td>0.25</td><td>1.03</td><td>0.341</td><td>0.627</td><td>1.000</td><td>2873</td><td>tags=32%, list=26%, signal=43%</td></tr><tr><td class='lessen'>853</td><td>RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN</td><td></td><td>24</td><td>0.33</td><td>1.03</td><td>0.429</td><td>0.627</td><td>1.000</td><td>1842</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>854</td><td>MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>73</td><td>0.27</td><td>1.03</td><td>0.431</td><td>0.627</td><td>1.000</td><td>2534</td><td>tags=30%, list=23%, signal=39%</td></tr><tr><td class='lessen'>855</td><td>NIELSEN_LEIOMYOSARCOMA_CNN1_UP</td><td></td><td>15</td><td>0.35</td><td>1.03</td><td>0.500</td><td>0.626</td><td>1.000</td><td>2942</td><td>tags=47%, list=27%, signal=64%</td></tr><tr><td class='lessen'>856</td><td>MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3</td><td></td><td>63</td><td>0.28</td><td>1.03</td><td>0.434</td><td>0.625</td><td>1.000</td><td>1862</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>857</td><td>LEE_LIVER_CANCER_SURVIVAL_UP</td><td></td><td>95</td><td>0.27</td><td>1.03</td><td>0.444</td><td>0.626</td><td>1.000</td><td>2721</td><td>tags=34%, list=25%, signal=45%</td></tr><tr><td class='lessen'>858</td><td>ROZANOV_MMP14_TARGETS_DN</td><td></td><td>18</td><td>0.38</td><td>1.03</td><td>0.455</td><td>0.627</td><td>1.000</td><td>2020</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>859</td><td>MARTENS_TRETINOIN_RESPONSE_UP</td><td></td><td>363</td><td>0.28</td><td>1.03</td><td>0.440</td><td>0.627</td><td>1.000</td><td>3083</td><td>tags=34%, list=28%, signal=46%</td></tr><tr><td class='lessen'>860</td><td>WANG_CLIM2_TARGETS_DN</td><td></td><td>99</td><td>0.26</td><td>1.03</td><td>0.429</td><td>0.627</td><td>1.000</td><td>1426</td><td>tags=21%, list=13%, signal=24%</td></tr><tr><td class='lessen'>861</td><td>XU_GH1_EXOGENOUS_TARGETS_DN</td><td></td><td>73</td><td>0.25</td><td>1.03</td><td>0.378</td><td>0.627</td><td>1.000</td><td>2168</td><td>tags=25%, list=20%, signal=31%</td></tr><tr><td class='lessen'>862</td><td>MARTINEZ_RB1_TARGETS_UP</td><td></td><td>370</td><td>0.20</td><td>1.03</td><td>0.405</td><td>0.628</td><td>1.000</td><td>2357</td><td>tags=27%, list=22%, signal=34%</td></tr><tr><td class='lessen'>863</td><td>STOSSI_RESPONSE_TO_ESTRADIOL</td><td></td><td>37</td><td>0.32</td><td>1.03</td><td>0.385</td><td>0.630</td><td>1.000</td><td>1900</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>864</td><td>MATZUK_SPERMATOGONIA</td><td></td><td>15</td><td>0.37</td><td>1.03</td><td>0.468</td><td>0.629</td><td>1.000</td><td>1973</td><td>tags=40%, list=18%, signal=49%</td></tr><tr><td class='lessen'>865</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS</td><td></td><td>476</td><td>0.20</td><td>1.03</td><td>0.360</td><td>0.630</td><td>1.000</td><td>1339</td><td>tags=16%, list=12%, signal=18%</td></tr><tr><td class='lessen'>866</td><td>VERHAAK_GLIOBLASTOMA_NEURAL</td><td></td><td>69</td><td>0.25</td><td>1.02</td><td>0.386</td><td>0.632</td><td>1.000</td><td>3434</td><td>tags=38%, list=32%, signal=55%</td></tr><tr><td class='lessen'>867</td><td>NELSON_RESPONSE_TO_ANDROGEN_UP</td><td></td><td>49</td><td>0.26</td><td>1.02</td><td>0.391</td><td>0.631</td><td>1.000</td><td>2644</td><td>tags=33%, list=24%, signal=43%</td></tr><tr><td class='lessen'>868</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM</td><td></td><td>16</td><td>0.31</td><td>1.02</td><td>0.451</td><td>0.633</td><td>1.000</td><td>2184</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>869</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP</td><td></td><td>54</td><td>0.28</td><td>1.02</td><td>0.400</td><td>0.632</td><td>1.000</td><td>2228</td><td>tags=35%, list=20%, signal=44%</td></tr><tr><td class='lessen'>870</td><td>VANOEVELEN_MYOGENESIS_SIN3A_TARGETS</td><td></td><td>103</td><td>0.23</td><td>1.02</td><td>0.447</td><td>0.633</td><td>1.000</td><td>2312</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>871</td><td>MCBRYAN_PUBERTAL_BREAST_6_7WK_UP</td><td></td><td>112</td><td>0.23</td><td>1.02</td><td>0.417</td><td>0.634</td><td>1.000</td><td>547</td><td>tags=12%, list=5%, signal=12%</td></tr><tr><td class='lessen'>872</td><td>MATZUK_SPERMATID_DIFFERENTIATION</td><td></td><td>23</td><td>0.35</td><td>1.02</td><td>0.362</td><td>0.633</td><td>1.000</td><td>169</td><td>tags=9%, list=2%, signal=9%</td></tr><tr><td class='lessen'>873</td><td>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP</td><td></td><td>21</td><td>0.33</td><td>1.02</td><td>0.478</td><td>0.633</td><td>1.000</td><td>2678</td><td>tags=43%, list=25%, signal=57%</td></tr><tr><td class='lessen'>874</td><td>AMIT_SERUM_RESPONSE_480_MCF10A</td><td></td><td>17</td><td>0.34</td><td>1.02</td><td>0.438</td><td>0.633</td><td>1.000</td><td>647</td><td>tags=18%, list=6%, signal=19%</td></tr><tr><td class='lessen'>875</td><td>BECKER_TAMOXIFEN_RESISTANCE_UP</td><td></td><td>26</td><td>0.32</td><td>1.02</td><td>0.490</td><td>0.633</td><td>1.000</td><td>391</td><td>tags=12%, list=4%, signal=12%</td></tr><tr><td class='lessen'>876</td><td>VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN</td><td></td><td>58</td><td>0.27</td><td>1.02</td><td>0.421</td><td>0.633</td><td>1.000</td><td>2149</td><td>tags=24%, list=20%, signal=30%</td></tr><tr><td class='lessen'>877</td><td>YANG_BREAST_CANCER_ESR1_LASER_DN</td><td></td><td>29</td><td>0.30</td><td>1.02</td><td>0.381</td><td>0.634</td><td>1.000</td><td>2270</td><td>tags=34%, list=21%, signal=43%</td></tr><tr><td class='lessen'>878</td><td>KONDO_PROSTATE_CANCER_WITH_H3K27ME3</td><td></td><td>79</td><td>0.30</td><td>1.02</td><td>0.400</td><td>0.636</td><td>1.000</td><td>2933</td><td>tags=37%, list=27%, signal=50%</td></tr><tr><td class='lessen'>879</td><td>CROONQUIST_STROMAL_STIMULATION_UP</td><td></td><td>32</td><td>0.33</td><td>1.02</td><td>0.391</td><td>0.637</td><td>1.000</td><td>1765</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>880</td><td>VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP</td><td></td><td>103</td><td>0.27</td><td>1.02</td><td>0.460</td><td>0.638</td><td>1.000</td><td>1405</td><td>tags=21%, list=13%, signal=24%</td></tr><tr><td class='lessen'>881</td><td>LOPEZ_MBD_TARGETS</td><td></td><td>494</td><td>0.21</td><td>1.02</td><td>0.383</td><td>0.638</td><td>1.000</td><td>2005</td><td>tags=23%, list=18%, signal=27%</td></tr><tr><td class='lessen'>882</td><td>WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER</td><td></td><td>30</td><td>0.31</td><td>1.02</td><td>0.478</td><td>0.639</td><td>1.000</td><td>2737</td><td>tags=47%, list=25%, signal=62%</td></tr><tr><td class='lessen'>883</td><td>WILCOX_RESPONSE_TO_PROGESTERONE_DN</td><td></td><td>41</td><td>0.27</td><td>1.01</td><td>0.365</td><td>0.641</td><td>1.000</td><td>1533</td><td>tags=22%, list=14%, signal=25%</td></tr><tr><td class='lessen'>884</td><td>HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN</td><td></td><td>15</td><td>0.32</td><td>1.01</td><td>0.404</td><td>0.641</td><td>1.000</td><td>1955</td><td>tags=33%, list=18%, signal=41%</td></tr><tr><td class='lessen'>885</td><td>ABE_INNER_EAR</td><td></td><td>18</td><td>0.34</td><td>1.01</td><td>0.500</td><td>0.643</td><td>1.000</td><td>144</td><td>tags=11%, list=1%, signal=11%</td></tr><tr><td class='lessen'>886</td><td>MIKKELSEN_NPC_ICP_WITH_H3K4ME3</td><td></td><td>221</td><td>0.21</td><td>1.01</td><td>0.449</td><td>0.643</td><td>1.000</td><td>2604</td><td>tags=28%, list=24%, signal=36%</td></tr><tr><td class='lessen'>887</td><td>ABE_VEGFA_TARGETS_2HR</td><td></td><td>21</td><td>0.36</td><td>1.01</td><td>0.388</td><td>0.643</td><td>1.000</td><td>1313</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>888</td><td>GOZGIT_ESR1_TARGETS_DN</td><td></td><td>373</td><td>0.21</td><td>1.01</td><td>0.396</td><td>0.644</td><td>1.000</td><td>1039</td><td>tags=14%, list=10%, signal=15%</td></tr><tr><td class='lessen'>889</td><td>BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP</td><td></td><td>444</td><td>0.22</td><td>1.01</td><td>0.365</td><td>0.648</td><td>1.000</td><td>1900</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>890</td><td>TSENG_ADIPOGENIC_POTENTIAL_UP</td><td></td><td>19</td><td>0.32</td><td>1.01</td><td>0.373</td><td>0.647</td><td>1.000</td><td>2341</td><td>tags=37%, list=22%, signal=47%</td></tr><tr><td class='lessen'>891</td><td>SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP</td><td></td><td>46</td><td>0.27</td><td>1.01</td><td>0.472</td><td>0.647</td><td>1.000</td><td>1762</td><td>tags=33%, list=16%, signal=39%</td></tr><tr><td class='lessen'>892</td><td>TOMLINS_PROSTATE_CANCER_DN</td><td></td><td>20</td><td>0.39</td><td>1.01</td><td>0.400</td><td>0.646</td><td>1.000</td><td>1354</td><td>tags=25%, list=12%, signal=28%</td></tr><tr><td class='lessen'>893</td><td>MURAKAMI_UV_RESPONSE_6HR_UP</td><td></td><td>18</td><td>0.29</td><td>1.01</td><td>0.500</td><td>0.646</td><td>1.000</td><td>2575</td><td>tags=39%, list=24%, signal=51%</td></tr><tr><td class='lessen'>894</td><td>ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN</td><td></td><td>25</td><td>0.32</td><td>1.01</td><td>0.392</td><td>0.645</td><td>1.000</td><td>2910</td><td>tags=48%, list=27%, signal=65%</td></tr><tr><td class='lessen'>895</td><td>BHAT_ESR1_TARGETS_VIA_AKT1_DN</td><td></td><td>57</td><td>0.26</td><td>1.01</td><td>0.378</td><td>0.646</td><td>1.000</td><td>1524</td><td>tags=23%, list=14%, signal=26%</td></tr><tr><td class='lessen'>896</td><td>SENESE_HDAC1_TARGETS_DN</td><td></td><td>132</td><td>0.21</td><td>1.01</td><td>0.440</td><td>0.646</td><td>1.000</td><td>1973</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>897</td><td>DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN</td><td></td><td>96</td><td>0.24</td><td>1.01</td><td>0.510</td><td>0.646</td><td>1.000</td><td>2064</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>898</td><td>LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT</td><td></td><td>63</td><td>0.31</td><td>1.01</td><td>0.489</td><td>0.647</td><td>1.000</td><td>2443</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>899</td><td>HENDRICKS_SMARCA4_TARGETS_DN</td><td></td><td>28</td><td>0.28</td><td>1.01</td><td>0.415</td><td>0.647</td><td>1.000</td><td>2199</td><td>tags=36%, list=20%, signal=45%</td></tr><tr><td class='lessen'>900</td><td>ONO_AML1_TARGETS_DN</td><td></td><td>23</td><td>0.35</td><td>1.00</td><td>0.468</td><td>0.650</td><td>1.000</td><td>2034</td><td>tags=39%, list=19%, signal=48%</td></tr><tr><td class='lessen'>901</td><td>SENESE_HDAC1_AND_HDAC2_TARGETS_UP</td><td></td><td>139</td><td>0.26</td><td>1.00</td><td>0.457</td><td>0.652</td><td>1.000</td><td>2231</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>902</td><td>MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN</td><td></td><td>79</td><td>0.24</td><td>1.00</td><td>0.492</td><td>0.651</td><td>1.000</td><td>2574</td><td>tags=28%, list=24%, signal=36%</td></tr><tr><td class='lessen'>903</td><td>DAZARD_RESPONSE_TO_UV_SCC_UP</td><td></td><td>74</td><td>0.24</td><td>1.00</td><td>0.460</td><td>0.652</td><td>1.000</td><td>2269</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>904</td><td>CHANDRAN_METASTASIS_DN</td><td></td><td>148</td><td>0.22</td><td>1.00</td><td>0.431</td><td>0.651</td><td>1.000</td><td>1969</td><td>tags=21%, list=18%, signal=25%</td></tr><tr><td class='lessen'>905</td><td>KENNY_CTNNB1_TARGETS_DN</td><td></td><td>27</td><td>0.29</td><td>1.00</td><td>0.511</td><td>0.651</td><td>1.000</td><td>955</td><td>tags=19%, list=9%, signal=20%</td></tr><tr><td class='lessen'>906</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_T7</td><td></td><td>43</td><td>0.27</td><td>1.00</td><td>0.479</td><td>0.651</td><td>1.000</td><td>1114</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>907</td><td>VANASSE_BCL2_TARGETS_DN</td><td></td><td>35</td><td>0.26</td><td>1.00</td><td>0.511</td><td>0.651</td><td>1.000</td><td>2443</td><td>tags=31%, list=22%, signal=40%</td></tr><tr><td class='lessen'>908</td><td>PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN</td><td></td><td>27</td><td>0.35</td><td>1.00</td><td>0.389</td><td>0.650</td><td>1.000</td><td>1274</td><td>tags=22%, list=12%, signal=25%</td></tr><tr><td class='lessen'>909</td><td>HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN</td><td></td><td>29</td><td>0.32</td><td>1.00</td><td>0.556</td><td>0.650</td><td>1.000</td><td>1901</td><td>tags=31%, list=17%, signal=38%</td></tr><tr><td class='lessen'>910</td><td>SCHRAETS_MLL_TARGETS_DN</td><td></td><td>19</td><td>0.31</td><td>1.00</td><td>0.500</td><td>0.651</td><td>1.000</td><td>1860</td><td>tags=32%, list=17%, signal=38%</td></tr><tr><td class='lessen'>911</td><td>HOQUE_METHYLATED_IN_CANCER</td><td></td><td>37</td><td>0.30</td><td>1.00</td><td>0.500</td><td>0.651</td><td>1.000</td><td>1636</td><td>tags=24%, list=15%, signal=29%</td></tr><tr><td class='lessen'>912</td><td>MALONEY_RESPONSE_TO_17AAG_DN</td><td></td><td>40</td><td>0.30</td><td>1.00</td><td>0.481</td><td>0.651</td><td>1.000</td><td>946</td><td>tags=20%, list=9%, signal=22%</td></tr><tr><td class='lessen'>913</td><td>SENESE_HDAC3_TARGETS_DN</td><td></td><td>259</td><td>0.20</td><td>1.00</td><td>0.362</td><td>0.651</td><td>1.000</td><td>988</td><td>tags=14%, list=9%, signal=15%</td></tr><tr><td class='lessen'>914</td><td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM</td><td></td><td>35</td><td>0.29</td><td>1.00</td><td>0.444</td><td>0.650</td><td>1.000</td><td>3272</td><td>tags=49%, list=30%, signal=69%</td></tr><tr><td class='lessen'>915</td><td>SCHLOSSER_SERUM_RESPONSE_DN</td><td></td><td>378</td><td>0.22</td><td>1.00</td><td>0.420</td><td>0.650</td><td>1.000</td><td>1657</td><td>tags=22%, list=15%, signal=25%</td></tr><tr><td class='lessen'>916</td><td>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP</td><td></td><td>311</td><td>0.24</td><td>1.00</td><td>0.420</td><td>0.650</td><td>1.000</td><td>2618</td><td>tags=30%, list=24%, signal=38%</td></tr><tr><td class='lessen'>917</td><td>ROZANOV_MMP14_TARGETS_SUBSET</td><td></td><td>22</td><td>0.30</td><td>1.00</td><td>0.519</td><td>0.652</td><td>1.000</td><td>1771</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>918</td><td>BROWNE_HCMV_INFECTION_14HR_DN</td><td></td><td>178</td><td>0.21</td><td>1.00</td><td>0.433</td><td>0.652</td><td>1.000</td><td>2071</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>919</td><td>GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP</td><td></td><td>24</td><td>0.33</td><td>1.00</td><td>0.500</td><td>0.652</td><td>1.000</td><td>985</td><td>tags=21%, list=9%, signal=23%</td></tr><tr><td class='lessen'>920</td><td>ENGELMANN_CANCER_PROGENITORS_UP</td><td></td><td>30</td><td>0.29</td><td>1.00</td><td>0.431</td><td>0.653</td><td>1.000</td><td>1763</td><td>tags=23%, list=16%, signal=28%</td></tr><tr><td class='lessen'>921</td><td>RICKMAN_HEAD_AND_NECK_CANCER_F</td><td></td><td>28</td><td>0.33</td><td>0.99</td><td>0.400</td><td>0.653</td><td>1.000</td><td>1651</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>922</td><td>CAIRO_LIVER_DEVELOPMENT_DN</td><td></td><td>134</td><td>0.23</td><td>0.99</td><td>0.500</td><td>0.652</td><td>1.000</td><td>2435</td><td>tags=23%, list=22%, signal=29%</td></tr><tr><td class='lessen'>923</td><td>GOLDRATH_HOMEOSTATIC_PROLIFERATION</td><td></td><td>84</td><td>0.27</td><td>0.99</td><td>0.478</td><td>0.652</td><td>1.000</td><td>2892</td><td>tags=42%, list=27%, signal=56%</td></tr><tr><td class='lessen'>924</td><td>RUIZ_TNC_TARGETS_UP</td><td></td><td>87</td><td>0.27</td><td>0.99</td><td>0.455</td><td>0.653</td><td>1.000</td><td>2807</td><td>tags=40%, list=26%, signal=54%</td></tr><tr><td class='lessen'>925</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_1</td><td></td><td>18</td><td>0.39</td><td>0.99</td><td>0.489</td><td>0.652</td><td>1.000</td><td>2165</td><td>tags=39%, list=20%, signal=48%</td></tr><tr><td class='lessen'>926</td><td>CHUNG_BLISTER_CYTOTOXICITY_UP</td><td></td><td>60</td><td>0.24</td><td>0.99</td><td>0.491</td><td>0.653</td><td>1.000</td><td>2102</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>927</td><td>GARY_CD5_TARGETS_UP</td><td></td><td>271</td><td>0.21</td><td>0.99</td><td>0.460</td><td>0.654</td><td>1.000</td><td>1576</td><td>tags=20%, list=14%, signal=23%</td></tr><tr><td class='lessen'>928</td><td>BROWNE_HCMV_INFECTION_2HR_DN</td><td></td><td>26</td><td>0.32</td><td>0.99</td><td>0.449</td><td>0.653</td><td>1.000</td><td>1387</td><td>tags=23%, list=13%, signal=26%</td></tr><tr><td class='lessen'>929</td><td>NUYTTEN_NIPP1_TARGETS_DN</td><td></td><td>449</td><td>0.19</td><td>0.99</td><td>0.490</td><td>0.653</td><td>1.000</td><td>1314</td><td>tags=16%, list=12%, signal=17%</td></tr><tr><td class='lessen'>930</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN</td><td></td><td>48</td><td>0.27</td><td>0.99</td><td>0.490</td><td>0.654</td><td>1.000</td><td>1316</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>931</td><td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP</td><td></td><td>242</td><td>0.24</td><td>0.99</td><td>0.527</td><td>0.654</td><td>1.000</td><td>2043</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>932</td><td>GAL_LEUKEMIC_STEM_CELL_DN</td><td></td><td>137</td><td>0.24</td><td>0.99</td><td>0.500</td><td>0.654</td><td>1.000</td><td>1741</td><td>tags=24%, list=16%, signal=28%</td></tr><tr><td class='lessen'>933</td><td>PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2</td><td></td><td>50</td><td>0.35</td><td>0.99</td><td>0.422</td><td>0.656</td><td>1.000</td><td>1923</td><td>tags=32%, list=18%, signal=39%</td></tr><tr><td class='lessen'>934</td><td>WONG_ENDMETRIUM_CANCER_DN</td><td></td><td>51</td><td>0.36</td><td>0.99</td><td>0.500</td><td>0.656</td><td>1.000</td><td>2813</td><td>tags=47%, list=26%, signal=63%</td></tr><tr><td class='lessen'>935</td><td>BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN</td><td></td><td>59</td><td>0.26</td><td>0.99</td><td>0.468</td><td>0.656</td><td>1.000</td><td>1831</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>936</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP</td><td></td><td>15</td><td>0.34</td><td>0.99</td><td>0.439</td><td>0.655</td><td>1.000</td><td>688</td><td>tags=20%, list=6%, signal=21%</td></tr><tr><td class='lessen'>937</td><td>BROWNE_HCMV_INFECTION_30MIN_UP</td><td></td><td>30</td><td>0.29</td><td>0.99</td><td>0.432</td><td>0.658</td><td>1.000</td><td>3031</td><td>tags=40%, list=28%, signal=55%</td></tr><tr><td class='lessen'>938</td><td>AMUNDSON_RESPONSE_TO_ARSENITE</td><td></td><td>119</td><td>0.23</td><td>0.99</td><td>0.489</td><td>0.660</td><td>1.000</td><td>784</td><td>tags=13%, list=7%, signal=14%</td></tr><tr><td class='lessen'>939</td><td>CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP</td><td></td><td>39</td><td>0.28</td><td>0.99</td><td>0.489</td><td>0.659</td><td>1.000</td><td>1853</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>940</td><td>TRAYNOR_RETT_SYNDROM_UP</td><td></td><td>27</td><td>0.30</td><td>0.98</td><td>0.467</td><td>0.662</td><td>1.000</td><td>930</td><td>tags=19%, list=9%, signal=20%</td></tr><tr><td class='lessen'>941</td><td>MCDOWELL_ACUTE_LUNG_INJURY_UP</td><td></td><td>25</td><td>0.33</td><td>0.98</td><td>0.500</td><td>0.661</td><td>1.000</td><td>2611</td><td>tags=36%, list=24%, signal=47%</td></tr><tr><td class='lessen'>942</td><td>ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN</td><td></td><td>381</td><td>0.22</td><td>0.98</td><td>0.529</td><td>0.662</td><td>1.000</td><td>1840</td><td>tags=19%, list=17%, signal=22%</td></tr><tr><td class='lessen'>943</td><td>KANG_IMMORTALIZED_BY_TERT_UP</td><td></td><td>60</td><td>0.24</td><td>0.98</td><td>0.419</td><td>0.663</td><td>1.000</td><td>1790</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>944</td><td>ENK_UV_RESPONSE_EPIDERMIS_UP</td><td></td><td>164</td><td>0.21</td><td>0.98</td><td>0.551</td><td>0.663</td><td>1.000</td><td>2522</td><td>tags=31%, list=23%, signal=40%</td></tr><tr><td class='lessen'>945</td><td>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP</td><td></td><td>127</td><td>0.24</td><td>0.98</td><td>0.480</td><td>0.665</td><td>1.000</td><td>2218</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>946</td><td>BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN</td><td></td><td>28</td><td>0.31</td><td>0.98</td><td>0.455</td><td>0.664</td><td>1.000</td><td>1965</td><td>tags=32%, list=18%, signal=39%</td></tr><tr><td class='lessen'>947</td><td>CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN</td><td></td><td>87</td><td>0.24</td><td>0.98</td><td>0.489</td><td>0.667</td><td>1.000</td><td>2883</td><td>tags=40%, list=26%, signal=54%</td></tr><tr><td class='lessen'>948</td><td>GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN</td><td></td><td>111</td><td>0.22</td><td>0.98</td><td>0.574</td><td>0.668</td><td>1.000</td><td>1943</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>949</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR</td><td></td><td>318</td><td>0.20</td><td>0.98</td><td>0.523</td><td>0.668</td><td>1.000</td><td>1895</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>950</td><td>WILLERT_WNT_SIGNALING</td><td></td><td>15</td><td>0.33</td><td>0.98</td><td>0.509</td><td>0.668</td><td>1.000</td><td>1669</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>951</td><td>VERRECCHIA_RESPONSE_TO_TGFB1_C5</td><td></td><td>16</td><td>0.40</td><td>0.98</td><td>0.479</td><td>0.668</td><td>1.000</td><td>1120</td><td>tags=31%, list=10%, signal=35%</td></tr><tr><td class='lessen'>952</td><td>CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN</td><td></td><td>51</td><td>0.24</td><td>0.98</td><td>0.510</td><td>0.669</td><td>1.000</td><td>3071</td><td>tags=39%, list=28%, signal=54%</td></tr><tr><td class='lessen'>953</td><td>LIU_SOX4_TARGETS_UP</td><td></td><td>81</td><td>0.26</td><td>0.98</td><td>0.500</td><td>0.669</td><td>1.000</td><td>2619</td><td>tags=30%, list=24%, signal=39%</td></tr><tr><td class='lessen'>954</td><td>NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON</td><td></td><td>140</td><td>0.21</td><td>0.98</td><td>0.580</td><td>0.670</td><td>1.000</td><td>2524</td><td>tags=28%, list=23%, signal=36%</td></tr><tr><td class='lessen'>955</td><td>GENTILE_RESPONSE_CLUSTER_D3</td><td></td><td>28</td><td>0.31</td><td>0.97</td><td>0.500</td><td>0.670</td><td>1.000</td><td>866</td><td>tags=18%, list=8%, signal=19%</td></tr><tr><td class='lessen'>956</td><td>STARK_HYPPOCAMPUS_22Q11_DELETION_UP</td><td></td><td>29</td><td>0.26</td><td>0.97</td><td>0.490</td><td>0.673</td><td>1.000</td><td>1680</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>957</td><td>GRADE_COLON_VS_RECTAL_CANCER_DN</td><td></td><td>32</td><td>0.28</td><td>0.97</td><td>0.500</td><td>0.673</td><td>1.000</td><td>1899</td><td>tags=28%, list=17%, signal=34%</td></tr><tr><td class='lessen'>958</td><td>GENTILE_UV_RESPONSE_CLUSTER_D5</td><td></td><td>19</td><td>0.29</td><td>0.97</td><td>0.472</td><td>0.672</td><td>1.000</td><td>701</td><td>tags=21%, list=6%, signal=22%</td></tr><tr><td class='lessen'>959</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN</td><td></td><td>217</td><td>0.22</td><td>0.97</td><td>0.558</td><td>0.674</td><td>1.000</td><td>2218</td><td>tags=25%, list=20%, signal=31%</td></tr><tr><td class='lessen'>960</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR</td><td></td><td>76</td><td>0.21</td><td>0.97</td><td>0.545</td><td>0.674</td><td>1.000</td><td>2109</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>961</td><td>BRACHAT_RESPONSE_TO_METHOTREXATE_UP</td><td></td><td>15</td><td>0.33</td><td>0.97</td><td>0.478</td><td>0.674</td><td>1.000</td><td>2561</td><td>tags=40%, list=24%, signal=52%</td></tr><tr><td class='lessen'>962</td><td>RATTENBACHER_BOUND_BY_CELF1</td><td></td><td>231</td><td>0.20</td><td>0.97</td><td>0.519</td><td>0.673</td><td>1.000</td><td>763</td><td>tags=10%, list=7%, signal=11%</td></tr><tr><td class='lessen'>963</td><td>AMIT_EGF_RESPONSE_240_HELA</td><td></td><td>35</td><td>0.28</td><td>0.97</td><td>0.488</td><td>0.674</td><td>1.000</td><td>665</td><td>tags=17%, list=6%, signal=18%</td></tr><tr><td class='lessen'>964</td><td>SU_PANCREAS</td><td></td><td>30</td><td>0.26</td><td>0.97</td><td>0.528</td><td>0.675</td><td>1.000</td><td>1472</td><td>tags=20%, list=14%, signal=23%</td></tr><tr><td class='lessen'>965</td><td>HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP</td><td></td><td>26</td><td>0.32</td><td>0.97</td><td>0.500</td><td>0.675</td><td>1.000</td><td>1737</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>966</td><td>ZHENG_FOXP3_TARGETS_IN_THYMUS_UP</td><td></td><td>104</td><td>0.24</td><td>0.97</td><td>0.477</td><td>0.676</td><td>1.000</td><td>2466</td><td>tags=33%, list=23%, signal=42%</td></tr><tr><td class='lessen'>967</td><td>BILD_HRAS_ONCOGENIC_SIGNATURE</td><td></td><td>142</td><td>0.26</td><td>0.97</td><td>0.520</td><td>0.679</td><td>1.000</td><td>2433</td><td>tags=30%, list=22%, signal=38%</td></tr><tr><td class='lessen'>968</td><td>DORSEY_GAB2_TARGETS</td><td></td><td>22</td><td>0.39</td><td>0.97</td><td>0.442</td><td>0.679</td><td>1.000</td><td>1955</td><td>tags=36%, list=18%, signal=44%</td></tr><tr><td class='lessen'>969</td><td>DELYS_THYROID_CANCER_UP</td><td></td><td>246</td><td>0.26</td><td>0.97</td><td>0.500</td><td>0.678</td><td>1.000</td><td>1763</td><td>tags=24%, list=16%, signal=28%</td></tr><tr><td class='lessen'>970</td><td>KYNG_DNA_DAMAGE_BY_4NQO</td><td></td><td>25</td><td>0.30</td><td>0.97</td><td>0.538</td><td>0.678</td><td>1.000</td><td>2662</td><td>tags=32%, list=24%, signal=42%</td></tr><tr><td class='lessen'>971</td><td>LIU_LIVER_CANCER</td><td></td><td>15</td><td>0.34</td><td>0.96</td><td>0.491</td><td>0.679</td><td>1.000</td><td>1368</td><td>tags=27%, list=13%, signal=30%</td></tr><tr><td class='lessen'>972</td><td>PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP</td><td></td><td>39</td><td>0.29</td><td>0.96</td><td>0.413</td><td>0.678</td><td>1.000</td><td>2694</td><td>tags=41%, list=25%, signal=54%</td></tr><tr><td class='lessen'>973</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP</td><td></td><td>55</td><td>0.25</td><td>0.96</td><td>0.571</td><td>0.679</td><td>1.000</td><td>3081</td><td>tags=36%, list=28%, signal=50%</td></tr><tr><td class='lessen'>974</td><td>CROMER_METASTASIS_UP</td><td></td><td>42</td><td>0.28</td><td>0.96</td><td>0.479</td><td>0.678</td><td>1.000</td><td>1873</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>975</td><td>WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN</td><td></td><td>18</td><td>0.35</td><td>0.96</td><td>0.540</td><td>0.678</td><td>1.000</td><td>2270</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>976</td><td>AMIT_SERUM_RESPONSE_60_MCF10A</td><td></td><td>32</td><td>0.31</td><td>0.96</td><td>0.583</td><td>0.678</td><td>1.000</td><td>2231</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>977</td><td>ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN</td><td></td><td>17</td><td>0.38</td><td>0.96</td><td>0.512</td><td>0.678</td><td>1.000</td><td>349</td><td>tags=18%, list=3%, signal=18%</td></tr><tr><td class='lessen'>978</td><td>HAN_JNK_SINGALING_DN</td><td></td><td>19</td><td>0.33</td><td>0.96</td><td>0.478</td><td>0.679</td><td>1.000</td><td>2199</td><td>tags=32%, list=20%, signal=40%</td></tr><tr><td class='lessen'>979</td><td>BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN</td><td></td><td>22</td><td>0.32</td><td>0.96</td><td>0.512</td><td>0.680</td><td>1.000</td><td>903</td><td>tags=18%, list=8%, signal=20%</td></tr><tr><td class='lessen'>980</td><td>CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP</td><td></td><td>21</td><td>0.37</td><td>0.96</td><td>0.475</td><td>0.680</td><td>1.000</td><td>1191</td><td>tags=24%, list=11%, signal=27%</td></tr><tr><td class='lessen'>981</td><td>HSIAO_HOUSEKEEPING_GENES</td><td></td><td>189</td><td>0.22</td><td>0.96</td><td>0.609</td><td>0.680</td><td>1.000</td><td>2338</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>982</td><td>BASSO_CD40_SIGNALING_DN</td><td></td><td>40</td><td>0.28</td><td>0.96</td><td>0.471</td><td>0.679</td><td>1.000</td><td>3261</td><td>tags=43%, list=30%, signal=60%</td></tr><tr><td class='lessen'>983</td><td>KAAB_FAILED_HEART_ATRIUM_DN</td><td></td><td>69</td><td>0.27</td><td>0.96</td><td>0.609</td><td>0.680</td><td>1.000</td><td>2860</td><td>tags=36%, list=26%, signal=49%</td></tr><tr><td class='lessen'>984</td><td>FOSTER_KDM1A_TARGETS_DN</td><td></td><td>96</td><td>0.23</td><td>0.96</td><td>0.591</td><td>0.680</td><td>1.000</td><td>890</td><td>tags=15%, list=8%, signal=16%</td></tr><tr><td class='lessen'>985</td><td>SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE</td><td></td><td>60</td><td>0.26</td><td>0.96</td><td>0.556</td><td>0.679</td><td>1.000</td><td>1313</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>986</td><td>JIANG_AGING_CEREBRAL_CORTEX_UP</td><td></td><td>23</td><td>0.30</td><td>0.96</td><td>0.525</td><td>0.680</td><td>1.000</td><td>1386</td><td>tags=22%, list=13%, signal=25%</td></tr><tr><td class='lessen'>987</td><td>YU_MYC_TARGETS_DN</td><td></td><td>24</td><td>0.30</td><td>0.96</td><td>0.455</td><td>0.680</td><td>1.000</td><td>2199</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>988</td><td>KAAB_FAILED_HEART_VENTRICLE_DN</td><td></td><td>15</td><td>0.34</td><td>0.96</td><td>0.510</td><td>0.680</td><td>1.000</td><td>376</td><td>tags=20%, list=3%, signal=21%</td></tr><tr><td class='lessen'>989</td><td>NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON</td><td></td><td>28</td><td>0.31</td><td>0.96</td><td>0.510</td><td>0.681</td><td>1.000</td><td>3276</td><td>tags=50%, list=30%, signal=71%</td></tr><tr><td class='lessen'>990</td><td>KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES</td><td></td><td>108</td><td>0.21</td><td>0.96</td><td>0.620</td><td>0.680</td><td>1.000</td><td>1933</td><td>tags=21%, list=18%, signal=26%</td></tr><tr><td class='lessen'>991</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D</td><td></td><td>347</td><td>0.18</td><td>0.96</td><td>0.634</td><td>0.680</td><td>1.000</td><td>1877</td><td>tags=19%, list=17%, signal=23%</td></tr><tr><td class='lessen'>992</td><td>BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP</td><td></td><td>23</td><td>0.32</td><td>0.96</td><td>0.559</td><td>0.680</td><td>1.000</td><td>1590</td><td>tags=30%, list=15%, signal=36%</td></tr><tr><td class='lessen'>993</td><td>KAAB_HEART_ATRIUM_VS_VENTRICLE_DN</td><td></td><td>138</td><td>0.22</td><td>0.96</td><td>0.512</td><td>0.681</td><td>1.000</td><td>2170</td><td>tags=24%, list=20%, signal=29%</td></tr><tr><td class='lessen'>994</td><td>LEE_NEURAL_CREST_STEM_CELL_DN</td><td></td><td>74</td><td>0.23</td><td>0.95</td><td>0.484</td><td>0.684</td><td>1.000</td><td>2377</td><td>tags=27%, list=22%, signal=34%</td></tr><tr><td class='lessen'>995</td><td>ZHOU_INFLAMMATORY_RESPONSE_LPS_UP</td><td></td><td>242</td><td>0.26</td><td>0.95</td><td>0.561</td><td>0.685</td><td>1.000</td><td>1976</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>996</td><td>TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN</td><td></td><td>16</td><td>0.32</td><td>0.95</td><td>0.435</td><td>0.685</td><td>1.000</td><td>1611</td><td>tags=31%, list=15%, signal=37%</td></tr><tr><td class='lessen'>997</td><td>LOPES_METHYLATED_IN_COLON_CANCER_DN</td><td></td><td>22</td><td>0.29</td><td>0.95</td><td>0.518</td><td>0.685</td><td>1.000</td><td>1452</td><td>tags=23%, list=13%, signal=26%</td></tr><tr><td class='lessen'>998</td><td>STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN</td><td></td><td>32</td><td>0.34</td><td>0.95</td><td>0.438</td><td>0.685</td><td>1.000</td><td>3033</td><td>tags=47%, list=28%, signal=65%</td></tr><tr><td class='lessen'>999</td><td>BROWNE_HCMV_INFECTION_10HR_UP</td><td></td><td>60</td><td>0.23</td><td>0.95</td><td>0.510</td><td>0.685</td><td>1.000</td><td>2224</td><td>tags=33%, list=20%, signal=42%</td></tr><tr><td class='lessen'>1000</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_DN</td><td></td><td>61</td><td>0.22</td><td>0.95</td><td>0.532</td><td>0.684</td><td>1.000</td><td>1065</td><td>tags=16%, list=10%, signal=18%</td></tr><tr><td class='lessen'>1001</td><td>HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP</td><td></td><td>30</td><td>0.27</td><td>0.95</td><td>0.510</td><td>0.684</td><td>1.000</td><td>1023</td><td>tags=17%, list=9%, signal=18%</td></tr><tr><td class='lessen'>1002</td><td>IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR</td><td></td><td>64</td><td>0.24</td><td>0.95</td><td>0.520</td><td>0.687</td><td>1.000</td><td>955</td><td>tags=14%, list=9%, signal=15%</td></tr><tr><td class='lessen'>1003</td><td>ALCALAY_AML_BY_NPM1_LOCALIZATION_UP</td><td></td><td>81</td><td>0.23</td><td>0.95</td><td>0.511</td><td>0.687</td><td>1.000</td><td>3335</td><td>tags=42%, list=31%, signal=60%</td></tr><tr><td class='lessen'>1004</td><td>EPPERT_HSC_R</td><td></td><td>62</td><td>0.24</td><td>0.95</td><td>0.556</td><td>0.687</td><td>1.000</td><td>3295</td><td>tags=44%, list=30%, signal=62%</td></tr><tr><td class='lessen'>1005</td><td>KYNG_DNA_DAMAGE_UP</td><td></td><td>134</td><td>0.19</td><td>0.95</td><td>0.556</td><td>0.694</td><td>1.000</td><td>2538</td><td>tags=26%, list=23%, signal=34%</td></tr><tr><td class='lessen'>1006</td><td>URS_ADIPOCYTE_DIFFERENTIATION_UP</td><td></td><td>36</td><td>0.25</td><td>0.95</td><td>0.529</td><td>0.694</td><td>1.000</td><td>2930</td><td>tags=39%, list=27%, signal=53%</td></tr><tr><td class='lessen'>1007</td><td>ZHU_CMV_24_HR_UP</td><td></td><td>47</td><td>0.25</td><td>0.94</td><td>0.580</td><td>0.693</td><td>1.000</td><td>1874</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>1008</td><td>KOYAMA_SEMA3B_TARGETS_DN</td><td></td><td>192</td><td>0.20</td><td>0.94</td><td>0.600</td><td>0.694</td><td>1.000</td><td>2098</td><td>tags=23%, list=19%, signal=29%</td></tr><tr><td class='lessen'>1009</td><td>MORI_SMALL_PRE_BII_LYMPHOCYTE_UP</td><td></td><td>51</td><td>0.24</td><td>0.94</td><td>0.512</td><td>0.693</td><td>1.000</td><td>1146</td><td>tags=16%, list=11%, signal=17%</td></tr><tr><td class='lessen'>1010</td><td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN</td><td></td><td>91</td><td>0.25</td><td>0.94</td><td>0.553</td><td>0.693</td><td>1.000</td><td>1471</td><td>tags=22%, list=14%, signal=25%</td></tr><tr><td class='lessen'>1011</td><td>MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>108</td><td>0.25</td><td>0.94</td><td>0.529</td><td>0.693</td><td>1.000</td><td>2182</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>1012</td><td>LIU_NASOPHARYNGEAL_CARCINOMA</td><td></td><td>43</td><td>0.23</td><td>0.94</td><td>0.500</td><td>0.693</td><td>1.000</td><td>3142</td><td>tags=47%, list=29%, signal=65%</td></tr><tr><td class='lessen'>1013</td><td>PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP</td><td></td><td>16</td><td>0.30</td><td>0.94</td><td>0.571</td><td>0.696</td><td>1.000</td><td>2574</td><td>tags=38%, list=24%, signal=49%</td></tr><tr><td class='lessen'>1014</td><td>HATADA_METHYLATED_IN_LUNG_CANCER_UP</td><td></td><td>187</td><td>0.21</td><td>0.94</td><td>0.511</td><td>0.695</td><td>1.000</td><td>1860</td><td>tags=20%, list=17%, signal=23%</td></tr><tr><td class='lessen'>1015</td><td>CHEBOTAEV_GR_TARGETS_UP</td><td></td><td>42</td><td>0.22</td><td>0.94</td><td>0.617</td><td>0.696</td><td>1.000</td><td>1968</td><td>tags=21%, list=18%, signal=26%</td></tr><tr><td class='lessen'>1016</td><td>PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP</td><td></td><td>45</td><td>0.25</td><td>0.94</td><td>0.622</td><td>0.705</td><td>1.000</td><td>1930</td><td>tags=24%, list=18%, signal=30%</td></tr><tr><td class='lessen'>1017</td><td>DAUER_STAT3_TARGETS_UP</td><td></td><td>32</td><td>0.35</td><td>0.93</td><td>0.595</td><td>0.712</td><td>1.000</td><td>2178</td><td>tags=41%, list=20%, signal=51%</td></tr><tr><td class='lessen'>1018</td><td>BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP</td><td></td><td>101</td><td>0.24</td><td>0.93</td><td>0.596</td><td>0.712</td><td>1.000</td><td>1901</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>1019</td><td>SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN</td><td></td><td>16</td><td>0.30</td><td>0.93</td><td>0.636</td><td>0.713</td><td>1.000</td><td>1693</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>1020</td><td>PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP</td><td></td><td>184</td><td>0.18</td><td>0.93</td><td>0.690</td><td>0.713</td><td>1.000</td><td>1983</td><td>tags=21%, list=18%, signal=25%</td></tr><tr><td class='lessen'>1021</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3</td><td></td><td>371</td><td>0.21</td><td>0.93</td><td>0.564</td><td>0.718</td><td>1.000</td><td>2157</td><td>tags=25%, list=20%, signal=30%</td></tr><tr><td class='lessen'>1022</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5</td><td></td><td>16</td><td>0.32</td><td>0.93</td><td>0.536</td><td>0.718</td><td>1.000</td><td>158</td><td>tags=13%, list=1%, signal=13%</td></tr><tr><td class='lessen'>1023</td><td>KIM_MYCN_AMPLIFICATION_TARGETS_DN</td><td></td><td>56</td><td>0.25</td><td>0.93</td><td>0.588</td><td>0.719</td><td>1.000</td><td>1335</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>1024</td><td>ROSS_AML_WITH_CBFB_MYH11_FUSION</td><td></td><td>33</td><td>0.31</td><td>0.92</td><td>0.490</td><td>0.725</td><td>1.000</td><td>2828</td><td>tags=42%, list=26%, signal=57%</td></tr><tr><td class='lessen'>1025</td><td>WIERENGA_STAT5A_TARGETS_UP</td><td></td><td>103</td><td>0.26</td><td>0.92</td><td>0.628</td><td>0.724</td><td>1.000</td><td>2611</td><td>tags=31%, list=24%, signal=40%</td></tr><tr><td class='lessen'>1026</td><td>BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN</td><td></td><td>23</td><td>0.28</td><td>0.92</td><td>0.600</td><td>0.725</td><td>1.000</td><td>2160</td><td>tags=35%, list=20%, signal=43%</td></tr><tr><td class='lessen'>1027</td><td>KIM_WT1_TARGETS_8HR_UP</td><td></td><td>100</td><td>0.25</td><td>0.92</td><td>0.540</td><td>0.726</td><td>1.000</td><td>1322</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>1028</td><td>FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL</td><td></td><td>178</td><td>0.19</td><td>0.92</td><td>0.754</td><td>0.727</td><td>1.000</td><td>1725</td><td>tags=18%, list=16%, signal=21%</td></tr><tr><td class='lessen'>1029</td><td>AFFAR_YY1_TARGETS_UP</td><td></td><td>125</td><td>0.22</td><td>0.92</td><td>0.625</td><td>0.728</td><td>1.000</td><td>1856</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>1030</td><td>STEIN_ESR1_TARGETS</td><td></td><td>53</td><td>0.24</td><td>0.92</td><td>0.604</td><td>0.728</td><td>1.000</td><td>1091</td><td>tags=15%, list=10%, signal=17%</td></tr><tr><td class='lessen'>1031</td><td>IVANOVSKA_MIR106B_TARGETS</td><td></td><td>50</td><td>0.24</td><td>0.92</td><td>0.542</td><td>0.730</td><td>1.000</td><td>2721</td><td>tags=32%, list=25%, signal=42%</td></tr><tr><td class='lessen'>1032</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR</td><td></td><td>17</td><td>0.30</td><td>0.92</td><td>0.633</td><td>0.729</td><td>1.000</td><td>2538</td><td>tags=41%, list=23%, signal=54%</td></tr><tr><td class='lessen'>1033</td><td>WANG_TARGETS_OF_MLL_CBP_FUSION_DN</td><td></td><td>20</td><td>0.30</td><td>0.92</td><td>0.531</td><td>0.731</td><td>1.000</td><td>1743</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>1034</td><td>LI_CISPLATIN_RESISTANCE_DN</td><td></td><td>17</td><td>0.31</td><td>0.92</td><td>0.489</td><td>0.733</td><td>1.000</td><td>1419</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>1035</td><td>MARKS_HDAC_TARGETS_UP</td><td></td><td>16</td><td>0.32</td><td>0.92</td><td>0.609</td><td>0.733</td><td>1.000</td><td>1657</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>1036</td><td>GUTIERREZ_MULTIPLE_MYELOMA_UP</td><td></td><td>17</td><td>0.32</td><td>0.92</td><td>0.578</td><td>0.733</td><td>1.000</td><td>2318</td><td>tags=35%, list=21%, signal=45%</td></tr><tr><td class='lessen'>1037</td><td>SEKI_INFLAMMATORY_RESPONSE_LPS_UP</td><td></td><td>46</td><td>0.35</td><td>0.91</td><td>0.523</td><td>0.735</td><td>1.000</td><td>2231</td><td>tags=35%, list=20%, signal=44%</td></tr><tr><td class='lessen'>1038</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_3_UP</td><td></td><td>80</td><td>0.21</td><td>0.91</td><td>0.596</td><td>0.735</td><td>1.000</td><td>3196</td><td>tags=39%, list=29%, signal=54%</td></tr><tr><td class='lessen'>1039</td><td>KIM_ALL_DISORDERS_DURATION_CORR_DN</td><td></td><td>67</td><td>0.23</td><td>0.91</td><td>0.480</td><td>0.736</td><td>1.000</td><td>1354</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>1040</td><td>KAYO_CALORIE_RESTRICTION_MUSCLE_DN</td><td></td><td>43</td><td>0.26</td><td>0.91</td><td>0.622</td><td>0.736</td><td>1.000</td><td>589</td><td>tags=12%, list=5%, signal=12%</td></tr><tr><td class='lessen'>1041</td><td>ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN</td><td></td><td>26</td><td>0.26</td><td>0.91</td><td>0.578</td><td>0.737</td><td>1.000</td><td>1799</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>1042</td><td>GENTILE_UV_HIGH_DOSE_DN</td><td></td><td>169</td><td>0.21</td><td>0.91</td><td>0.635</td><td>0.737</td><td>1.000</td><td>1452</td><td>tags=19%, list=13%, signal=22%</td></tr><tr><td class='lessen'>1043</td><td>MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP</td><td></td><td>83</td><td>0.21</td><td>0.91</td><td>0.623</td><td>0.737</td><td>1.000</td><td>1908</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>1044</td><td>ACEVEDO_LIVER_CANCER_UP</td><td></td><td>411</td><td>0.21</td><td>0.91</td><td>0.591</td><td>0.739</td><td>1.000</td><td>1898</td><td>tags=21%, list=17%, signal=24%</td></tr><tr><td class='lessen'>1045</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8</td><td></td><td>24</td><td>0.27</td><td>0.91</td><td>0.580</td><td>0.739</td><td>1.000</td><td>3370</td><td>tags=54%, list=31%, signal=78%</td></tr><tr><td class='lessen'>1046</td><td>PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN</td><td></td><td>24</td><td>0.31</td><td>0.91</td><td>0.595</td><td>0.739</td><td>1.000</td><td>2822</td><td>tags=46%, list=26%, signal=62%</td></tr><tr><td class='lessen'>1047</td><td>KYNG_DNA_DAMAGE_BY_UV</td><td></td><td>30</td><td>0.26</td><td>0.91</td><td>0.580</td><td>0.740</td><td>1.000</td><td>2561</td><td>tags=37%, list=24%, signal=48%</td></tr><tr><td class='lessen'>1048</td><td>SIMBULAN_PARP1_TARGETS_UP</td><td></td><td>20</td><td>0.36</td><td>0.91</td><td>0.683</td><td>0.743</td><td>1.000</td><td>3014</td><td>tags=45%, list=28%, signal=62%</td></tr><tr><td class='lessen'>1049</td><td>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN</td><td></td><td>145</td><td>0.22</td><td>0.91</td><td>0.553</td><td>0.744</td><td>1.000</td><td>2189</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>1050</td><td>HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR</td><td></td><td>19</td><td>0.28</td><td>0.90</td><td>0.490</td><td>0.749</td><td>1.000</td><td>2250</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>1051</td><td>LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN</td><td></td><td>56</td><td>0.23</td><td>0.90</td><td>0.638</td><td>0.749</td><td>1.000</td><td>2900</td><td>tags=38%, list=27%, signal=51%</td></tr><tr><td class='lessen'>1052</td><td>SWEET_LUNG_CANCER_KRAS_UP</td><td></td><td>248</td><td>0.21</td><td>0.90</td><td>0.610</td><td>0.749</td><td>1.000</td><td>2406</td><td>tags=26%, list=22%, signal=33%</td></tr><tr><td class='lessen'>1053</td><td>MCCLUNG_CREB1_TARGETS_DN</td><td></td><td>37</td><td>0.25</td><td>0.90</td><td>0.605</td><td>0.749</td><td>1.000</td><td>2843</td><td>tags=30%, list=26%, signal=40%</td></tr><tr><td class='lessen'>1054</td><td>KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP</td><td></td><td>353</td><td>0.20</td><td>0.90</td><td>0.551</td><td>0.751</td><td>1.000</td><td>1759</td><td>tags=21%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1055</td><td>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN</td><td></td><td>64</td><td>0.21</td><td>0.90</td><td>0.692</td><td>0.751</td><td>1.000</td><td>2141</td><td>tags=27%, list=20%, signal=33%</td></tr><tr><td class='lessen'>1056</td><td>BILANGES_SERUM_SENSITIVE_GENES</td><td></td><td>43</td><td>0.24</td><td>0.90</td><td>0.625</td><td>0.751</td><td>1.000</td><td>1675</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>1057</td><td>KEEN_RESPONSE_TO_ROSIGLITAZONE_UP</td><td></td><td>17</td><td>0.30</td><td>0.90</td><td>0.605</td><td>0.750</td><td>1.000</td><td>1653</td><td>tags=29%, list=15%, signal=35%</td></tr><tr><td class='lessen'>1058</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN</td><td></td><td>306</td><td>0.21</td><td>0.90</td><td>0.548</td><td>0.750</td><td>1.000</td><td>2435</td><td>tags=27%, list=22%, signal=34%</td></tr><tr><td class='lessen'>1059</td><td>GNATENKO_PLATELET_SIGNATURE</td><td></td><td>24</td><td>0.30</td><td>0.90</td><td>0.659</td><td>0.750</td><td>1.000</td><td>2678</td><td>tags=38%, list=25%, signal=50%</td></tr><tr><td class='lessen'>1060</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A</td><td></td><td>407</td><td>0.19</td><td>0.90</td><td>0.694</td><td>0.750</td><td>1.000</td><td>2985</td><td>tags=31%, list=27%, signal=41%</td></tr><tr><td class='lessen'>1061</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN</td><td></td><td>57</td><td>0.28</td><td>0.90</td><td>0.553</td><td>0.749</td><td>1.000</td><td>2032</td><td>tags=25%, list=19%, signal=30%</td></tr><tr><td class='lessen'>1062</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP</td><td></td><td>37</td><td>0.34</td><td>0.90</td><td>0.625</td><td>0.750</td><td>1.000</td><td>1765</td><td>tags=30%, list=16%, signal=35%</td></tr><tr><td class='lessen'>1063</td><td>JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN</td><td></td><td>23</td><td>0.27</td><td>0.90</td><td>0.604</td><td>0.750</td><td>1.000</td><td>2300</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>1064</td><td>MARTINEZ_RB1_TARGETS_DN</td><td></td><td>259</td><td>0.19</td><td>0.90</td><td>0.733</td><td>0.749</td><td>1.000</td><td>1660</td><td>tags=18%, list=15%, signal=20%</td></tr><tr><td class='lessen'>1065</td><td>BURTON_ADIPOGENESIS_PEAK_AT_0HR</td><td></td><td>38</td><td>0.25</td><td>0.90</td><td>0.595</td><td>0.749</td><td>1.000</td><td>644</td><td>tags=16%, list=6%, signal=17%</td></tr><tr><td class='lessen'>1066</td><td>BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN</td><td></td><td>64</td><td>0.22</td><td>0.90</td><td>0.595</td><td>0.750</td><td>1.000</td><td>1595</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>1067</td><td>HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN</td><td></td><td>43</td><td>0.25</td><td>0.90</td><td>0.551</td><td>0.749</td><td>1.000</td><td>1855</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>1068</td><td>WHITEHURST_PACLITAXEL_SENSITIVITY</td><td></td><td>18</td><td>0.29</td><td>0.90</td><td>0.635</td><td>0.749</td><td>1.000</td><td>2534</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>1069</td><td>LEE_TARGETS_OF_PTCH1_AND_SUFU_DN</td><td></td><td>41</td><td>0.24</td><td>0.89</td><td>0.643</td><td>0.752</td><td>1.000</td><td>1387</td><td>tags=20%, list=13%, signal=22%</td></tr><tr><td class='lessen'>1070</td><td>ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN</td><td></td><td>34</td><td>0.26</td><td>0.89</td><td>0.682</td><td>0.756</td><td>1.000</td><td>422</td><td>tags=12%, list=4%, signal=12%</td></tr><tr><td class='lessen'>1071</td><td>JIANG_VHL_TARGETS</td><td></td><td>66</td><td>0.22</td><td>0.89</td><td>0.707</td><td>0.758</td><td>1.000</td><td>2896</td><td>tags=38%, list=27%, signal=51%</td></tr><tr><td class='lessen'>1072</td><td>MEISSNER_NPC_HCP_WITH_H3K4ME2</td><td></td><td>239</td><td>0.22</td><td>0.89</td><td>0.647</td><td>0.758</td><td>1.000</td><td>1859</td><td>tags=19%, list=17%, signal=23%</td></tr><tr><td class='lessen'>1073</td><td>DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN</td><td></td><td>273</td><td>0.20</td><td>0.89</td><td>0.635</td><td>0.758</td><td>1.000</td><td>2237</td><td>tags=24%, list=21%, signal=29%</td></tr><tr><td class='lessen'>1074</td><td>ZHAN_LATE_DIFFERENTIATION_GENES_UP</td><td></td><td>21</td><td>0.31</td><td>0.89</td><td>0.629</td><td>0.758</td><td>1.000</td><td>2364</td><td>tags=33%, list=22%, signal=43%</td></tr><tr><td class='lessen'>1075</td><td>JIANG_AGING_HYPOTHALAMUS_UP</td><td></td><td>27</td><td>0.26</td><td>0.89</td><td>0.580</td><td>0.758</td><td>1.000</td><td>1930</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>1076</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_5</td><td></td><td>78</td><td>0.24</td><td>0.89</td><td>0.721</td><td>0.758</td><td>1.000</td><td>1719</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>1077</td><td>PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN</td><td></td><td>92</td><td>0.21</td><td>0.89</td><td>0.681</td><td>0.758</td><td>1.000</td><td>1608</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>1078</td><td>PASINI_SUZ12_TARGETS_UP</td><td></td><td>46</td><td>0.22</td><td>0.89</td><td>0.566</td><td>0.760</td><td>1.000</td><td>2735</td><td>tags=28%, list=25%, signal=38%</td></tr><tr><td class='lessen'>1079</td><td>KAYO_AGING_MUSCLE_UP</td><td></td><td>139</td><td>0.21</td><td>0.89</td><td>0.638</td><td>0.761</td><td>1.000</td><td>2408</td><td>tags=26%, list=22%, signal=33%</td></tr><tr><td class='lessen'>1080</td><td>RIZ_ERYTHROID_DIFFERENTIATION_HBZ</td><td></td><td>28</td><td>0.28</td><td>0.89</td><td>0.680</td><td>0.760</td><td>1.000</td><td>275</td><td>tags=11%, list=3%, signal=11%</td></tr><tr><td class='lessen'>1081</td><td>WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH</td><td></td><td>39</td><td>0.25</td><td>0.89</td><td>0.682</td><td>0.760</td><td>1.000</td><td>2608</td><td>tags=31%, list=24%, signal=40%</td></tr><tr><td class='lessen'>1082</td><td>TAKAO_RESPONSE_TO_UVB_RADIATION_UP</td><td></td><td>43</td><td>0.26</td><td>0.89</td><td>0.674</td><td>0.760</td><td>1.000</td><td>2617</td><td>tags=33%, list=24%, signal=43%</td></tr><tr><td class='lessen'>1083</td><td>WELCSH_BRCA1_TARGETS_UP</td><td></td><td>112</td><td>0.23</td><td>0.89</td><td>0.625</td><td>0.760</td><td>1.000</td><td>1860</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>1084</td><td>HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP</td><td></td><td>43</td><td>0.25</td><td>0.88</td><td>0.622</td><td>0.761</td><td>1.000</td><td>2244</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>1085</td><td>SMIRNOV_RESPONSE_TO_IR_2HR_UP</td><td></td><td>24</td><td>0.29</td><td>0.88</td><td>0.653</td><td>0.760</td><td>1.000</td><td>1300</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>1086</td><td>DITTMER_PTHLH_TARGETS_UP</td><td></td><td>66</td><td>0.22</td><td>0.88</td><td>0.686</td><td>0.763</td><td>1.000</td><td>2667</td><td>tags=33%, list=25%, signal=44%</td></tr><tr><td class='lessen'>1087</td><td>WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN</td><td></td><td>22</td><td>0.32</td><td>0.88</td><td>0.538</td><td>0.763</td><td>1.000</td><td>1886</td><td>tags=41%, list=17%, signal=49%</td></tr><tr><td class='lessen'>1088</td><td>LIN_MELANOMA_COPY_NUMBER_DN</td><td></td><td>26</td><td>0.30</td><td>0.88</td><td>0.638</td><td>0.766</td><td>1.000</td><td>3486</td><td>tags=62%, list=32%, signal=90%</td></tr><tr><td class='lessen'>1089</td><td>ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN</td><td></td><td>181</td><td>0.19</td><td>0.88</td><td>0.608</td><td>0.766</td><td>1.000</td><td>1978</td><td>tags=20%, list=18%, signal=25%</td></tr><tr><td class='lessen'>1090</td><td>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP</td><td></td><td>43</td><td>0.26</td><td>0.88</td><td>0.568</td><td>0.769</td><td>1.000</td><td>2829</td><td>tags=35%, list=26%, signal=47%</td></tr><tr><td class='lessen'>1091</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN</td><td></td><td>179</td><td>0.20</td><td>0.88</td><td>0.720</td><td>0.772</td><td>1.000</td><td>2256</td><td>tags=25%, list=21%, signal=30%</td></tr><tr><td class='lessen'>1092</td><td>BROWNE_HCMV_INFECTION_16HR_UP</td><td></td><td>118</td><td>0.22</td><td>0.88</td><td>0.628</td><td>0.771</td><td>1.000</td><td>1762</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1093</td><td>SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER</td><td></td><td>23</td><td>0.29</td><td>0.88</td><td>0.649</td><td>0.772</td><td>1.000</td><td>2642</td><td>tags=39%, list=24%, signal=52%</td></tr><tr><td class='lessen'>1094</td><td>BROWNE_HCMV_INFECTION_24HR_DN</td><td></td><td>92</td><td>0.20</td><td>0.88</td><td>0.745</td><td>0.772</td><td>1.000</td><td>1310</td><td>tags=16%, list=12%, signal=18%</td></tr><tr><td class='lessen'>1095</td><td>TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA</td><td></td><td>63</td><td>0.23</td><td>0.88</td><td>0.642</td><td>0.772</td><td>1.000</td><td>2587</td><td>tags=30%, list=24%, signal=39%</td></tr><tr><td class='lessen'>1096</td><td>LEE_TARGETS_OF_PTCH1_AND_SUFU_UP</td><td></td><td>25</td><td>0.27</td><td>0.87</td><td>0.711</td><td>0.772</td><td>1.000</td><td>1982</td><td>tags=32%, list=18%, signal=39%</td></tr><tr><td class='lessen'>1097</td><td>DALESSIO_TSA_RESPONSE</td><td></td><td>20</td><td>0.37</td><td>0.87</td><td>0.673</td><td>0.772</td><td>1.000</td><td>2270</td><td>tags=35%, list=21%, signal=44%</td></tr><tr><td class='lessen'>1098</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10</td><td></td><td>29</td><td>0.30</td><td>0.87</td><td>0.698</td><td>0.773</td><td>1.000</td><td>2269</td><td>tags=34%, list=21%, signal=43%</td></tr><tr><td class='lessen'>1099</td><td>GRUETZMANN_PANCREATIC_CANCER_DN</td><td></td><td>116</td><td>0.20</td><td>0.87</td><td>0.595</td><td>0.773</td><td>1.000</td><td>1952</td><td>tags=21%, list=18%, signal=25%</td></tr><tr><td class='lessen'>1100</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_1_DN</td><td></td><td>203</td><td>0.20</td><td>0.87</td><td>0.679</td><td>0.777</td><td>1.000</td><td>2178</td><td>tags=25%, list=20%, signal=31%</td></tr><tr><td class='lessen'>1101</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15</td><td></td><td>21</td><td>0.28</td><td>0.87</td><td>0.667</td><td>0.777</td><td>1.000</td><td>2430</td><td>tags=43%, list=22%, signal=55%</td></tr><tr><td class='lessen'>1102</td><td>MANTOVANI_VIRAL_GPCR_SIGNALING_UP</td><td></td><td>46</td><td>0.24</td><td>0.87</td><td>0.681</td><td>0.781</td><td>1.000</td><td>3307</td><td>tags=39%, list=30%, signal=56%</td></tr><tr><td class='lessen'>1103</td><td>HAMAI_APOPTOSIS_VIA_TRAIL_DN</td><td></td><td>87</td><td>0.24</td><td>0.87</td><td>0.694</td><td>0.782</td><td>1.000</td><td>2565</td><td>tags=31%, list=24%, signal=40%</td></tr><tr><td class='lessen'>1104</td><td>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN</td><td></td><td>150</td><td>0.20</td><td>0.87</td><td>0.638</td><td>0.783</td><td>1.000</td><td>2825</td><td>tags=31%, list=26%, signal=42%</td></tr><tr><td class='lessen'>1105</td><td>ALCALAY_AML_BY_NPM1_LOCALIZATION_DN</td><td></td><td>101</td><td>0.23</td><td>0.86</td><td>0.620</td><td>0.783</td><td>1.000</td><td>1591</td><td>tags=22%, list=15%, signal=25%</td></tr><tr><td class='lessen'>1106</td><td>SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY</td><td></td><td>20</td><td>0.27</td><td>0.86</td><td>0.708</td><td>0.783</td><td>1.000</td><td>1935</td><td>tags=30%, list=18%, signal=36%</td></tr><tr><td class='lessen'>1107</td><td>KUNINGER_IGF1_VS_PDGFB_TARGETS_UP</td><td></td><td>40</td><td>0.25</td><td>0.86</td><td>0.636</td><td>0.784</td><td>1.000</td><td>3379</td><td>tags=38%, list=31%, signal=54%</td></tr><tr><td class='lessen'>1108</td><td>SENESE_HDAC1_TARGETS_UP</td><td></td><td>269</td><td>0.20</td><td>0.86</td><td>0.667</td><td>0.784</td><td>1.000</td><td>2433</td><td>tags=29%, list=22%, signal=37%</td></tr><tr><td class='lessen'>1109</td><td>HONMA_DOCETAXEL_RESISTANCE</td><td></td><td>16</td><td>0.25</td><td>0.86</td><td>0.660</td><td>0.785</td><td>1.000</td><td>2082</td><td>tags=31%, list=19%, signal=39%</td></tr><tr><td class='lessen'>1110</td><td>DARWICHE_SKIN_TUMOR_PROMOTER_DN</td><td></td><td>86</td><td>0.20</td><td>0.86</td><td>0.653</td><td>0.787</td><td>1.000</td><td>2424</td><td>tags=29%, list=22%, signal=37%</td></tr><tr><td class='lessen'>1111</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN</td><td></td><td>289</td><td>0.18</td><td>0.86</td><td>0.771</td><td>0.786</td><td>1.000</td><td>2985</td><td>tags=31%, list=27%, signal=42%</td></tr><tr><td class='lessen'>1112</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_4_UP</td><td></td><td>53</td><td>0.23</td><td>0.86</td><td>0.681</td><td>0.786</td><td>1.000</td><td>3240</td><td>tags=34%, list=30%, signal=48%</td></tr><tr><td class='lessen'>1113</td><td>NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN</td><td></td><td>64</td><td>0.22</td><td>0.86</td><td>0.689</td><td>0.786</td><td>1.000</td><td>2880</td><td>tags=38%, list=26%, signal=51%</td></tr><tr><td class='lessen'>1114</td><td>LIM_MAMMARY_LUMINAL_PROGENITOR_UP</td><td></td><td>28</td><td>0.30</td><td>0.86</td><td>0.620</td><td>0.787</td><td>1.000</td><td>1406</td><td>tags=18%, list=13%, signal=20%</td></tr><tr><td class='lessen'>1115</td><td>LUI_THYROID_CANCER_PAX8_PPARG_DN</td><td></td><td>20</td><td>0.26</td><td>0.86</td><td>0.667</td><td>0.787</td><td>1.000</td><td>422</td><td>tags=15%, list=4%, signal=16%</td></tr><tr><td class='lessen'>1116</td><td>MIKKELSEN_ES_LCP_WITH_H3K4ME3</td><td></td><td>60</td><td>0.25</td><td>0.86</td><td>0.760</td><td>0.787</td><td>1.000</td><td>2285</td><td>tags=25%, list=21%, signal=31%</td></tr><tr><td class='lessen'>1117</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN</td><td></td><td>71</td><td>0.25</td><td>0.86</td><td>0.620</td><td>0.787</td><td>1.000</td><td>1649</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>1118</td><td>MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN</td><td></td><td>38</td><td>0.23</td><td>0.86</td><td>0.587</td><td>0.786</td><td>1.000</td><td>2803</td><td>tags=42%, list=26%, signal=57%</td></tr><tr><td class='lessen'>1119</td><td>BROWNE_HCMV_INFECTION_4HR_UP</td><td></td><td>37</td><td>0.25</td><td>0.86</td><td>0.717</td><td>0.786</td><td>1.000</td><td>1754</td><td>tags=24%, list=16%, signal=29%</td></tr><tr><td class='lessen'>1120</td><td>JAZAG_TGFB1_SIGNALING_UP</td><td></td><td>62</td><td>0.22</td><td>0.86</td><td>0.780</td><td>0.785</td><td>1.000</td><td>3210</td><td>tags=40%, list=29%, signal=57%</td></tr><tr><td class='lessen'>1121</td><td>ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN</td><td></td><td>181</td><td>0.20</td><td>0.86</td><td>0.762</td><td>0.785</td><td>1.000</td><td>1914</td><td>tags=21%, list=18%, signal=25%</td></tr><tr><td class='lessen'>1122</td><td>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP</td><td></td><td>123</td><td>0.27</td><td>0.86</td><td>0.574</td><td>0.785</td><td>1.000</td><td>2853</td><td>tags=34%, list=26%, signal=46%</td></tr><tr><td class='lessen'>1123</td><td>MUELLER_METHYLATED_IN_GLIOBLASTOMA</td><td></td><td>20</td><td>0.32</td><td>0.86</td><td>0.638</td><td>0.784</td><td>1.000</td><td>1042</td><td>tags=20%, list=10%, signal=22%</td></tr><tr><td class='lessen'>1124</td><td>HUANG_FOXA2_TARGETS_DN</td><td></td><td>23</td><td>0.29</td><td>0.86</td><td>0.625</td><td>0.786</td><td>1.000</td><td>931</td><td>tags=22%, list=9%, signal=24%</td></tr><tr><td class='lessen'>1125</td><td>YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN</td><td></td><td>127</td><td>0.21</td><td>0.86</td><td>0.724</td><td>0.786</td><td>1.000</td><td>2339</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>1126</td><td>AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53</td><td></td><td>64</td><td>0.23</td><td>0.86</td><td>0.660</td><td>0.786</td><td>1.000</td><td>1206</td><td>tags=19%, list=11%, signal=21%</td></tr><tr><td class='lessen'>1127</td><td>KOYAMA_SEMA3B_TARGETS_UP</td><td></td><td>139</td><td>0.18</td><td>0.85</td><td>0.840</td><td>0.789</td><td>1.000</td><td>2600</td><td>tags=26%, list=24%, signal=34%</td></tr><tr><td class='lessen'>1128</td><td>KUNINGER_IGF1_VS_PDGFB_TARGETS_DN</td><td></td><td>23</td><td>0.25</td><td>0.85</td><td>0.788</td><td>0.790</td><td>1.000</td><td>1202</td><td>tags=17%, list=11%, signal=20%</td></tr><tr><td class='lessen'>1129</td><td>HOOI_ST7_TARGETS_UP</td><td></td><td>43</td><td>0.23</td><td>0.85</td><td>0.807</td><td>0.789</td><td>1.000</td><td>50</td><td>tags=7%, list=0%, signal=7%</td></tr><tr><td class='lessen'>1130</td><td>JAZAG_TGFB1_SIGNALING_DN</td><td></td><td>23</td><td>0.25</td><td>0.85</td><td>0.702</td><td>0.788</td><td>1.000</td><td>2966</td><td>tags=35%, list=27%, signal=48%</td></tr><tr><td class='lessen'>1131</td><td>MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5</td><td></td><td>15</td><td>0.31</td><td>0.85</td><td>0.627</td><td>0.788</td><td>1.000</td><td>189</td><td>tags=13%, list=2%, signal=14%</td></tr><tr><td class='lessen'>1132</td><td>SESTO_RESPONSE_TO_UV_C8</td><td></td><td>38</td><td>0.24</td><td>0.85</td><td>0.611</td><td>0.788</td><td>1.000</td><td>1322</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>1133</td><td>PHONG_TNF_RESPONSE_VIA_P38_PARTIAL</td><td></td><td>84</td><td>0.24</td><td>0.85</td><td>0.660</td><td>0.788</td><td>1.000</td><td>2231</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>1134</td><td>GAL_LEUKEMIC_STEM_CELL_UP</td><td></td><td>83</td><td>0.20</td><td>0.85</td><td>0.754</td><td>0.788</td><td>1.000</td><td>2477</td><td>tags=25%, list=23%, signal=33%</td></tr><tr><td class='lessen'>1135</td><td>BILD_MYC_ONCOGENIC_SIGNATURE</td><td></td><td>97</td><td>0.20</td><td>0.85</td><td>0.800</td><td>0.787</td><td>1.000</td><td>2068</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>1136</td><td>MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN</td><td></td><td>35</td><td>0.25</td><td>0.85</td><td>0.721</td><td>0.787</td><td>1.000</td><td>1780</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>1137</td><td>YAMASHITA_LIVER_CANCER_STEM_CELL_DN</td><td></td><td>50</td><td>0.24</td><td>0.85</td><td>0.655</td><td>0.787</td><td>1.000</td><td>3171</td><td>tags=42%, list=29%, signal=59%</td></tr><tr><td class='lessen'>1138</td><td>GHANDHI_BYSTANDER_IRRADIATION_UP</td><td></td><td>49</td><td>0.32</td><td>0.85</td><td>0.574</td><td>0.791</td><td>1.000</td><td>2115</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>1139</td><td>THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP</td><td></td><td>46</td><td>0.26</td><td>0.85</td><td>0.571</td><td>0.792</td><td>1.000</td><td>2595</td><td>tags=33%, list=24%, signal=43%</td></tr><tr><td class='lessen'>1140</td><td>NEWMAN_ERCC6_TARGETS_DN</td><td></td><td>19</td><td>0.29</td><td>0.85</td><td>0.609</td><td>0.792</td><td>1.000</td><td>3203</td><td>tags=37%, list=29%, signal=52%</td></tr><tr><td class='lessen'>1141</td><td>NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON</td><td></td><td>58</td><td>0.23</td><td>0.85</td><td>0.688</td><td>0.792</td><td>1.000</td><td>1737</td><td>tags=24%, list=16%, signal=29%</td></tr><tr><td class='lessen'>1142</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN</td><td></td><td>88</td><td>0.25</td><td>0.85</td><td>0.705</td><td>0.792</td><td>1.000</td><td>2444</td><td>tags=27%, list=22%, signal=35%</td></tr><tr><td class='lessen'>1143</td><td>VALK_AML_CLUSTER_3</td><td></td><td>17</td><td>0.26</td><td>0.84</td><td>0.686</td><td>0.793</td><td>1.000</td><td>2333</td><td>tags=29%, list=21%, signal=37%</td></tr><tr><td class='lessen'>1144</td><td>WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP</td><td></td><td>33</td><td>0.24</td><td>0.84</td><td>0.720</td><td>0.794</td><td>1.000</td><td>1223</td><td>tags=15%, list=11%, signal=17%</td></tr><tr><td class='lessen'>1145</td><td>WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP</td><td></td><td>56</td><td>0.22</td><td>0.84</td><td>0.627</td><td>0.793</td><td>1.000</td><td>2404</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>1146</td><td>FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP</td><td></td><td>46</td><td>0.23</td><td>0.84</td><td>0.791</td><td>0.794</td><td>1.000</td><td>3071</td><td>tags=35%, list=28%, signal=48%</td></tr><tr><td class='lessen'>1147</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN</td><td></td><td>31</td><td>0.26</td><td>0.84</td><td>0.640</td><td>0.797</td><td>1.000</td><td>2323</td><td>tags=32%, list=21%, signal=41%</td></tr><tr><td class='lessen'>1148</td><td>KIM_WT1_TARGETS_UP</td><td></td><td>132</td><td>0.25</td><td>0.84</td><td>0.674</td><td>0.799</td><td>1.000</td><td>1941</td><td>tags=27%, list=18%, signal=32%</td></tr><tr><td class='lessen'>1149</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP</td><td></td><td>32</td><td>0.23</td><td>0.84</td><td>0.776</td><td>0.801</td><td>1.000</td><td>1303</td><td>tags=16%, list=12%, signal=18%</td></tr><tr><td class='lessen'>1150</td><td>MULLIGHAN_MLL_SIGNATURE_1_DN</td><td></td><td>140</td><td>0.18</td><td>0.84</td><td>0.848</td><td>0.801</td><td>1.000</td><td>2813</td><td>tags=29%, list=26%, signal=38%</td></tr><tr><td class='lessen'>1151</td><td>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP</td><td></td><td>63</td><td>0.26</td><td>0.84</td><td>0.633</td><td>0.801</td><td>1.000</td><td>2976</td><td>tags=41%, list=27%, signal=56%</td></tr><tr><td class='lessen'>1152</td><td>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN</td><td></td><td>31</td><td>0.27</td><td>0.84</td><td>0.766</td><td>0.801</td><td>1.000</td><td>2038</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>1153</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP</td><td></td><td>19</td><td>0.27</td><td>0.84</td><td>0.688</td><td>0.802</td><td>1.000</td><td>1258</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>1154</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9</td><td></td><td>37</td><td>0.26</td><td>0.84</td><td>0.634</td><td>0.802</td><td>1.000</td><td>2143</td><td>tags=27%, list=20%, signal=34%</td></tr><tr><td class='lessen'>1155</td><td>UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN</td><td></td><td>17</td><td>0.35</td><td>0.83</td><td>0.630</td><td>0.802</td><td>1.000</td><td>496</td><td>tags=18%, list=5%, signal=18%</td></tr><tr><td class='lessen'>1156</td><td>WILLIAMS_ESR2_TARGETS_UP</td><td></td><td>15</td><td>0.29</td><td>0.83</td><td>0.791</td><td>0.802</td><td>1.000</td><td>504</td><td>tags=13%, list=5%, signal=14%</td></tr><tr><td class='lessen'>1157</td><td>TSENG_IRS1_TARGETS_UP</td><td></td><td>66</td><td>0.19</td><td>0.83</td><td>0.805</td><td>0.805</td><td>1.000</td><td>1686</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>1158</td><td>TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN</td><td></td><td>49</td><td>0.22</td><td>0.83</td><td>0.667</td><td>0.806</td><td>1.000</td><td>1872</td><td>tags=20%, list=17%, signal=25%</td></tr><tr><td class='lessen'>1159</td><td>PEDRIOLI_MIR31_TARGETS_UP</td><td></td><td>101</td><td>0.20</td><td>0.83</td><td>0.750</td><td>0.807</td><td>1.000</td><td>1490</td><td>tags=14%, list=14%, signal=16%</td></tr><tr><td class='lessen'>1160</td><td>MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>16</td><td>0.29</td><td>0.83</td><td>0.760</td><td>0.807</td><td>1.000</td><td>2808</td><td>tags=44%, list=26%, signal=59%</td></tr><tr><td class='lessen'>1161</td><td>NAKAMURA_ADIPOGENESIS_LATE_UP</td><td></td><td>50</td><td>0.23</td><td>0.83</td><td>0.667</td><td>0.808</td><td>1.000</td><td>544</td><td>tags=10%, list=5%, signal=10%</td></tr><tr><td class='lessen'>1162</td><td>SMIRNOV_RESPONSE_TO_IR_6HR_DN</td><td></td><td>68</td><td>0.24</td><td>0.83</td><td>0.750</td><td>0.810</td><td>1.000</td><td>2203</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>1163</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6</td><td></td><td>25</td><td>0.26</td><td>0.83</td><td>0.660</td><td>0.812</td><td>1.000</td><td>2644</td><td>tags=32%, list=24%, signal=42%</td></tr><tr><td class='lessen'>1164</td><td>KANG_IMMORTALIZED_BY_TERT_DN</td><td></td><td>64</td><td>0.22</td><td>0.83</td><td>0.860</td><td>0.812</td><td>1.000</td><td>2535</td><td>tags=31%, list=23%, signal=40%</td></tr><tr><td class='lessen'>1165</td><td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12</td><td></td><td>173</td><td>0.21</td><td>0.82</td><td>0.725</td><td>0.816</td><td>1.000</td><td>2524</td><td>tags=26%, list=23%, signal=33%</td></tr><tr><td class='lessen'>1166</td><td>GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN</td><td></td><td>45</td><td>0.31</td><td>0.82</td><td>0.622</td><td>0.817</td><td>1.000</td><td>3585</td><td>tags=44%, list=33%, signal=66%</td></tr><tr><td class='lessen'>1167</td><td>MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3</td><td></td><td>191</td><td>0.22</td><td>0.82</td><td>0.717</td><td>0.818</td><td>1.000</td><td>2892</td><td>tags=30%, list=27%, signal=40%</td></tr><tr><td class='lessen'>1168</td><td>RICKMAN_HEAD_AND_NECK_CANCER_C</td><td></td><td>52</td><td>0.25</td><td>0.82</td><td>0.660</td><td>0.818</td><td>1.000</td><td>2330</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>1169</td><td>SENESE_HDAC2_TARGETS_UP</td><td></td><td>68</td><td>0.21</td><td>0.82</td><td>0.765</td><td>0.818</td><td>1.000</td><td>2951</td><td>tags=37%, list=27%, signal=50%</td></tr><tr><td class='lessen'>1170</td><td>SESTO_RESPONSE_TO_UV_C1</td><td></td><td>34</td><td>0.24</td><td>0.82</td><td>0.778</td><td>0.818</td><td>1.000</td><td>1300</td><td>tags=18%, list=12%, signal=20%</td></tr><tr><td class='lessen'>1171</td><td>LEE_LIVER_CANCER_MYC_TGFA_DN</td><td></td><td>38</td><td>0.22</td><td>0.82</td><td>0.755</td><td>0.817</td><td>1.000</td><td>242</td><td>tags=8%, list=2%, signal=8%</td></tr><tr><td class='lessen'>1172</td><td>LEE_LIVER_CANCER</td><td></td><td>35</td><td>0.28</td><td>0.82</td><td>0.667</td><td>0.818</td><td>1.000</td><td>2838</td><td>tags=31%, list=26%, signal=42%</td></tr><tr><td class='lessen'>1173</td><td>LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP</td><td></td><td>42</td><td>0.21</td><td>0.82</td><td>0.760</td><td>0.818</td><td>1.000</td><td>2048</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>1174</td><td>MORI_PLASMA_CELL_UP</td><td></td><td>26</td><td>0.32</td><td>0.82</td><td>0.650</td><td>0.817</td><td>1.000</td><td>2373</td><td>tags=31%, list=22%, signal=39%</td></tr><tr><td class='lessen'>1175</td><td>TOMLINS_PROSTATE_CANCER_UP</td><td></td><td>21</td><td>0.25</td><td>0.82</td><td>0.702</td><td>0.817</td><td>1.000</td><td>1465</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>1176</td><td>HOSHIDA_LIVER_CANCER_SURVIVAL_DN</td><td></td><td>64</td><td>0.22</td><td>0.82</td><td>0.756</td><td>0.818</td><td>1.000</td><td>1688</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1177</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP</td><td></td><td>41</td><td>0.24</td><td>0.81</td><td>0.691</td><td>0.823</td><td>1.000</td><td>1820</td><td>tags=24%, list=17%, signal=29%</td></tr><tr><td class='lessen'>1178</td><td>BROWNE_HCMV_INFECTION_10HR_DN</td><td></td><td>33</td><td>0.22</td><td>0.81</td><td>0.822</td><td>0.823</td><td>1.000</td><td>1452</td><td>tags=18%, list=13%, signal=21%</td></tr><tr><td class='lessen'>1179</td><td>MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS</td><td></td><td>18</td><td>0.28</td><td>0.81</td><td>0.638</td><td>0.824</td><td>1.000</td><td>1884</td><td>tags=22%, list=17%, signal=27%</td></tr><tr><td class='lessen'>1180</td><td>WEI_MYCN_TARGETS_WITH_E_BOX</td><td></td><td>390</td><td>0.20</td><td>0.81</td><td>0.688</td><td>0.827</td><td>1.000</td><td>1720</td><td>tags=20%, list=16%, signal=23%</td></tr><tr><td class='lessen'>1181</td><td>TIEN_INTESTINE_PROBIOTICS_2HR_DN</td><td></td><td>45</td><td>0.22</td><td>0.81</td><td>0.740</td><td>0.826</td><td>1.000</td><td>2818</td><td>tags=36%, list=26%, signal=48%</td></tr><tr><td class='lessen'>1182</td><td>BROWNE_HCMV_INFECTION_2HR_UP</td><td></td><td>20</td><td>0.27</td><td>0.81</td><td>0.674</td><td>0.829</td><td>1.000</td><td>2407</td><td>tags=35%, list=22%, signal=45%</td></tr><tr><td class='lessen'>1183</td><td>ZHAN_MULTIPLE_MYELOMA_PR_DN</td><td></td><td>19</td><td>0.28</td><td>0.81</td><td>0.756</td><td>0.828</td><td>1.000</td><td>2779</td><td>tags=47%, list=26%, signal=63%</td></tr><tr><td class='lessen'>1184</td><td>CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY</td><td></td><td>20</td><td>0.26</td><td>0.81</td><td>0.750</td><td>0.828</td><td>1.000</td><td>2191</td><td>tags=25%, list=20%, signal=31%</td></tr><tr><td class='lessen'>1185</td><td>ONO_FOXP3_TARGETS_DN</td><td></td><td>21</td><td>0.27</td><td>0.81</td><td>0.717</td><td>0.828</td><td>1.000</td><td>2045</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>1186</td><td>FAELT_B_CLL_WITH_VH3_21_UP</td><td></td><td>25</td><td>0.27</td><td>0.81</td><td>0.721</td><td>0.828</td><td>1.000</td><td>3078</td><td>tags=52%, list=28%, signal=72%</td></tr><tr><td class='lessen'>1187</td><td>MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER</td><td></td><td>25</td><td>0.26</td><td>0.81</td><td>0.745</td><td>0.827</td><td>1.000</td><td>717</td><td>tags=12%, list=7%, signal=13%</td></tr><tr><td class='lessen'>1188</td><td>DUTTA_APOPTOSIS_VIA_NFKB</td><td></td><td>21</td><td>0.30</td><td>0.81</td><td>0.681</td><td>0.827</td><td>1.000</td><td>1754</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>1189</td><td>BURTON_ADIPOGENESIS_5</td><td></td><td>56</td><td>0.22</td><td>0.81</td><td>0.818</td><td>0.827</td><td>1.000</td><td>2129</td><td>tags=23%, list=20%, signal=29%</td></tr><tr><td class='lessen'>1190</td><td>VALK_AML_CLUSTER_2</td><td></td><td>19</td><td>0.28</td><td>0.80</td><td>0.733</td><td>0.828</td><td>1.000</td><td>144</td><td>tags=11%, list=1%, signal=11%</td></tr><tr><td class='lessen'>1191</td><td>VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP</td><td></td><td>49</td><td>0.25</td><td>0.80</td><td>0.689</td><td>0.830</td><td>1.000</td><td>2433</td><td>tags=29%, list=22%, signal=37%</td></tr><tr><td class='lessen'>1192</td><td>WOO_LIVER_CANCER_RECURRENCE_DN</td><td></td><td>52</td><td>0.23</td><td>0.80</td><td>0.721</td><td>0.833</td><td>1.000</td><td>2024</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>1193</td><td>SERVITJA_LIVER_HNF1A_TARGETS_DN</td><td></td><td>100</td><td>0.21</td><td>0.80</td><td>0.723</td><td>0.832</td><td>1.000</td><td>2563</td><td>tags=27%, list=24%, signal=35%</td></tr><tr><td class='lessen'>1194</td><td>ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP</td><td></td><td>261</td><td>0.20</td><td>0.80</td><td>0.673</td><td>0.834</td><td>1.000</td><td>1976</td><td>tags=23%, list=18%, signal=27%</td></tr><tr><td class='lessen'>1195</td><td>ONDER_CDH1_TARGETS_2_DN</td><td></td><td>263</td><td>0.23</td><td>0.80</td><td>0.745</td><td>0.834</td><td>1.000</td><td>1406</td><td>tags=18%, list=13%, signal=20%</td></tr><tr><td class='lessen'>1196</td><td>BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN</td><td></td><td>81</td><td>0.20</td><td>0.80</td><td>0.800</td><td>0.835</td><td>1.000</td><td>1053</td><td>tags=14%, list=10%, signal=15%</td></tr><tr><td class='lessen'>1197</td><td>MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>236</td><td>0.19</td><td>0.80</td><td>0.875</td><td>0.834</td><td>1.000</td><td>2235</td><td>tags=22%, list=21%, signal=27%</td></tr><tr><td class='lessen'>1198</td><td>BROWNE_HCMV_INFECTION_8HR_UP</td><td></td><td>62</td><td>0.22</td><td>0.80</td><td>0.718</td><td>0.835</td><td>1.000</td><td>1762</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>1199</td><td>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN</td><td></td><td>15</td><td>0.26</td><td>0.80</td><td>0.783</td><td>0.835</td><td>1.000</td><td>1985</td><td>tags=33%, list=18%, signal=41%</td></tr><tr><td class='lessen'>1200</td><td>SMITH_TERT_TARGETS_DN</td><td></td><td>53</td><td>0.20</td><td>0.80</td><td>0.909</td><td>0.835</td><td>1.000</td><td>1588</td><td>tags=21%, list=15%, signal=24%</td></tr><tr><td class='lessen'>1201</td><td>LEE_CALORIE_RESTRICTION_NEOCORTEX_DN</td><td></td><td>52</td><td>0.20</td><td>0.80</td><td>0.854</td><td>0.835</td><td>1.000</td><td>2098</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>1202</td><td>DANG_REGULATED_BY_MYC_UP</td><td></td><td>44</td><td>0.25</td><td>0.79</td><td>0.700</td><td>0.837</td><td>1.000</td><td>1323</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>1203</td><td>VANASSE_BCL2_TARGETS_UP</td><td></td><td>21</td><td>0.24</td><td>0.79</td><td>0.807</td><td>0.838</td><td>1.000</td><td>2242</td><td>tags=24%, list=21%, signal=30%</td></tr><tr><td class='lessen'>1204</td><td>JOHNSTONE_PARVB_TARGETS_2_DN</td><td></td><td>189</td><td>0.19</td><td>0.79</td><td>0.816</td><td>0.840</td><td>1.000</td><td>1882</td><td>tags=21%, list=17%, signal=25%</td></tr><tr><td class='lessen'>1205</td><td>ALONSO_METASTASIS_UP</td><td></td><td>87</td><td>0.22</td><td>0.79</td><td>0.650</td><td>0.841</td><td>1.000</td><td>2297</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>1206</td><td>SHEPARD_CRUSH_AND_BURN_MUTANT_UP</td><td></td><td>100</td><td>0.20</td><td>0.79</td><td>0.825</td><td>0.842</td><td>1.000</td><td>1403</td><td>tags=16%, list=13%, signal=18%</td></tr><tr><td class='lessen'>1207</td><td>HILLION_HMGA1_TARGETS</td><td></td><td>53</td><td>0.19</td><td>0.79</td><td>0.889</td><td>0.843</td><td>1.000</td><td>1433</td><td>tags=13%, list=13%, signal=15%</td></tr><tr><td class='lessen'>1208</td><td>HU_GENOTOXIC_DAMAGE_24HR</td><td></td><td>15</td><td>0.26</td><td>0.79</td><td>0.848</td><td>0.843</td><td>1.000</td><td>1923</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>1209</td><td>FIRESTEIN_PROLIFERATION</td><td></td><td>103</td><td>0.18</td><td>0.78</td><td>0.898</td><td>0.845</td><td>1.000</td><td>2221</td><td>tags=22%, list=20%, signal=28%</td></tr><tr><td class='lessen'>1210</td><td>YANG_BCL3_TARGETS_UP</td><td></td><td>185</td><td>0.17</td><td>0.78</td><td>0.854</td><td>0.845</td><td>1.000</td><td>1922</td><td>tags=17%, list=18%, signal=21%</td></tr><tr><td class='lessen'>1211</td><td>WU_CELL_MIGRATION</td><td></td><td>90</td><td>0.21</td><td>0.78</td><td>0.761</td><td>0.846</td><td>1.000</td><td>1488</td><td>tags=20%, list=14%, signal=23%</td></tr><tr><td class='lessen'>1212</td><td>NIKOLSKY_BREAST_CANCER_16P13_AMPLICON</td><td></td><td>57</td><td>0.22</td><td>0.78</td><td>0.745</td><td>0.849</td><td>1.000</td><td>2340</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>1213</td><td>LU_IL4_SIGNALING</td><td></td><td>53</td><td>0.21</td><td>0.78</td><td>0.881</td><td>0.850</td><td>1.000</td><td>3527</td><td>tags=47%, list=32%, signal=69%</td></tr><tr><td class='lessen'>1214</td><td>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN</td><td></td><td>23</td><td>0.25</td><td>0.78</td><td>0.774</td><td>0.850</td><td>1.000</td><td>869</td><td>tags=17%, list=8%, signal=19%</td></tr><tr><td class='lessen'>1215</td><td>KORKOLA_SEMINOMA_UP</td><td></td><td>21</td><td>0.27</td><td>0.78</td><td>0.667</td><td>0.850</td><td>1.000</td><td>3429</td><td>tags=52%, list=32%, signal=76%</td></tr><tr><td class='lessen'>1216</td><td>RODWELL_AGING_KIDNEY_DN</td><td></td><td>81</td><td>0.19</td><td>0.78</td><td>0.796</td><td>0.850</td><td>1.000</td><td>2443</td><td>tags=27%, list=22%, signal=35%</td></tr><tr><td class='lessen'>1217</td><td>LIU_VMYB_TARGETS_UP</td><td></td><td>60</td><td>0.20</td><td>0.78</td><td>0.820</td><td>0.851</td><td>1.000</td><td>3188</td><td>tags=37%, list=29%, signal=52%</td></tr><tr><td class='lessen'>1218</td><td>CHEN_ETV5_TARGETS_SERTOLI</td><td></td><td>16</td><td>0.28</td><td>0.78</td><td>0.788</td><td>0.851</td><td>1.000</td><td>449</td><td>tags=13%, list=4%, signal=13%</td></tr><tr><td class='lessen'>1219</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP</td><td></td><td>27</td><td>0.23</td><td>0.78</td><td>0.755</td><td>0.852</td><td>1.000</td><td>2268</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>1220</td><td>MIKKELSEN_MEF_ICP_WITH_H3K27ME3</td><td></td><td>90</td><td>0.24</td><td>0.78</td><td>0.723</td><td>0.852</td><td>1.000</td><td>1957</td><td>tags=22%, list=18%, signal=27%</td></tr><tr><td class='lessen'>1221</td><td>TANG_SENESCENCE_TP53_TARGETS_UP</td><td></td><td>20</td><td>0.27</td><td>0.78</td><td>0.723</td><td>0.851</td><td>1.000</td><td>1935</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>1222</td><td>YIH_RESPONSE_TO_ARSENITE_C3</td><td></td><td>25</td><td>0.26</td><td>0.77</td><td>0.844</td><td>0.852</td><td>1.000</td><td>1346</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>1223</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN</td><td></td><td>81</td><td>0.18</td><td>0.77</td><td>0.882</td><td>0.852</td><td>1.000</td><td>3141</td><td>tags=31%, list=29%, signal=43%</td></tr><tr><td class='lessen'>1224</td><td>VALK_AML_CLUSTER_7</td><td></td><td>23</td><td>0.29</td><td>0.77</td><td>0.780</td><td>0.854</td><td>1.000</td><td>2435</td><td>tags=35%, list=22%, signal=45%</td></tr><tr><td class='lessen'>1225</td><td>OKAWA_NEUROBLASTOMA_1P36_31_DELETION</td><td></td><td>15</td><td>0.26</td><td>0.77</td><td>0.760</td><td>0.855</td><td>1.000</td><td>777</td><td>tags=13%, list=7%, signal=14%</td></tr><tr><td class='lessen'>1226</td><td>AMIT_EGF_RESPONSE_480_HELA</td><td></td><td>98</td><td>0.21</td><td>0.77</td><td>0.731</td><td>0.855</td><td>1.000</td><td>2759</td><td>tags=31%, list=25%, signal=41%</td></tr><tr><td class='lessen'>1227</td><td>WANG_TARGETS_OF_MLL_CBP_FUSION_UP</td><td></td><td>21</td><td>0.23</td><td>0.77</td><td>0.863</td><td>0.856</td><td>1.000</td><td>2873</td><td>tags=38%, list=26%, signal=52%</td></tr><tr><td class='lessen'>1228</td><td>OHGUCHI_LIVER_HNF4A_TARGETS_DN</td><td></td><td>86</td><td>0.20</td><td>0.77</td><td>0.830</td><td>0.858</td><td>1.000</td><td>1539</td><td>tags=16%, list=14%, signal=19%</td></tr><tr><td class='lessen'>1229</td><td>MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>25</td><td>0.27</td><td>0.76</td><td>0.717</td><td>0.863</td><td>1.000</td><td>1030</td><td>tags=16%, list=9%, signal=18%</td></tr><tr><td class='lessen'>1230</td><td>UEDA_CENTRAL_CLOCK</td><td></td><td>45</td><td>0.21</td><td>0.76</td><td>0.773</td><td>0.864</td><td>1.000</td><td>2303</td><td>tags=22%, list=21%, signal=28%</td></tr><tr><td class='lessen'>1231</td><td>QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2</td><td></td><td>19</td><td>0.24</td><td>0.76</td><td>0.804</td><td>0.867</td><td>1.000</td><td>2617</td><td>tags=26%, list=24%, signal=35%</td></tr><tr><td class='lessen'>1232</td><td>SUBTIL_PROGESTIN_TARGETS</td><td></td><td>19</td><td>0.27</td><td>0.76</td><td>0.804</td><td>0.867</td><td>1.000</td><td>544</td><td>tags=16%, list=5%, signal=17%</td></tr><tr><td class='lessen'>1233</td><td>SMIRNOV_RESPONSE_TO_IR_2HR_DN</td><td></td><td>33</td><td>0.23</td><td>0.76</td><td>0.768</td><td>0.866</td><td>1.000</td><td>1146</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>1234</td><td>WANG_METHYLATED_IN_BREAST_CANCER</td><td></td><td>22</td><td>0.24</td><td>0.76</td><td>0.824</td><td>0.869</td><td>1.000</td><td>2433</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>1235</td><td>HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN</td><td></td><td>28</td><td>0.23</td><td>0.76</td><td>0.796</td><td>0.870</td><td>1.000</td><td>2020</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>1236</td><td>SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN</td><td></td><td>20</td><td>0.26</td><td>0.75</td><td>0.935</td><td>0.871</td><td>1.000</td><td>1907</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>1237</td><td>KAMIKUBO_MYELOID_CEBPA_NETWORK</td><td></td><td>16</td><td>0.30</td><td>0.75</td><td>0.706</td><td>0.872</td><td>1.000</td><td>3636</td><td>tags=56%, list=33%, signal=84%</td></tr><tr><td class='lessen'>1238</td><td>TERAO_AOX4_TARGETS_SKIN_UP</td><td></td><td>20</td><td>0.25</td><td>0.75</td><td>0.846</td><td>0.871</td><td>1.000</td><td>2085</td><td>tags=30%, list=19%, signal=37%</td></tr><tr><td class='lessen'>1239</td><td>PENG_LEUCINE_DEPRIVATION_UP</td><td></td><td>66</td><td>0.18</td><td>0.75</td><td>0.904</td><td>0.873</td><td>1.000</td><td>1837</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>1240</td><td>LIM_MAMMARY_LUMINAL_MATURE_UP</td><td></td><td>46</td><td>0.21</td><td>0.75</td><td>0.846</td><td>0.877</td><td>1.000</td><td>3071</td><td>tags=35%, list=28%, signal=48%</td></tr><tr><td class='lessen'>1241</td><td>KENNY_CTNNB1_TARGETS_UP</td><td></td><td>32</td><td>0.22</td><td>0.75</td><td>0.825</td><td>0.877</td><td>1.000</td><td>3057</td><td>tags=38%, list=28%, signal=52%</td></tr><tr><td class='lessen'>1242</td><td>HOELZEL_NF1_TARGETS_UP</td><td></td><td>77</td><td>0.19</td><td>0.74</td><td>0.918</td><td>0.878</td><td>1.000</td><td>2433</td><td>tags=26%, list=22%, signal=33%</td></tr><tr><td class='lessen'>1243</td><td>ROSS_AML_OF_FAB_M7_TYPE</td><td></td><td>43</td><td>0.19</td><td>0.74</td><td>0.875</td><td>0.878</td><td>1.000</td><td>2706</td><td>tags=30%, list=25%, signal=40%</td></tr><tr><td class='lessen'>1244</td><td>SEIDEN_ONCOGENESIS_BY_MET</td><td></td><td>49</td><td>0.23</td><td>0.74</td><td>0.848</td><td>0.880</td><td>1.000</td><td>1846</td><td>tags=22%, list=17%, signal=27%</td></tr><tr><td class='lessen'>1245</td><td>SMID_BREAST_CANCER_ERBB2_UP</td><td></td><td>85</td><td>0.20</td><td>0.74</td><td>0.885</td><td>0.880</td><td>1.000</td><td>1313</td><td>tags=15%, list=12%, signal=17%</td></tr><tr><td class='lessen'>1246</td><td>BURTON_ADIPOGENESIS_6</td><td></td><td>97</td><td>0.19</td><td>0.74</td><td>0.783</td><td>0.886</td><td>1.000</td><td>1923</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>1247</td><td>KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN</td><td></td><td>68</td><td>0.22</td><td>0.74</td><td>0.725</td><td>0.886</td><td>1.000</td><td>1281</td><td>tags=15%, list=12%, signal=17%</td></tr><tr><td class='lessen'>1248</td><td>LABBE_TGFB1_TARGETS_UP</td><td></td><td>55</td><td>0.20</td><td>0.74</td><td>0.870</td><td>0.886</td><td>1.000</td><td>313</td><td>tags=7%, list=3%, signal=7%</td></tr><tr><td class='lessen'>1249</td><td>PENG_GLUTAMINE_DEPRIVATION_UP</td><td></td><td>26</td><td>0.22</td><td>0.73</td><td>0.906</td><td>0.888</td><td>1.000</td><td>3364</td><td>tags=42%, list=31%, signal=61%</td></tr><tr><td class='lessen'>1250</td><td>BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN</td><td></td><td>19</td><td>0.24</td><td>0.73</td><td>0.846</td><td>0.888</td><td>1.000</td><td>665</td><td>tags=16%, list=6%, signal=17%</td></tr><tr><td class='lessen'>1251</td><td>HORTON_SREBF_TARGETS</td><td></td><td>17</td><td>0.27</td><td>0.73</td><td>0.808</td><td>0.887</td><td>1.000</td><td>1313</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>1252</td><td>SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN</td><td></td><td>17</td><td>0.25</td><td>0.73</td><td>0.829</td><td>0.887</td><td>1.000</td><td>2630</td><td>tags=35%, list=24%, signal=46%</td></tr><tr><td class='lessen'>1253</td><td>ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP</td><td></td><td>278</td><td>0.18</td><td>0.73</td><td>0.894</td><td>0.888</td><td>1.000</td><td>1984</td><td>tags=21%, list=18%, signal=25%</td></tr><tr><td class='lessen'>1254</td><td>NOUSHMEHR_GBM_SILENCED_BY_METHYLATION</td><td></td><td>22</td><td>0.24</td><td>0.73</td><td>0.778</td><td>0.889</td><td>1.000</td><td>1936</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>1255</td><td>LI_INDUCED_T_TO_NATURAL_KILLER_DN</td><td></td><td>69</td><td>0.20</td><td>0.73</td><td>0.868</td><td>0.889</td><td>1.000</td><td>2514</td><td>tags=25%, list=23%, signal=32%</td></tr><tr><td class='lessen'>1256</td><td>NAGASHIMA_NRG1_SIGNALING_UP</td><td></td><td>93</td><td>0.23</td><td>0.73</td><td>0.708</td><td>0.889</td><td>1.000</td><td>2340</td><td>tags=29%, list=21%, signal=37%</td></tr><tr><td class='lessen'>1257</td><td>BURTON_ADIPOGENESIS_PEAK_AT_2HR</td><td></td><td>21</td><td>0.31</td><td>0.73</td><td>0.660</td><td>0.890</td><td>1.000</td><td>1842</td><td>tags=24%, list=17%, signal=29%</td></tr><tr><td class='lessen'>1258</td><td>BYSTROEM_CORRELATED_WITH_IL5_UP</td><td></td><td>30</td><td>0.21</td><td>0.73</td><td>0.907</td><td>0.890</td><td>1.000</td><td>834</td><td>tags=13%, list=8%, signal=14%</td></tr><tr><td class='lessen'>1259</td><td>ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP</td><td></td><td>17</td><td>0.25</td><td>0.72</td><td>0.766</td><td>0.892</td><td>1.000</td><td>1874</td><td>tags=24%, list=17%, signal=28%</td></tr><tr><td class='lessen'>1260</td><td>ZHAN_MULTIPLE_MYELOMA_LB_UP</td><td></td><td>20</td><td>0.20</td><td>0.72</td><td>0.900</td><td>0.893</td><td>1.000</td><td>2805</td><td>tags=30%, list=26%, signal=40%</td></tr><tr><td class='lessen'>1261</td><td>KLEIN_TARGETS_OF_BCR_ABL1_FUSION</td><td></td><td>31</td><td>0.24</td><td>0.72</td><td>0.820</td><td>0.894</td><td>1.000</td><td>3141</td><td>tags=42%, list=29%, signal=59%</td></tr><tr><td class='lessen'>1262</td><td>PETROVA_PROX1_TARGETS_UP</td><td></td><td>19</td><td>0.25</td><td>0.72</td><td>0.860</td><td>0.894</td><td>1.000</td><td>1711</td><td>tags=26%, list=16%, signal=31%</td></tr><tr><td class='lessen'>1263</td><td>SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL</td><td></td><td>42</td><td>0.21</td><td>0.72</td><td>0.865</td><td>0.894</td><td>1.000</td><td>1279</td><td>tags=14%, list=12%, signal=16%</td></tr><tr><td class='lessen'>1264</td><td>XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR</td><td></td><td>18</td><td>0.24</td><td>0.72</td><td>0.800</td><td>0.894</td><td>1.000</td><td>2595</td><td>tags=33%, list=24%, signal=44%</td></tr><tr><td class='lessen'>1265</td><td>WALLACE_JAK2_TARGETS_UP</td><td></td><td>15</td><td>0.25</td><td>0.71</td><td>0.851</td><td>0.899</td><td>1.000</td><td>2149</td><td>tags=20%, list=20%, signal=25%</td></tr><tr><td class='lessen'>1266</td><td>ODONNELL_METASTASIS_UP</td><td></td><td>56</td><td>0.20</td><td>0.71</td><td>0.873</td><td>0.901</td><td>1.000</td><td>1789</td><td>tags=21%, list=16%, signal=26%</td></tr><tr><td class='lessen'>1267</td><td>CROMER_METASTASIS_DN</td><td></td><td>39</td><td>0.23</td><td>0.71</td><td>0.837</td><td>0.903</td><td>1.000</td><td>2811</td><td>tags=36%, list=26%, signal=48%</td></tr><tr><td class='lessen'>1268</td><td>BROWNE_HCMV_INFECTION_1HR_UP</td><td></td><td>43</td><td>0.23</td><td>0.71</td><td>0.820</td><td>0.904</td><td>1.000</td><td>1313</td><td>tags=16%, list=12%, signal=18%</td></tr><tr><td class='lessen'>1269</td><td>SU_LIVER</td><td></td><td>42</td><td>0.24</td><td>0.71</td><td>0.796</td><td>0.904</td><td>1.000</td><td>2412</td><td>tags=26%, list=22%, signal=34%</td></tr><tr><td class='lessen'>1270</td><td>DARWICHE_PAPILLOMA_PROGRESSION_RISK</td><td></td><td>33</td><td>0.20</td><td>0.70</td><td>0.882</td><td>0.913</td><td>1.000</td><td>2392</td><td>tags=27%, list=22%, signal=35%</td></tr><tr><td class='lessen'>1271</td><td>JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN</td><td></td><td>31</td><td>0.20</td><td>0.70</td><td>0.886</td><td>0.914</td><td>1.000</td><td>3492</td><td>tags=45%, list=32%, signal=66%</td></tr><tr><td class='lessen'>1272</td><td>BROWNE_HCMV_INFECTION_18HR_DN</td><td></td><td>98</td><td>0.18</td><td>0.70</td><td>0.978</td><td>0.914</td><td>1.000</td><td>2731</td><td>tags=27%, list=25%, signal=35%</td></tr><tr><td class='lessen'>1273</td><td>DAIRKEE_TERT_TARGETS_UP</td><td></td><td>186</td><td>0.17</td><td>0.70</td><td>0.891</td><td>0.913</td><td>1.000</td><td>2259</td><td>tags=23%, list=21%, signal=29%</td></tr><tr><td class='lessen'>1274</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP</td><td></td><td>15</td><td>0.28</td><td>0.69</td><td>0.766</td><td>0.915</td><td>1.000</td><td>2869</td><td>tags=53%, list=26%, signal=72%</td></tr><tr><td class='lessen'>1275</td><td>LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP</td><td></td><td>59</td><td>0.21</td><td>0.68</td><td>0.936</td><td>0.924</td><td>1.000</td><td>2085</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>1276</td><td>NOUZOVA_TRETINOIN_AND_H4_ACETYLATION</td><td></td><td>67</td><td>0.17</td><td>0.68</td><td>0.915</td><td>0.928</td><td>1.000</td><td>2769</td><td>tags=30%, list=25%, signal=40%</td></tr><tr><td class='lessen'>1277</td><td>MEISSNER_BRAIN_HCP_WITH_H3K27ME3</td><td></td><td>139</td><td>0.20</td><td>0.68</td><td>0.815</td><td>0.928</td><td>1.000</td><td>2194</td><td>tags=22%, list=20%, signal=27%</td></tr><tr><td class='lessen'>1278</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP</td><td></td><td>33</td><td>0.20</td><td>0.68</td><td>0.943</td><td>0.927</td><td>1.000</td><td>2932</td><td>tags=36%, list=27%, signal=50%</td></tr><tr><td class='lessen'>1279</td><td>CLIMENT_BREAST_CANCER_COPY_NUMBER_UP</td><td></td><td>15</td><td>0.27</td><td>0.68</td><td>0.872</td><td>0.928</td><td>1.000</td><td>1222</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>1280</td><td>MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>67</td><td>0.19</td><td>0.67</td><td>0.940</td><td>0.930</td><td>1.000</td><td>1086</td><td>tags=12%, list=10%, signal=13%</td></tr><tr><td class='lessen'>1281</td><td>NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON</td><td></td><td>59</td><td>0.19</td><td>0.67</td><td>0.865</td><td>0.933</td><td>1.000</td><td>715</td><td>tags=10%, list=7%, signal=11%</td></tr><tr><td class='lessen'>1282</td><td>MIKKELSEN_MCV6_HCP_WITH_H3K27ME3</td><td></td><td>212</td><td>0.19</td><td>0.66</td><td>0.868</td><td>0.935</td><td>1.000</td><td>3377</td><td>tags=31%, list=31%, signal=44%</td></tr><tr><td class='lessen'>1283</td><td>DAZARD_UV_RESPONSE_CLUSTER_G1</td><td></td><td>38</td><td>0.20</td><td>0.66</td><td>0.917</td><td>0.938</td><td>1.000</td><td>2554</td><td>tags=24%, list=23%, signal=31%</td></tr><tr><td class='lessen'>1284</td><td>GALLUZZI_PERMEABILIZE_MITOCHONDRIA</td><td></td><td>26</td><td>0.21</td><td>0.65</td><td>0.950</td><td>0.943</td><td>1.000</td><td>2113</td><td>tags=23%, list=19%, signal=29%</td></tr><tr><td class='lessen'>1285</td><td>GU_PDEF_TARGETS_DN</td><td></td><td>15</td><td>0.22</td><td>0.65</td><td>0.875</td><td>0.942</td><td>1.000</td><td>2213</td><td>tags=27%, list=20%, signal=33%</td></tr><tr><td class='lessen'>1286</td><td>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP</td><td></td><td>53</td><td>0.17</td><td>0.65</td><td>0.936</td><td>0.942</td><td>1.000</td><td>1521</td><td>tags=15%, list=14%, signal=17%</td></tr><tr><td class='lessen'>1287</td><td>SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN</td><td></td><td>31</td><td>0.20</td><td>0.65</td><td>0.932</td><td>0.943</td><td>1.000</td><td>1563</td><td>tags=16%, list=14%, signal=19%</td></tr><tr><td class='lessen'>1288</td><td>MOOTHA_GLUCONEOGENESIS</td><td></td><td>22</td><td>0.22</td><td>0.65</td><td>0.837</td><td>0.944</td><td>1.000</td><td>713</td><td>tags=9%, list=7%, signal=10%</td></tr><tr><td class='lessen'>1289</td><td>MIKKELSEN_MEF_LCP_WITH_H3K27ME3</td><td></td><td>26</td><td>0.22</td><td>0.65</td><td>0.923</td><td>0.945</td><td>1.000</td><td>3623</td><td>tags=46%, list=33%, signal=69%</td></tr><tr><td class='lessen'>1290</td><td>YANG_MUC2_TARGETS_DUODENUM_3MO_DN</td><td></td><td>15</td><td>0.24</td><td>0.64</td><td>0.918</td><td>0.949</td><td>1.000</td><td>3227</td><td>tags=33%, list=30%, signal=47%</td></tr><tr><td class='lessen'>1291</td><td>TIEN_INTESTINE_PROBIOTICS_6HR_UP</td><td></td><td>31</td><td>0.19</td><td>0.64</td><td>0.933</td><td>0.949</td><td>1.000</td><td>2576</td><td>tags=29%, list=24%, signal=38%</td></tr><tr><td class='lessen'>1292</td><td>MADAN_DPPA4_TARGETS</td><td></td><td>23</td><td>0.20</td><td>0.64</td><td>0.950</td><td>0.949</td><td>1.000</td><td>460</td><td>tags=9%, list=4%, signal=9%</td></tr><tr><td class='lessen'>1293</td><td>CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN</td><td></td><td>104</td><td>0.17</td><td>0.64</td><td>0.935</td><td>0.950</td><td>1.000</td><td>2435</td><td>tags=22%, list=22%, signal=28%</td></tr><tr><td class='lessen'>1294</td><td>ZWANG_EGF_PERSISTENTLY_UP</td><td></td><td>16</td><td>0.22</td><td>0.63</td><td>0.922</td><td>0.956</td><td>1.000</td><td>2488</td><td>tags=31%, list=23%, signal=40%</td></tr><tr><td class='lessen'>1295</td><td>ROPERO_HDAC2_TARGETS</td><td></td><td>62</td><td>0.16</td><td>0.61</td><td>1.000</td><td>0.964</td><td>1.000</td><td>1935</td><td>tags=18%, list=18%, signal=21%</td></tr><tr><td class='lessen'>1296</td><td>SERVITJA_ISLET_HNF1A_TARGETS_DN</td><td></td><td>60</td><td>0.18</td><td>0.61</td><td>0.957</td><td>0.963</td><td>1.000</td><td>3630</td><td>tags=35%, list=33%, signal=52%</td></tr><tr><td class='lessen'>1297</td><td>BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP</td><td></td><td>23</td><td>0.22</td><td>0.60</td><td>0.935</td><td>0.966</td><td>1.000</td><td>1018</td><td>tags=13%, list=9%, signal=14%</td></tr><tr><td class='lessen'>1298</td><td>HUNSBERGER_EXERCISE_REGULATED_GENES</td><td></td><td>17</td><td>0.21</td><td>0.60</td><td>0.947</td><td>0.966</td><td>1.000</td><td>2146</td><td>tags=24%, list=20%, signal=29%</td></tr><tr><td class='lessen'>1299</td><td>XU_CREBBP_TARGETS_DN</td><td></td><td>27</td><td>0.20</td><td>0.60</td><td>0.925</td><td>0.968</td><td>1.000</td><td>1605</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>1300</td><td>ABE_VEGFA_TARGETS_30MIN</td><td></td><td>16</td><td>0.23</td><td>0.60</td><td>0.886</td><td>0.968</td><td>1.000</td><td>1217</td><td>tags=19%, list=11%, signal=21%</td></tr><tr><td class='lessen'>1301</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN</td><td></td><td>15</td><td>0.23</td><td>0.59</td><td>0.960</td><td>0.970</td><td>1.000</td><td>1621</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>1302</td><td>DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS</td><td></td><td>18</td><td>0.23</td><td>0.59</td><td>0.837</td><td>0.971</td><td>1.000</td><td>1568</td><td>tags=22%, list=14%, signal=26%</td></tr><tr><td class='lessen'>1303</td><td>MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>91</td><td>0.15</td><td>0.56</td><td>1.000</td><td>0.981</td><td>1.000</td><td>3311</td><td>tags=27%, list=30%, signal=39%</td></tr><tr><td class='lessen'>1304</td><td>GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP</td><td></td><td>15</td><td>0.24</td><td>0.55</td><td>0.872</td><td>0.983</td><td>1.000</td><td>1754</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1305</td><td>MIKKELSEN_NPC_HCP_WITH_H3K27ME3</td><td></td><td>188</td><td>0.14</td><td>0.54</td><td>1.000</td><td>0.985</td><td>1.000</td><td>2240</td><td>tags=18%, list=21%, signal=22%</td></tr><tr><td class='lessen'>1306</td><td>WOTTON_RUNX_TARGETS_DN</td><td></td><td>15</td><td>0.20</td><td>0.54</td><td>0.983</td><td>0.984</td><td>1.000</td><td>1452</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>1307</td><td>MIKKELSEN_MEF_HCP_WITH_H3K27ME3</td><td></td><td>287</td><td>0.15</td><td>0.54</td><td>0.964</td><td>0.985</td><td>1.000</td><td>3215</td><td>tags=26%, list=30%, signal=36%</td></tr><tr><td class='lessen'>1308</td><td>MIKKELSEN_ES_HCP_WITH_H3K27ME3</td><td></td><td>22</td><td>0.17</td><td>0.50</td><td>0.980</td><td>0.992</td><td>1.000</td><td>3198</td><td>tags=36%, list=29%, signal=51%</td></tr><tr><td class='lessen'>1309</td><td>NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON</td><td></td><td>18</td><td>0.16</td><td>0.50</td><td>0.980</td><td>0.991</td><td>1.000</td><td>3037</td><td>tags=28%, list=28%, signal=38%</td></tr><tr><td class='lessen'>1310</td><td>SHEN_SMARCA2_TARGETS_DN</td><td></td><td>218</td><td>0.15</td><td>0.49</td><td>0.963</td><td>0.992</td><td>1.000</td><td>3239</td><td>tags=26%, list=30%, signal=36%</td></tr><tr><td class='lessen'>1311</td><td>HUPER_BREAST_BASAL_VS_LUMINAL_UP</td><td></td><td>33</td><td>0.14</td><td>0.48</td><td>1.000</td><td>0.993</td><td>1.000</td><td>1178</td><td>tags=9%, list=11%, signal=10%</td></tr><tr><td class='lessen'>1312</td><td>MIKKELSEN_ES_ICP_WITH_H3K27ME3</td><td></td><td>19</td><td>0.17</td><td>0.48</td><td>0.981</td><td>0.993</td><td>1.000</td><td>2806</td><td>tags=26%, list=26%, signal=35%</td></tr><tr><td class='lessen'>1313</td><td>ONDER_CDH1_TARGETS_3_DN</td><td></td><td>32</td><td>0.18</td><td>0.47</td><td>0.962</td><td>0.993</td><td>1.000</td><td>1403</td><td>tags=16%, list=13%, signal=18%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>IUP (13 samples)<b>&nbsp<a href='gsea_report_for_IUP_1489395374806.xls'>[plain text format]</a></caption></table></div><br></body></html>